2019 CHINA CPHI E2A62
2019 WORLD CPHI 101C45
FDA New, GMP Do
Clinical Phase II, III Intermediates
GMP Custom synthesis, Full Document
R&D Center: 8000 sq, More than 100 hoods
Pilot Plant: 20000sq, 40 reactors from 5-200L
Manufacturing Site: 800000sq, 40 reactors from 100-5000L
Web:
www.eosmedchem.comEmail: info@eosmedchem.com ; eosmedchem@gmail.com
| Drug_Names: 2,2-Dimethylcyclohexane-1,3-dione, CAS: 562-13-0, stock 810.8g, assay 98.7%, MWt 140.18, Formula C8H12O2, Purity >98%, SMILES CC1(C)C(=O)CCCC1=O, MDL NA |
| Drug_Names: 2,2-Dimethyl-3-oxocyclobutane-1-carboxylic acid, CAS: 3183-43-5, stock 371.2g, assay 98.1%, MWt 142.15, Formula C7H10O3, Purity >98%, SMILES CC1(C)C(CC1=O)C(O)=O, MDL NA |
| Drug_Names: 2,2-Difluoro-7-azaspiro[3.5]nonane hydrochloride, CAS: 1523618-02-1, stock 846.9g, assay 98.3%, MWt 197.65, Formula C8H14ClF2N, Purity >98%, SMILES Cl.FC1(F)CC2(C1)CCNCC2, MDL NA |
| Drug_Names: 2,2-Difluorobenzo[d][1,3]dioxole-4-carbaldehyde, CAS: 119895-68-0, stock 31.3g, assay 98.2%, MWt 186.11, Formula C8H4F2O3, Purity >98%, SMILES O=CC1=C2OC(F)(F)OC2=CC=C1, MDL MFCD00792419 |
| Drug_Names: 2,2-Difluoro-2-(pyridin-2-yl)acetic acid, CAS: 1039621-73-2, stock 551.1g, assay 98.3%, MWt 173.12, Formula C7H5F2NO2, Purity >98%, SMILES OC(=O)C(F)(F)C1=NC=CC=C1, MDL NA |
| Drug_Names: 2,2,6,6-Tetramethyltetrahydro-2H-pyran-4-ol, CAS: 20931-50-4, stock 293g, assay 98.8%, MWt 158.24, Formula C9H18O2, Purity >98%, SMILES CC1(C)CC(O)CC(C)(C)O1, MDL NA |
| Drug_Names: 2,2,4,4-Tetramethylcyclopentanamine hydrochloride, CAS: 1523618-17-8, stock 20.4g, assay 98.1%, MWt 177.71, Formula C9H20ClN, Purity >98%, SMILES Cl.CC1(C)CC(N)C(C)(C)C1, MDL NA |
| Drug_Names: 2,2,2-Trifluoro-1-(pyridin-2-yl)ethanamine hydrochloride, CAS: 1187929-38-9, stock 285.8g, assay 98.9%, MWt 212.60, Formula C7H8ClF3N2, Purity >98%, SMILES Cl.NC(C1=NC=CC=C1)C(F)(F)F, MDL NA |
| Drug_Names: tert-Butyl 3-oxo-2,7-diazaspiro[4.5]decane-7-carboxylate, CAS: 1158750-91-4, stock 459.9g, assay 98.7%, MWt 254.33, Formula C13H22N2O3, Purity >98%, SMILES CC(C)(C)OC(=O)N1CCCC2(CNC(=O)C2)C1, MDL NA |
| Drug_Names: Benzyl 2,7-diazaspiro[3.5]nonane-2-carboxylate hydrochloride, CAS: 1227381-91-0, stock 86.9g, assay 98.9%, MWt 296.79, Formula C15H21ClN2O2, Purity >98%, SMILES Cl.O=C(OCC1=CC=CC=C1)N1CC2(C1)CCNCC2, MDL NA |
| Drug_Names: 2,4-Dichloro-5H-pyrrolo[3,2-d]pyrimidine-6-carboxylic acid, CAS: 1781241-35-7, stock 744g, assay 98.8%, MWt 232.02, Formula C7H3Cl2N3O2, Purity >98%, SMILES O=C(C1=CC2=NC(Cl)=NC(Cl)=C2N1)O, MDL NA |
| Drug_Names: 2-(Trifluoromethyl)piperidine-4-carboxylic acid hydrochloride, CAS: 2007919-93-7, stock 566g, assay 98.8%, MWt 233.62, Formula C7H11ClF3NO2, Purity >98%, SMILES Cl.OC(=O)C1CCNC(C1)C(F)(F)F, MDL NA |
| Drug_Names: 2-(Trifluoromethyl)cyclopropane-1-carboxylic acid, CAS: 22581-33-5, stock 541.2g, assay 98.1%, MWt 154.09, Formula C5H5F3O2, Purity >98%, SMILES OC(=O)C1CC1C(F)(F)F, MDL NA |
| Drug_Names: 2-(Trifluoromethyl)cyclopropan-1-amine hydrochloride, CAS: 1172072-62-6, stock 844.3g, assay 98.5%, MWt 161.55, Formula C4H7ClF3N, Purity >98%, SMILES Cl.NC1CC1C(F)(F)F, MDL NA |
| Drug_Names: 2-(Trifluoromethyl)-1H-imidazole, CAS: 66675-22-7, stock 125.5g, assay 98.1%, MWt 136.08, Formula C4H3F3N2, Purity >98%, SMILES FC(F)(F)C1=NC=CN1, MDL NA |
| Drug_Names: 2-(Pyrrolidin-3-yl)ethanol hydrochloride, CAS: 664364-46-9, stock 48.5g, assay 98.7%, MWt 151.63, Formula C6H14ClNO, Purity >98%, SMILES Cl.OCCC1CCNC1, MDL NA |
| Drug_Names: 2-(Pyrrolidin-3-yl)acetic acid, CAS: 89203-64-5, stock 436.6g, assay 98.2%, MWt 129.16, Formula C6H11NO2, Purity >98%, SMILES OC(=O)CC1CCNC1, MDL NA |
| Drug_Names: 2-(Pyrimidin-5-yl)acetonitrile, CAS: 1000564-45-3, stock 493g, assay 98.5%, MWt 119.12, Formula C6H5N3, Purity >98%, SMILES N#CCC1=CN=CN=C1, MDL NA |
| Drug_Names: 2-(Pyrimidin-4-yl)acetonitrile, CAS: 794522-90-0, stock 423.6g, assay 98.9%, MWt 119.12, Formula C6H5N3, Purity >98%, SMILES N#CCC1=CC=NC=N1, MDL NA |
| Drug_Names: 2-(Pyrimidin-2-yl)acetonitrile, CAS: 59566-45-9, stock 9.8g, assay 98.6%, MWt 119.12, Formula C6H5N3, Purity >98%, SMILES N#CCC1=NC=CC=N1, MDL NA |
| Drug_Names: 2-(Pyridazin-4-yl)acetonitrile, CAS: 1142927-95-4, stock 796.5g, assay 98.8%, MWt 119.12, Formula C6H5N3, Purity >98%, SMILES N#CCC1=CC=NN=C1, MDL NA |
| Drug_Names: 2-(Pyridazin-3-yl)acetonitrile, CAS: 27349-80-0, stock 569.3g, assay 98.2%, MWt 119.12, Formula C6H5N3, Purity >98%, SMILES N#CCC1=NN=CC=C1, MDL NA |
| Drug_Names: 2-(Pyridazin-3-yl)acetic acid lithium salt, CAS: 1845687-62-8, stock 519g, assay 98.7%, MWt 144.06, Formula C6H5LiN2O2, Purity >98%, SMILES O=C([O-])CC1=NN=CC=C1.[Li+], MDL NA |
| Drug_Names: 2-(Piperazin-1-yl)propan-1-ol, CAS: 71850-04-9, stock 722.9g, assay 98.1%, MWt 144.21, Formula C7H16N2O, Purity >98%, SMILES CC(CO)N1CCNCC1, MDL NA |
| Drug_Names: 2-(Oxetan-3-yloxy)pyrimidin-5-amine, CAS: 1349709-06-3, stock 136.4g, assay 98.2%, MWt 167.17, Formula C7H9N3O2, Purity >98%, SMILES NC1=CN=C(OC2COC2)N=C1, MDL NA |
| Drug_Names: 2-(Oxetan-3-yl)ethanol, CAS: 251922-46-0, stock 356.4g, assay 98.9%, MWt 102.13, Formula C5H10O2, Purity >98%, SMILES OCCC1COC1, MDL NA |
| Drug_Names: 2-(Oxetan-2-yl)propan-1-ol, CAS: 1438898-86-2, stock 667g, assay 98.1%, MWt 116.16, Formula C6H12O2, Purity >98%, SMILES CC(CO)C1CCO1, MDL NA |
| Drug_Names: 2-(Oxetan-2-yl)ethan-1-ol, CAS: 362604-33-9, stock 389.5g, assay 98.3%, MWt 102.13, Formula C5H10O2, Purity >98%, SMILES OCCC1CCO1, MDL NA |
| Drug_Names: 2-(Oxetan-2-yl)ethan-1-amine, CAS: 1536914-60-9, stock 429.5g, assay 98.5%, MWt 101.15, Formula C5H11NO, Purity >98%, SMILES NCCC1CCO1, MDL NA |
| Drug_Names: 2-(Methylsulfonyl)-5-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)pyridine, CAS: 1052138-94-9, stock 179.1g, assay 98.9%, MWt 283.15, Formula C12H18BNO4S, Purity >98%, SMILES CC1(C)OB(OC1(C)C)C1=CN=C(C=C1)S(C)(=O)=O, MDL NA |
| Drug_Names: 2-(Methylthio)pyrrolo[2,1-f][1,2,4]triazin-4(3H)-one, CAS: 1232815-50-7, stock 289.1g, assay 98.4%, MWt 181.21, Formula C7H7N3OS, Purity >98%, SMILES CSC1=NN2C=CC=C2C(=O)N1, MDL NA |
| Drug_Names: (S)-2-(Methoxymethyl)azetidine oxalate(2:1), CAS: 1523530-72-4, stock 81g, assay 99%, MWt 292.33, Formula C12H24N2O6, Purity >98%, SMILES COC[C@H]1NCC1.COC[C@H]2NCC2.O=C(O)C(O)=O, MDL NA |
| Drug_Names: 2-(Methoxymethyl)azetidine, CAS: 1290136-94-5, stock 402.5g, assay 98.4%, MWt 101.15, Formula C5H11NO, Purity >98%, SMILES COCC1CCN1, MDL NA |
| Drug_Names: 2-(Iodomethyl)oxetane, CAS: 121138-00-9, stock 485.3g, assay 98.8%, MWt 198.00, Formula C4H7IO, Purity >98%, SMILES ICC1CCO1, MDL NA |
| Drug_Names: 2-(Hydrazinylmethyl)pyridine dihydrochloride, CAS: 89729-00-0, stock 880.6g, assay 98.6%, MWt 196.08, Formula C6H11Cl2N3, Purity >98%, SMILES Cl.Cl.NNCC1=NC=CC=C1, MDL NA |
| Drug_Names: 2-(Hexahydro-1H-pyrrolizin-7a-yl)ethanamine dihydrochloride, CAS: 78449-85-1, stock 492.2g, assay 98.1%, MWt 227.17, Formula C9H20Cl2N2, Purity >98%, SMILES Cl.Cl.NCCC12CCCN1CCC2, MDL NA |
| Drug_Names: 2-Benzhydryl-2-azaspiro[3.3]heptan-5-one, CAS: 1263296-80-5, stock 518.1g, assay 98.7%, MWt 277.36, Formula C19H19NO, Purity >98%, SMILES O=C1CCC11CN(C1)C(C1=CC=CC=C1)C1=CC=CC=C1, MDL NA |
| Drug_Names: 2-(Diphenylmethyl)-2-azaspiro[3.3]heptan-5-ol, CAS: 1263296-81-6, stock 696.5g, assay 98.2%, MWt 279.38, Formula C19H21NO, Purity >98%, SMILES OC1CCC11CN(C1)C(C1=CC=CC=C1)C1=CC=CC=C1, MDL NA |
| Drug_Names: 2-(Diphenylmethyl)-2-azaspiro[3.3]heptan-5-amine, CAS: 1263296-82-7, stock 565g, assay 98.1%, MWt 278.39, Formula C19H22N2, Purity >98%, SMILES NC1CCC11CN(C1)C(C1=CC=CC=C1)C1=CC=CC=C1, MDL NA |
| Drug_Names: 2-(Diphenylmethyl)-2,6-diazaspiro[3.4]octane, CAS: 1250443-61-8, stock 428.4g, assay 98.8%, MWt 278.39, Formula C19H22N2, Purity >98%, SMILES C1N(CC11CCNC1)C(C1=CC=CC=C1)C1=CC=CC=C1, MDL NA |
| Drug_Names: 2-(2,4-Dimethylthiazol-5-yl)acetic acid, CAS: 34272-65-6, stock 778.7g, assay 98.3%, MWt 171.22, Formula C7H9NO2S, Purity >98%, SMILES CC1=NC(C)=C(CC(O)=O)S1, MDL NA |
| Drug_Names: 2-(Difluoromethyl)-1H-pyrrolo[2,3-b]pyridine, CAS: 1261844-48-7, stock 259.3g, assay 98.1%, MWt 168.14, Formula C8H6F2N2, Purity >98%, SMILES FC(F)C1=CC2=CC=CN=C2N1, MDL NA |
| Drug_Names: 2-(Chloromethyl)-6-(difluoromethyl)pyridine, CAS: 1211525-99-3, stock 213.4g, assay 99%, MWt 177.58, Formula C7H6ClF2N, Purity >98%, SMILES FC(F)C1=CC=CC(CCl)=N1, MDL NA |
| Drug_Names: 2-(Chloromethyl)-5-methylpyrazine, CAS: 81831-68-7, stock 817g, assay 98.5%, MWt 142.59, Formula C6H7ClN2, Purity >98%, SMILES CC1=NC=C(CCl)N=C1, MDL NA |
| Drug_Names: 2-(Chloromethyl)-5-methoxypyridine hydrochloride, CAS: 82401-91-0, stock 590.1g, assay 98.6%, MWt 194.06, Formula C7H9Cl2NO, Purity >98%, SMILES COC1=CN=C(CCl)C=C1.[H]Cl, MDL MFCD11109567 |
| Drug_Names: 2-(Chloromethyl)-5-fluoropyrimidine hydrochloride, CAS: 2052356-33-7, stock 29.5g, assay 98.4%, MWt 183.01, Formula C5H5Cl2FN2, Purity >98%, SMILES Cl.FC1=CN=C(CCl)N=C1, MDL NA |
| Drug_Names: 2-(Chloromethyl)-3-methylpyrazine hydrochloride, CAS: 1609400-79-4, stock 283.3g, assay 98.6%, MWt 179.05, Formula C6H8Cl2N2, Purity >98%, SMILES Cl.CC1=C(CCl)N=CC=N1, MDL NA |
| Drug_Names: 2-(Carboxymethyl)-1-methyl-1H-pyrrole-3-carboxylic acid, CAS: 83863-74-5, stock 361.6g, assay 98.7%, MWt 183.16, Formula C8H9NO4, Purity >98%, SMILES CN1C=CC(C(O)=O)=C1CC(O)=O, MDL NA |
| Drug_Names: 2-(Bromomethyl)tetrahydrofuran, CAS: 1192-30-9, stock 829.7g, assay 98.6%, MWt 165.03, Formula C5H9BrO, Purity >98%, SMILES BrCC1CCCO1, MDL NA |
| Drug_Names: 2-(Bromomethyl)-5,8-dioxaspiro[3.4]octane, CAS: 1057641-71-0, stock 596.5g, assay 98.3%, MWt 207.07, Formula C7H11BrO2, Purity >98%, SMILES BrCC1CC2(C1)OCCO2, MDL NA |
| Drug_Names: 2-(Benzyloxy)cyclobutanone, CAS: 206751-75-9, stock 660.5g, assay 98.8%, MWt 176.21, Formula C11H12O2, Purity >98%, SMILES O=C1CCC1OCC1=CC=CC=C1, MDL NA |
| Drug_Names: 2-(Benzylamino)-2-(tetrahydro-2H-pyran-4-yl)acetonitrile, CAS: 1274825-09-0, stock 95g, assay 98.5%, MWt 230.31, Formula C14H18N2O, Purity >98%, SMILES N#CC(NCC1=CC=CC=C1)C1CCOCC1, MDL NA |
| Drug_Names: 2-(Azetidin-3-yl)propan-2-ol hydrochloride, CAS: 1357923-33-1, stock 619g, assay 98.1%, MWt 151.63, Formula C6H14ClNO, Purity >98%, SMILES Cl.CC(C)(O)C1CNC1, MDL NA |
| Drug_Names: 2-(Azetidin-3-yl)ethan-1-ol hydrochloride, CAS: 152537-02-5, stock 528.1g, assay 98.1%, MWt 137.61, Formula C5H12ClNO, Purity >98%, SMILES Cl.OCCC1CNC1, MDL NA |
| Drug_Names: 2-(Azetidin-3-yl)acetonitrile hydrochloride, CAS: 1423057-36-6, stock 848.9g, assay 98.8%, MWt 132.59, Formula C5H9ClN2, Purity >98%, SMILES Cl.N#CCC1CNC1, MDL NA |
| Drug_Names: 2-(Azetidin-2-yl)propan-2-ol hydrochloride, CAS: 1824166-46-2, stock 460.2g, assay 99%, MWt 151.63, Formula C6H14ClNO, Purity >98%, SMILES Cl.CC(C)(O)C1CCN1, MDL NA |
| Drug_Names: 2-(6-Fluoropyridin-2-yl)acetic acid, CAS: 1000517-25-8, stock 771.2g, assay 98.5%, MWt 155.13, Formula C7H6FNO2, Purity >98%, SMILES OC(=O)CC1=NC(F)=CC=C1, MDL NA |
| Drug_Names: 6-Fluoroindole-3-acetonitrile, CAS: 2341-25-5, stock 311g, assay 98.2%, MWt 174.17, Formula C10H7FN2, Purity >98%, SMILES FC1=CC2=C(C=C1)C(CC#N)=CN2, MDL NA |
| Drug_Names: 2-(6-Bromopyridin-3-yl)pyrimidine, CAS: 942189-65-3, stock 888.3g, assay 98.1%, MWt 236.07, Formula C9H6BrN3, Purity >98%, SMILES BrC1=CC=C(C=N1)C1=NC=CC=N1, MDL NA |
| Drug_Names: 2-(5-Methylpyridin-3-yl)acetic acid, CAS: 1000518-77-3, stock 592.9g, assay 98.8%, MWt 151.16, Formula C8H9NO2, Purity >98%, SMILES CC1=CC(CC(O)=O)=CN=C1, MDL NA |
| Drug_Names: 2-(5-Methyl-6-oxo-1,6-dihydropyridazin-3-yl)acetic acid, CAS: 1922898-82-5, stock 199.6g, assay 98.4%, MWt 168.15, Formula C7H8N2O3, Purity >98%, SMILES CC1=CC(CC(O)=O)=NNC1=O, MDL NA |
| Drug_Names: 2-(5-Methoxy-2-methyl-1H-inden-3-yl)acetic acid, CAS: 33413-42-2, stock 36.6g, assay 98.9%, MWt 218.25, Formula C13H14O3, Purity >98%, SMILES COC1=CC2=C(CC(C)=C2CC(O)=O)C=C1, MDL NA |
| Drug_Names: 2-(5-Fluoropyridin-3-yl)acetonitrile, CAS: 39891-06-0, stock 536.9g, assay 98%, MWt 136.13, Formula C7H5FN2, Purity >98%, SMILES FC1=CN=CC(CC#N)=C1, MDL NA |
| Drug_Names: 2-(5-Fluoropyridin-3-yl)acetic acid, CAS: 38129-24-7, stock 461.7g, assay 98.4%, MWt 155.13, Formula C7H6FNO2, Purity >98%, SMILES OC(=O)CC1=CC(F)=CN=C1, MDL NA |
| Drug_Names: 2-(5-Fluoro-1H-indol-3-yl)ethan-1-ol, CAS: 101349-12-6, stock 590.2g, assay 98.7%, MWt 179.19, Formula C10H10FNO, Purity >98%, SMILES OCCC1=CNC2=C1C=C(F)C=C2, MDL MFCD09752697 |
| Drug_Names: 2-(5-Bromopyridin-3-yl)acetonitrile, CAS: 39891-08-2, stock 481.5g, assay 99%, MWt 197.03, Formula C7H5BrN2, Purity >98%, SMILES BrC1=CN=CC(CC#N)=C1, MDL NA |
| Drug_Names: 2-(5-Bromopyridin-2-yl)ethanol, CAS: 1206968-77-5, stock 257.3g, assay 98.8%, MWt 202.05, Formula C7H8BrNO, Purity >98%, SMILES OCCC1=CC=C(Br)C=N1, MDL NA |
| Drug_Names: 2-(5-Bromopyridin-2-yl)ethanamine, CAS: 691872-17-0, stock 64.6g, assay 98.9%, MWt 201.06, Formula C7H9BrN2, Purity >98%, SMILES NCCC1=CC=C(Br)C=N1, MDL NA |
| Drug_Names: 2-(5-Bromo-6-chloropyridin-3-yl)ethan-1-ol, CAS: 2007919-90-4, stock 505.5g, assay 98%, MWt 236.49, Formula C7H7BrClNO, Purity >98%, SMILES OCCC1=CC(Br)=C(Cl)N=C1, MDL NA |
| Drug_Names: 2-(5,6-Dihydro-2H-pyran-3-yl)-4,4,5,5-tetramethyl-1,3,2-dioxaborolane, CAS: 212127-81-6, stock 458.6g, assay 98.1%, MWt 210.08, Formula C11H19BO3, Purity >98%, SMILES CC1(C)OB(OC1(C)C)C1=CCCOC1, MDL NA |
| Drug_Names: 2-(4-Nitro-1H-pyrazol-3-yl)pyridine, CAS: 192711-20-9, stock 403.3g, assay 98.5%, MWt 190.16, Formula C8H6N4O2, Purity >98%, SMILES O=[N+](C1=CNN=C1C2=NC=CC=C2)[O-], MDL NA |
| Drug_Names: 2-(4-Methoxyphenyl)pyrrolidine hydrochloride, CAS: 1049740-97-7, stock 252.9g, assay 99%, MWt 213.70, Formula C11H16ClNO, Purity >98%, SMILES Cl.COC1=CC=C(C=C1)C1CCCN1, MDL NA |
| Drug_Names: 2-(4-Methoxyphenyl)-1-{[5-(2-nitrophenyl)furan-2-yl]methyl}pyrrolidine, CAS: 1019158-02-1, stock 42.1g, assay 98.2%, MWt 378.42, Formula C22H22N2O4, Purity >98%, SMILES COC1=CC=C(C=C1)C1CCCN1CC1=CC=C(O1)C1=CC=CC=C1[N+]([O-])=O, MDL NA |
| Drug_Names: 2-(4-Methoxycyclohex-1-en-1-yl)-4,4,5,5-tetramethyl-1,3,2-dioxaborolane, CAS: 1092938-92-5, stock 445.4g, assay 98.9%, MWt 238.13, Formula C13H23BO3, Purity >98%, SMILES COC1CCC(=CC1)B1OC(C)(C)C(C)(C)O1, MDL NA |
| Drug_Names: 2-(4-Chlorophenoxy)acetonitrile, CAS: 3598-13-8, stock 390g, assay 98.1%, MWt 167.59, Formula C8H6ClNO, Purity >98%, SMILES ClC1=CC=C(OCC#N)C=C1, MDL NA |
| Drug_Names: 2-(4-Chloro-1,3-thiazol-2-yl)acetic acid, CAS: 1392804-23-7, stock 787.6g, assay 98.5%, MWt 177.61, Formula C5H4ClNO2S, Purity >98%, SMILES OC(=O)CC1=NC(Cl)=CS1, MDL NA |
| Drug_Names: 2-(4-Bromo-1-methyl-1H-pyrazol-3-yl)acetic acid, CAS: 1310379-41-9, stock 251.2g, assay 98.3%, MWt 219.04, Formula C6H7BrN2O2, Purity >98%, SMILES CN1C=C(Br)C(CC(O)=O)=N1, MDL NA |
| Drug_Names: 2-(4-Aminophenyl)-2-methylpropanoic acid, CAS: 36402-24-1, stock 603.6g, assay 98.2%, MWt 179.22, Formula C10H13NO2, Purity >98%, SMILES CC(C)(C(O)=O)C1=CC=C(N)C=C1, MDL NA |
| Drug_Names: 2-(4,4-Difluorocyclohex-1-en-1-yl)-4,4,5,5-tetramethyl-1,3,2-dioxaborolane, CAS: 1227068-84-9, stock 833.9g, assay 98.3%, MWt 244.09, Formula C12H19BF2O2, Purity >98%, SMILES CC1(C)OB(OC1(C)C)C1=CCC(F)(F)CC1, MDL NA |
| Drug_Names: 2-(3-Oxocyclobutyl)acetonitrile, CAS: 2007916-61-0, stock 857.3g, assay 98.2%, MWt 109.13, Formula C6H7NO, Purity >98%, SMILES O=C1CC(CC#N)C1, MDL NA |
| Drug_Names: 2-(3-Hydroxypyridin-2-yl)acetic acid, CAS: 69022-71-5, stock 372.3g, assay 98.1%, MWt 153.14, Formula C7H7NO3, Purity >98%, SMILES OC(=O)CC1=NC=CC=C1O, MDL NA |
| Drug_Names: 2-(3-Fluoropyridin-2-yl)ethan-1-ol, CAS: 1000549-37-0, stock 106.5g, assay 98.1%, MWt 141.14, Formula C7H8FNO, Purity >98%, SMILES OCCC1=NC=CC=C1F, MDL NA |
| Drug_Names: 2-(3-Chloropyrazin-2-yl)acetonitrile, CAS: 914360-88-6, stock 351.5g, assay 98.6%, MWt 153.57, Formula C6H4ClN3, Purity >98%, SMILES ClC1=NC=CN=C1CC#N, MDL NA |
| Drug_Names: 2-(3-Chloro-4-fluorophenyl)-4,4-dimethyl-1,2,3,4-tetrahydroquinoline-6-carboxylic acid, CAS: 1353971-43-3, stock 116.7g, assay 98.4%, MWt 333.78, Formula C18H17ClFNO2, Purity >98%, SMILES CC1(C)CC(NC2=C1C=C(C=C2)C(O)=O)C1=CC(Cl)=C(F)C=C1, MDL NA |
| Drug_Names: 2-(3-Bromopyridin-2-yl)ethanamine, CAS: 910386-57-1, stock 238.1g, assay 98.3%, MWt 201.06, Formula C7H9BrN2, Purity >98%, SMILES NCCC1=NC=CC=C1Br, MDL NA |
| Drug_Names: 2-(3-Bromopyridin-2-yl)acetic acid, CAS: 698970-84-2, stock 449.5g, assay 98.5%, MWt 216.03, Formula C7H6BrNO2, Purity >98%, SMILES OC(=O)CC1=NC=CC=C1Br, MDL NA |
| Drug_Names: 2-(3-Bromophenyl)-N-isopropyl-4,4-dimethyl-1,2,3,4-tetrahydroquinoline-6-sulfonamide, CAS: 1391609-03-2, stock 722.6g, assay 98.8%, MWt 437.39, Formula C20H25BrN2O2S, Purity >98%, SMILES CC(C)NS(=O)(=O)C1=CC2=C(NC(CC2(C)C)C2=CC(Br)=CC=C2)C=C1, MDL NA |
| Drug_Names: 2-(3-Aminooxetan-3-yl)ethanol oxalate(2:1), CAS: 1523618-22-5, stock 711.7g, assay 98.2%, MWt 324.33, Formula C12H24N2O8, Purity >98%, SMILES OC(C(O)=O)=O.NC1(COC1)CCO.NC2(COC2)CCO, MDL NA |
| Drug_Names: 2-(3-Aminocyclobutyl)acetic acid, CAS: 1408076-40-3, stock 883.8g, assay 98.5%, MWt 129.16, Formula C6H11NO2, Purity >98%, SMILES NC1CC(CC(O)=O)C1, MDL NA |
| Drug_Names: 2-(3-((tert-Butoxycarbonyl)amino)oxetan-3-yl)acetic acid, CAS: 1221715-78-1, stock 46.7g, assay 98.9%, MWt 231.25, Formula C10H17NO5, Purity >98%, SMILES CC(C)(C)OC(=O)NC1(CC(O)=O)COC1, MDL NA |
| Drug_Names: 2-(3,3-Dimethoxycyclobutyl)ethanol, CAS: 1788043-94-6, stock 749.7g, assay 98.6%, MWt 160.21, Formula C8H16O3, Purity >98%, SMILES COC1(CC(CCO)C1)OC, MDL NA |
| Drug_Names: 2-(3,3-Difluorocyclobutyl)ethan-1-ol, CAS: 1056467-54-9, stock 474.3g, assay 98.7%, MWt 136.14, Formula C6H10F2O, Purity >98%, SMILES OCCC1CC(F)(F)C1, MDL NA |
| Drug_Names: 2-(3,3-Difluorocyclobutyl)ethan-1-amine hydrochloride, CAS: 1427173-51-0, stock 223.8g, assay 98.7%, MWt 171.62, Formula C6H12ClF2N, Purity >98%, SMILES Cl.NCCC1CC(F)(F)C1, MDL NA |
| Drug_Names: 2-(3,3-Difluorocyclobutyl)acetonitrile, CAS: 1219019-02-9, stock 487.2g, assay 98.1%, MWt 131.12, Formula C6H7F2N, Purity >98%, SMILES FC1(F)CC(CC#N)C1, MDL NA |
| Drug_Names: 2-(3,3-Difluorocyclobutyl)acetic acid, CAS: 1373503-48-0, stock 757.5g, assay 98.7%, MWt 150.12, Formula C6H8F2O2, Purity >98%, SMILES OC(=O)CC1CC(F)(F)C1, MDL NA |
| Drug_Names: 2-(3,3-Difluorocyclobutyl)acetaldehyde, CAS: 1374657-08-5, stock 252.2g, assay 98.2%, MWt 134.12, Formula C6H8F2O, Purity >98%, SMILES O=CCC1CC(F)(F)C1, MDL NA |
| Drug_Names: 2-(3,3-Difluoroazetidin-1-yl)ethan-1-amine, CAS: 2045189-46-4, stock 124.6g, assay 98.6%, MWt 136.14, Formula C5H10F2N2, Purity >98%, SMILES NCCN1CC(F)(F)C1, MDL NA |
| Drug_Names: 2-(2-Hydroxyphenyl)-[1,2,4]triazolo[1,5-a]pyridine-8-carboxylic acid, CAS: 1368386-88-2, stock 622.3g, assay 99%, MWt 255.23, Formula C13H9N3O3, Purity >98%, SMILES OC(=O)C1=CC=CN2N=C(N=C12)C1=CC=CC=C1O, MDL NA |
| Drug_Names: 2-(2-Hydroxyethyl)isonicotinonitrile, CAS: 106474-82-2, stock 319.5g, assay 98.5%, MWt 148.16, Formula C8H8N2O, Purity >98%, SMILES OCCC1=NC=CC(=C1)C#N, MDL NA |
| Drug_Names: 2-(2-Hexyldecyl)thiophene, CAS: 1215857-68-3, stock 576.9g, assay 99%, MWt 308.56, Formula C20H36S, Purity >98%, SMILES CCCCCCCCC(CCCCCC)CC1=CC=CS1, MDL NA |
| Drug_Names: 2-(2H-1,2,3-Triazol-2-yl)benzoic acid, CAS: 1001401-62-2, stock 356.5g, assay 98.8%, MWt 189.17, Formula C9H7N3O2, Purity >98%, SMILES OC(=O)C1=CC=CC=C1N1N=CC=N1, MDL NA |
| Drug_Names: 2-(2-Chlorophenyl)cyclopropanecarboxylic acid, CAS: 1181230-38-5, stock 719.6g, assay 98.2%, MWt 196.63, Formula C10H9ClO2, Purity >98%, SMILES OC(=O)C1CC1C1=C(Cl)C=CC=C1, MDL NA |
| Drug_Names: 2-(2-Chlorophenyl)cyclopentan-1-one, CAS: 1242029-81-7, stock 721.3g, assay 98.1%, MWt 194.66, Formula C11H11ClO, Purity >98%, SMILES ClC1=CC=CC=C1C1CCCC1=O, MDL NA |
| Drug_Names: 2-(2,5-Dihydrofuran-3-yl)-4,4,5,5-tetramethyl-1,3,2-dioxaborolane, CAS: 212127-80-5, stock 1.4g, assay 98.7%, MWt 196.05, Formula C10H17BO3, Purity >98%, SMILES CC1(C)OB(OC1(C)C)C1=CCOC1, MDL NA |
| Drug_Names: 2-(2,5-Difluorophenyl)pyrrolidine, CAS: 886503-15-7, stock 121.1g, assay 99%, MWt 183.20, Formula C10H11F2N, Purity >98%, SMILES FC1=CC(C2CCCN2)=C(F)C=C1, MDL NA |
| Drug_Names: 2-(2,3,4-Trifluorophenyl)acetic acid, CAS: 243666-12-8, stock 440.1g, assay 98.9%, MWt 190.12, Formula C8H5F3O2, Purity >98%, SMILES OC(=O)CC1=CC=C(F)C(F)=C1F, MDL MFCD00061235 |
| Drug_Names: 2-(2,2-Difluorobenzo[d][1,3]dioxol-5-yl)acetic acid, CAS: 398156-38-2, stock 750.9g, assay 98.4%, MWt 216.14, Formula C9H6F2O4, Purity >98%, SMILES OC(=O)CC1=CC=C2OC(F)(F)OC2=C1, MDL NA |
| Drug_Names: 2-(2,2,2-Trifluoroethyl)-2,6-diazaspiro[3.3]heptane ditrifluoroacetate, CAS: 1810069-99-8, stock 614.4g, assay 98.5%, MWt 408.22, Formula C11H13F9N2O4, Purity >98%, SMILES OC(=O)C(F)(F)F.OC(=O)C(F)(F)F.FC(F)(F)CN1CC2(CNC2)C1, MDL NA |
| Drug_Names: 2-(1-Methylpyrrolidin-3-yl)ethan-1-ol, CAS: 36763-96-9, stock 52.4g, assay 98%, MWt 129.20, Formula C7H15NO, Purity >98%, SMILES CN1CCC(CCO)C1, MDL NA |
| Drug_Names: 2-(1-Methylpyrrolidin-3-yl)ethan-1-amine, CAS: 774213-88-6, stock 748.3g, assay 98.8%, MWt 128.22, Formula C7H16N2, Purity >98%, SMILES CN1CCC(CCN)C1, MDL NA |
| Drug_Names: 2-(1-Methylpyrrolidin-2-yl)propan-1-amine dihydrochloride, CAS: 1097931-13-9, stock 45.8g, assay 99%, MWt 215.16, Formula C8H20Cl2N2, Purity >98%, SMILES Cl.Cl.CC(CN)C1CCCN1C, MDL NA |
| Drug_Names: 2-(1-Methylpiperidin-4-yl)ethan-1-ol, CAS: 21156-84-3, stock 304.2g, assay 98.1%, MWt 143.23, Formula C8H17NO, Purity >98%, SMILES CN1CCC(CCO)CC1, MDL NA |
| Drug_Names: 2-(1-Methylpiperidin-3-yl)ethan-1-ol, CAS: 101257-32-3, stock 539.5g, assay 98.8%, MWt 143.23, Formula C8H17NO, Purity >98%, SMILES CN1CCCC(CCO)C1, MDL NA |
| Drug_Names: 2-(1-Methylpiperidin-3-yl)ethan-1-amine, CAS: 53295-72-0, stock 247.3g, assay 98.4%, MWt 142.24, Formula C8H18N2, Purity >98%, SMILES CN1CCCC(CCN)C1, MDL NA |
| Drug_Names: 2-(1-Methylazetidin-3-yl)ethan-1-ol, CAS: 1363381-66-1, stock 600.9g, assay 98.2%, MWt 115.17, Formula C6H13NO, Purity >98%, SMILES CN1CC(CCO)C1, MDL NA |
| Drug_Names: 2-(1-Methyl-1H-imidazol-4-yl)acetic acid hydrochloride, CAS: 35454-39-8, stock 238.6g, assay 98.7%, MWt 176.60, Formula C6H9ClN2O2, Purity >98%, SMILES Cl.CN1C=NC(CC(O)=O)=C1, MDL NA |
| Drug_Names: 2-(1-(Methylsulfonyl)azetidin-3-ylidene)acetonitrile, CAS: 1638759-68-8, stock 497.2g, assay 98.4%, MWt 172.20, Formula C6H8N2O2S, Purity >98%, SMILES CS(=O)(=O)N1CC(C1)=CC#N, MDL NA |
| Drug_Names: 2-(1H-Imidazol-4-yl)acetonitrile, CAS: 18502-05-1, stock 385.4g, assay 98.4%, MWt 107.11, Formula C5H5N3, Purity >98%, SMILES N#CCC1=CNC=N1, MDL NA |
| Drug_Names: 2-(1H-Imidazol-2-yl)morpholine hydrochloride, CAS: 1523571-89-2, stock 797g, assay 98.7%, MWt 189.64, Formula C7H12ClN3O, Purity >98%, SMILES Cl.C1COC(CN1)C1=NC=CN1, MDL NA |
| Drug_Names: 2-(1H-1,2,3-Triazol-1-yl)benzoic acid, CAS: 1085458-53-2, stock 813.5g, assay 98.6%, MWt 189.17, Formula C9H7N3O2, Purity >98%, SMILES OC(=O)C1=C(C=CC=C1)N1C=CN=N1, MDL NA |
| Drug_Names: 2-(1-Aminocyclobutyl)acetic acid, CAS: 58885-90-8, stock 201.3g, assay 98.3%, MWt 129.16, Formula C6H11NO2, Purity >98%, SMILES NC1(CC(O)=O)CCC1, MDL NA |
| Drug_Names: 2-(1-((tert-Butoxycarbonyl)amino)cyclobutyl)acetic acid, CAS: 249762-02-5, stock 58g, assay 98.7%, MWt 229.27, Formula C11H19NO4, Purity >98%, SMILES O=C(O)CC1(NC(OC(C)(C)C)=O)CCC1, MDL NA |
| Drug_Names: 2-(1-(((Benzyloxy)carbonyl)amino)ethyl)thiazole-5-carboxylic acid, CAS: 1095823-52-1, stock 299.6g, assay 98.5%, MWt 306.34, Formula C14H14N2O4S, Purity >98%, SMILES CC(NC(=O)OCC1=CC=CC=C1)C1=NC=C(S1)C(O)=O, MDL NA |
| Drug_Names: 2-(1,4-Dioxan-2-yl)acetic acid, CAS: 210647-03-3, stock 498g, assay 98.2%, MWt 146.14, Formula C6H10O4, Purity >98%, SMILES OC(=O)CC1COCCO1, MDL NA |
| Drug_Names: 2-(1,3,4-Thiadiazol-2-yl)ethanamine dihydrochloride, CAS: 1523571-16-5, stock 869.3g, assay 98.3%, MWt 202.11, Formula C4H9Cl2N3S, Purity >98%, SMILES Cl.Cl.NCCC1=NN=CS1, MDL NA |
| Drug_Names: 4-(2-Aminoethyl)tetrahydro-2H-thiopyran 1,1-dioxide, CAS: 1247501-81-0, stock 517.7g, assay 98.4%, MWt 177.26, Formula C7H15NO2S, Purity >98%, SMILES NCCC1CCS(=O)(=O)CC1, MDL NA |
| Drug_Names: 2-((((Benzyloxy)carbonyl)amino)methyl)thiazole-5-carboxylic acid, CAS: 1095823-37-2, stock 169.9g, assay 98.8%, MWt 292.31, Formula C13H12N2O4S, Purity >98%, SMILES OC(=O)C1=CN=C(CNC(=O)OCC2=CC=CC=C2)S1, MDL NA |
| Drug_Names: 2-((tert-Butoxycarbonyl)amino)-2-(tetrahydro-2H-pyran-4-yl)acetic acid, CAS: 182287-49-6, stock 378.1g, assay 98.7%, MWt 259.30, Formula C12H21NO5, Purity >98%, SMILES CC(C)(C)OC(=O)NC(C1CCOCC1)C(O)=O, MDL NA |
| Drug_Names: Methyl 2-(5-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)thiophen-2-yl)acetate, CAS: 1788894-41-6, stock 592.5g, assay 99%, MWt 282.16, Formula C13H19BO4S, Purity >98%, SMILES COC(=O)CC1=CC=C(S1)B1OC(C)(C)C(C)(C)O1, MDL NA |
| Drug_Names: Ethyl 2-(5-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)thiophen-2-yl)acetate, CAS: 1620318-41-3, stock 378.5g, assay 98.7%, MWt 296.19, Formula C14H21BO4S, Purity >98%, SMILES CCOC(=O)CC1=CC=C(S1)B1OC(C)(C)C(C)(C)O1, MDL NA |
| Drug_Names: N-((3R,4R)-3-((6-(2,6-dichloro-3,5-dimethoxyphenyl)quinazolin-2-yl)amino)tetrahydro-2H-pyran-4-yl)acrylamide, CAS: 1707289-24-4, stock 23.2g, assay 98.6%, MWt 503.38, Formula C24H24Cl2N4O4, Purity >98%, SMILES COC1=CC(OC)=C(Cl)C(=C1Cl)C1=CC2=C(C=C1)N=C(N[C@H]1COCC[C@H]1NC(=O)C=C)N=C2, MDL NA |
| Drug_Names: Methyl 1-methyl-6-oxopiperidine-2-carboxylate, CAS: 20845-27-6, stock 61.5g, assay 98.9%, MWt 171.19, Formula C8H13NO3, Purity >98%, SMILES COC(=O)C1CCCC(=O)N1C, MDL NA |
| Drug_Names: Sodium 2-oxaspiro[3.3]heptane-6-carboxylate, CAS: 2095409-78-0, stock 667.3g, assay 98%, MWt 164.13, Formula C7H9NaO3, Purity >98%, SMILES O=C(C(C1)CC21COC2)[O-].[Na+], MDL NA |
| Drug_Names: (3S,4S)-3-Methyl-2-oxa-8-azaspiro[4.5]decan-4-amine dihydrochloride, CAS: 2055761-19-6, stock 610.9g, assay 98.7%, MWt 243.17, Formula C9H20Cl2N2O, Purity >98%, SMILES Cl.Cl.C[C@@H]1OCC2(CCNCC2)[C@@H]1N, MDL NA |
| Drug_Names: (2S)-3-ethyl-1-methylazetidine-2-carboxylic acid, CAS: 1860067-55-5, stock 821.5g, assay 98.7%, MWt 143.18, Formula C7H13NO2, Purity >98%, SMILES CCC1CN(C)[C@@H]1C(O)=O, MDL NA |
| Drug_Names: (S)-3,3-dimethylazetidine-2-carboxylic acid, CAS: 1860033-50-6, stock 821.1g, assay 98.6%, MWt 129.16, Formula C6H11NO2, Purity >98%, SMILES CC1(C)CN[C@@H]1C(O)=O, MDL NA |
| Drug_Names: (S)-1-propylazetidine-2-carboxylic acid, CAS: 255882-97-4, stock 724.6g, assay 98.7%, MWt 143.18, Formula C7H13NO2, Purity >98%, SMILES CCCN1CC[C@H]1C(O)=O, MDL NA |
| Drug_Names: (S)-1-ethylazetidine-2-carboxylic acid, CAS: 255882-96-3, stock 633.8g, assay 98.6%, MWt 129.16, Formula C6H11NO2, Purity >98%, SMILES CCN1CC[C@H]1C(O)=O, MDL NA |
| Drug_Names: (S)-1-Isopropylazetidine-2-carboxylic acid, CAS: 255882-98-5, stock 3.8g, assay 98.5%, MWt 143.18, Formula C7H13NO2, Purity >98%, SMILES CC(C)N1CC[C@H]1C(O)=O, MDL NA |
| Drug_Names: (S)-1-(2-fluoroethyl)azetidine-2-carboxylic acid, CAS: 1946010-84-9, stock 114.5g, assay 98%, MWt 147.15, Formula C6H10FNO2, Purity >98%, SMILES OC(=O)[C@@H]1CCN1CCF, MDL NA |
| Drug_Names: (S)-1,3,3-trimethylazetidine-2-carboxylic acid, CAS: 1860033-49-3, stock 456.8g, assay 98.8%, MWt 143.18, Formula C7H13NO2, Purity >98%, SMILES CN1CC(C)(C)[C@H]1C(O)=O, MDL NA |
| Drug_Names: (2S)-1,3-dimethylazetidine-2-carboxylic acid, CAS: 1860067-54-4, stock 423.3g, assay 98.7%, MWt 129.16, Formula C6H11NO2, Purity >98%, SMILES CC1CN(C)[C@@H]1C(O)=O, MDL NA |
| Drug_Names: 1-Thia-6-azaspiro[3.3]heptane 1,1-dioxide hydrochloride, CAS: 1427358-97-1, stock 767.4g, assay 98.9%, MWt 183.66, Formula C5H10ClNO2S, Purity >98%, SMILES Cl.O=S1(=O)CCC11CNC1, MDL NA |
| Drug_Names: 1-Thia-6-azaspiro[3.3]heptane hydrochloride, CAS: 1427452-92-3, stock 882.1g, assay 98.1%, MWt 151.66, Formula C5H10ClNS, Purity >98%, SMILES Cl.C1CC2(CNC2)S1, MDL NA |
| Drug_Names: 1-(tert-Butyl)azetidin-3-amine, CAS: 18713-70-7, stock 859.6g, assay 98.2%, MWt 128.22, Formula C7H16N2, Purity >98%, SMILES CC(C)(C)N1CC(N)C1, MDL NA |
| Drug_Names: 1-(1,1-Dimethylethyl)-1,3-dihydro-2H-pyrrolo[2,3-b]pyridin-2-one, CAS: 1455358-06-1, stock 599.3g, assay 98.4%, MWt 190.24, Formula C11H14N2O, Purity >98%, SMILES CC(C)(C)N1C(=O)CC2=C1N=CC=C2, MDL NA |
| Drug_Names: 1-tert-Butyl 6-methyl 5-bromo-2,3-dihydro-1h-indole-1,6-dicarboxylate, CAS: 1788044-06-3, stock 702.3g, assay 98.6%, MWt 356.21, Formula C15H18BrNO4, Purity >98%, SMILES COC(=O)C1=CC2=C(CCN2C(=O)OC(C)(C)C)C=C1Br, MDL NA |
| Drug_Names: 1-tert-Butyl 6-methyl 2,3-dihydro-1h-indole-1,6-dicarboxylate, CAS: 1220039-51-9, stock 616.7g, assay 98.1%, MWt 277.32, Formula C15H19NO4, Purity >98%, SMILES COC(=O)C1=CC2=C(CCN2C(=O)OC(C)(C)C)C=C1, MDL NA |
| Drug_Names: 1-tert-Butyl 4-methyl azepane-1,4-dicarboxylate, CAS: 1259065-07-0, stock 290.6g, assay 98.7%, MWt 257.33, Formula C13H23NO4, Purity >98%, SMILES COC(=O)C1CCCN(CC1)C(=O)OC(C)(C)C, MDL NA |
| Drug_Names: 1-tert-Butyl 4-methyl 4-fluoropiperidine-1,4-dicarboxylate, CAS: 1048994-21-3, stock 238.7g, assay 98.8%, MWt 261.29, Formula C12H20FNO4, Purity >98%, SMILES COC(=O)C1(F)CCN(CC1)C(=O)OC(C)(C)C, MDL NA |
| Drug_Names: 1-tert-Butyl 4-methyl 4-(aminomethyl)piperidine-1,4-dicarboxylate, CAS: 362703-35-3, stock 559.3g, assay 98.9%, MWt 272.34, Formula C13H24N2O4, Purity >98%, SMILES COC(=O)C1(CN)CCN(CC1)C(=O)OC(C)(C)C, MDL NA |
| Drug_Names: 1-tert-Butyl 4-ethyl 4-(aminomethyl)piperidine-1,4-dicarboxylate, CAS: 1016258-69-7, stock 358g, assay 98.1%, MWt 286.37, Formula C14H26N2O4, Purity >98%, SMILES CCOC(=O)C1(CN)CCN(CC1)C(=O)OC(C)(C)C, MDL NA |
| Drug_Names: 1-tert-Butyl 3-methyl 5-methylpiperidine-1,3-dicarboxylate, CAS: 1365887-44-0, stock 552.8g, assay 98%, MWt 257.33, Formula C13H23NO4, Purity >98%, SMILES COC(=O)C1CC(C)CN(C1)C(=O)OC(C)(C)C, MDL NA |
| Drug_Names: 1-tert-Butyl 3-methyl 4-methylpiperidine-1,3-dicarboxylate, CAS: 1201192-62-2, stock 328.4g, assay 98.4%, MWt 257.33, Formula C13H23NO4, Purity >98%, SMILES COC(=O)C1CN(CCC1C)C(=O)OC(C)(C)C, MDL NA |
| Drug_Names: 1-tert-Butyl 3-methyl 3-methylpyrrolidine-1,3-dicarboxylate, CAS: 457657-68-0, stock 587g, assay 98.2%, MWt 243.30, Formula C12H21NO4, Purity >98%, SMILES O=C(N1CC(C(OC)=O)(C)CC1)OC(C)(C)C, MDL NA |
| Drug_Names: 1-tert-Butyl 3-methyl 3-methylazetidine-1,3-dicarboxylate, CAS: 898228-37-0, stock 439.1g, assay 98.1%, MWt 229.27, Formula C11H19NO4, Purity >98%, SMILES COC(=O)C1(C)CN(C1)C(=O)OC(C)(C)C, MDL NA |
| Drug_Names: 1-tert-Butyl 3-methyl 3-hydroxyazetidine-1,3-dicarboxylate, CAS: 1884303-05-2, stock 191.5g, assay 98.9%, MWt 231.25, Formula C10H17NO5, Purity >98%, SMILES COC(=O)C1(O)CN(C1)C(=O)OC(C)(C)C, MDL NA |
| Drug_Names: 1-tert-Butyl 3-methyl 3-fluoropyrrolidine-1,3-dicarboxylate, CAS: 942189-96-0, stock 200.9g, assay 98.8%, MWt 247.26, Formula C11H18FNO4, Purity >98%, SMILES COC(=O)C1(F)CCN(C1)C(=O)OC(C)(C)C, MDL NA |
| Drug_Names: 1-tert-Butyl 3-methyl 3-ethylazetidine-1,3-dicarboxylate, CAS: 1262410-80-9, stock 333.5g, assay 98.8%, MWt 243.30, Formula C12H21NO4, Purity >98%, SMILES CCC1(CN(C1)C(=O)OC(C)(C)C)C(=O)OC, MDL NA |
| Drug_Names: 1-tert-Butyl 3-methyl 3-aminopyrrolidine-1,3-dicarboxylate, CAS: 942190-47-8, stock 111.6g, assay 98.4%, MWt 244.29, Formula C11H20N2O4, Purity >98%, SMILES COC(=O)C1(N)CCN(C1)C(=O)OC(C)(C)C, MDL NA |
| Drug_Names: 1-tert-Butyl 3-methyl 3-(prop-2-en-1-yl)piperidine-1,3-dicarboxylate, CAS: 1349644-17-2, stock 60g, assay 98.2%, MWt 283.36, Formula C15H25NO4, Purity >98%, SMILES COC(=O)C1(CC=C)CCCN(C1)C(=O)OC(C)(C)C, MDL NA |
| Drug_Names: 1-tert-Butyl 3-methyl (3S,6R)-6-methylpiperidine-1,3-dicarboxylate, CAS: 1009376-98-0, stock 674g, assay 98.5%, MWt 257.33, Formula C13H23NO4, Purity >98%, SMILES COC(=O)[C@H]1CC[C@@H](C)N(C1)C(=O)OC(C)(C)C, MDL NA |
| Drug_Names: 1-tert-Butyl 3-methyl (3S,4R)-rel-4-methylpiperidine-1,3-dicarboxylate, CAS: 1009376-54-8, stock 71.9g, assay 99%, MWt 257.33, Formula C13H23NO4, Purity >98%, SMILES COC(=O)[C@@H]1CN(CC[C@H]1C)C(=O)OC(C)(C)C, MDL NA |
| Drug_Names: 1-tert-Butyl 3-methyl (3S)-3-fluoropyrrolidine-1,3-dicarboxylate, CAS: 1438852-71-1, stock 63.3g, assay 98.9%, MWt 247.26, Formula C11H18FNO4, Purity >98%, SMILES COC(=O)[C@]1(F)CCN(C1)C(=O)OC(C)(C)C, MDL NA |
| Drug_Names: rel-(1-tert-Butyl 3-methyl (3R,6S)-6-methylpiperidine-1,3-dicarboxylate), CAS: 1009376-76-4, stock 339g, assay 98.9%, MWt 257.33, Formula C13H23NO4, Purity >98%, SMILES C[C@@H]1N(C(OC(C)(C)C)=O)C[C@H](C(OC)=O)CC1, MDL MFCD29472370 |
| Drug_Names: 1-tert-Butyl 3-methyl (3R,4R)-rel-4-methylpiperidine-1,3-dicarboxylate, CAS: 1009376-53-7, stock 170.9g, assay 98.7%, MWt 257.33, Formula C13H23NO4, Purity >98%, SMILES COC(=O)[C@H]1CN(CC[C@H]1C)C(=O)OC(C)(C)C, MDL NA |
| Drug_Names: 1-tert-Butyl 3-methyl (3R)-3-fluoropyrrolidine-1,3-dicarboxylate, CAS: 1438852-70-0, stock 734.1g, assay 98.5%, MWt 247.26, Formula C11H18FNO4, Purity >98%, SMILES COC(=O)[C@@]1(F)CCN(C1)C(=O)OC(C)(C)C, MDL NA |
| Drug_Names: 1-tert-Butyl 3-ethyl trans-4-hydroxypyrrolidine-1,3-dicarboxylate, CAS: 849935-83-7, stock 324.7g, assay 98.6%, MWt 259.30, Formula C12H21NO5, Purity >98%, SMILES CCOC(=O)[C@@H]1CN(C[C@H]1O)C(=O)OC(C)(C)C, MDL NA |
| Drug_Names: 1-tert-Butyl 3-ethyl 3-fluoropiperidine-1,3-dicarboxylate, CAS: 1228631-45-5, stock 23g, assay 98.2%, MWt 275.32, Formula C13H22FNO4, Purity >98%, SMILES CCOC(=O)C1(F)CCCN(C1)C(=O)OC(C)(C)C, MDL NA |
| Drug_Names: 1-tert-Butyl 3-ethyl 3-cyanoazetidine-1,3-dicarboxylate, CAS: 1105663-96-4, stock 886.1g, assay 98.4%, MWt 254.28, Formula C12H18N2O4, Purity >98%, SMILES CCOC(=O)C1(CN(C1)C(=O)OC(C)(C)C)C#N, MDL NA |
| Drug_Names: 1-tert-Butyl 3-ethyl 3-carbamoylazetidine-1,3-dicarboxylate, CAS: 1105663-94-2, stock 223.2g, assay 98.2%, MWt 272.30, Formula C12H20N2O5, Purity >98%, SMILES CCOC(=O)C1(CN(C1)C(=O)OC(C)(C)C)C(N)=O, MDL NA |
| Drug_Names: 1-tert-Butyl 3,3-diethyl azetidine-1,3,3-tricarboxylate, CAS: 1011479-75-6, stock 510.9g, assay 98.8%, MWt 301.34, Formula C14H23NO6, Purity >98%, SMILES CCOC(=O)C1(CN(C1)C(=O)OC(C)(C)C)C(=O)OCC, MDL NA |
| Drug_Names: 1-tert-Butyl 2-methyl cis-4-hydroxypiperidine-1,2-dicarboxylate, CAS: 181269-87-4, stock 373.9g, assay 98.7%, MWt 259.30, Formula C12H21NO5, Purity >98%, SMILES COC(=O)[C@@H]1C[C@H](O)CCN1C(=O)OC(C)(C)C, MDL NA |
| Drug_Names: 1-tert-Butyl 2-methyl 3-bromo-1H-pyrrole-1,2-dicarboxylate, CAS: 1097834-88-2, stock 777.1g, assay 98.1%, MWt 304.14, Formula C11H14BrNO4, Purity >98%, SMILES COC(=O)C1=C(Br)C=CN1C(=O)OC(C)(C)C, MDL NA |
| Drug_Names: 1-tert-Butyl 2-methyl 3,3-dimethyl-4-oxopyrrolidine-1,2-dicarboxylate, CAS: 848444-88-2, stock 458.2g, assay 98.2%, MWt 271.31, Formula C13H21NO5, Purity >98%, SMILES COC(=O)C1N(CC(=O)C1(C)C)C(=O)OC(C)(C)C, MDL NA |
| Drug_Names: 1-tert-Butyl 2-methyl 2-methylazetidine-1,2-dicarboxylate, CAS: 309977-81-9, stock 876.4g, assay 98.5%, MWt 229.27, Formula C11H19NO4, Purity >98%, SMILES COC(=O)C1(C)CCN1C(=O)OC(C)(C)C, MDL NA |
| Drug_Names: (2S,4S)-1-tert-Butyl 2-methyl 4-(trifluoromethyl)pyrrolidine-1,2-dicarboxylate, CAS: 1523541-90-3, stock 817.5g, assay 98.6%, MWt 297.27, Formula C12H18F3NO4, Purity >98%, SMILES COC(=O)[C@@H]1C[C@@H](CN1C(=O)OC(C)(C)C)C(F)(F)F, MDL NA |
| Drug_Names: 1-tert-Butyl 2-methyl (2S,3R)-3-hydroxypyrrolidine-1,2-dicarboxylate, CAS: 130966-46-0, stock 693.5g, assay 98.3%, MWt 245.27, Formula C11H19NO5, Purity >98%, SMILES COC(=O)[C@@H]1[C@H](O)CCN1C(=O)OC(C)(C)C, MDL NA |
| Drug_Names: 1-(tert-Butyl) 2-methyl (S)-aziridine-1,2-dicarboxylate, CAS: 126496-79-5, stock 474.8g, assay 98.3%, MWt 201.22, Formula C9H15NO4, Purity >98%, SMILES O=C(N1[C@H](C(OC)=O)C1)OC(C)(C)C, MDL NA |
| Drug_Names: 1-(tert-Butyl) 2-methyl (S)-azetidine-1,2-dicarboxylate, CAS: 107020-12-2, stock 591g, assay 98.1%, MWt 215.25, Formula C10H17NO4, Purity >98%, SMILES O=C(N1[C@H](C(OC)=O)CC1)OC(C)(C)C, MDL NA |
| Drug_Names: 1-tert-Butyl 2-methyl (2S)-3,3-dimethyl-4-oxopyrrolidine-1,2-dicarboxylate, CAS: 478698-30-5, stock 322.3g, assay 98.9%, MWt 271.31, Formula C13H21NO5, Purity >98%, SMILES COC(=O)[C@H]1N(CC(=O)C1(C)C)C(=O)OC(C)(C)C, MDL NA |
| Drug_Names: 1-tert-Butyl 2-methyl (2R,4R)-4-fluoropyrrolidine-1,2-dicarboxylate, CAS: 647857-43-0, stock 173.7g, assay 98.7%, MWt 247.26, Formula C11H18FNO4, Purity >98%, SMILES COC(=O)[C@H]1C[C@@H](F)CN1C(=O)OC(C)(C)C, MDL NA |
| Drug_Names: 1-(tert-Butyl) 2-methyl (R)-azetidine-1,2-dicarboxylate, CAS: 1260593-39-2, stock 370.1g, assay 98.8%, MWt 215.25, Formula C10H17NO4, Purity >98%, SMILES O=C(N1[C@@H](C(OC)=O)CC1)OC(C)(C)C, MDL NA |
| Drug_Names: 1-tert-Butyl 2-methyl (2R)-4,4-difluoropyrrolidine-1,2-dicarboxylate, CAS: 647857-74-7, stock 891.5g, assay 98.5%, MWt 265.25, Formula C11H17F2NO4, Purity >98%, SMILES COC(=O)[C@H]1CC(F)(F)CN1C(=O)OC(C)(C)C, MDL NA |
| Drug_Names: 1-tert-Butyl 2-ethyl 2-methylazetidine-1,2-dicarboxylate, CAS: 1391077-73-8, stock 122.4g, assay 98.3%, MWt 243.30, Formula C12H21NO4, Purity >98%, SMILES CCOC(=O)C1(C)CCN1C(=O)OC(C)(C)C, MDL NA |
| Drug_Names: 1-tert-Butyl 2-ethyl (2S)-4-oxopiperidine-1,2-dicarboxylate, CAS: 180854-44-8, stock 5.7g, assay 98.7%, MWt 271.31, Formula C13H21NO5, Purity >98%, SMILES CCOC(=O)[C@@H]1CC(=O)CCN1C(=O)OC(C)(C)C, MDL NA |
| Drug_Names: (R)-2-((1-(((9H-Fluoren-9-yl)methoxy)carbonyl)pyrrolidin-2-yl)methoxy)acetic acid, CAS: 1335206-44-4, stock 841.9g, assay 98.4%, MWt 381.42, Formula C22H23NO5, Purity >98%, SMILES OC(=O)COC[C@H]1CCCN1C(=O)OCC1C2=C(C=CC=C2)C2=C1C=CC=C2, MDL NA |
| Drug_Names: 4-(2,3,4-Trimethoxybenzyl)piperazine-1-carbaldehyde hydrochloride, CAS: 879646-17-0, stock 136.4g, assay 98%, MWt 330.81, Formula C15H23ClN2O4, Purity >98%, SMILES O=CN1CCN(CC2=CC=C(OC)C(OC)=C2OC)CC1.Cl, MDL NA |
| Drug_Names: 2-(4-Oxo-3,4-dihydrophthalazin-1-yl)acetic acid, CAS: 25947-11-9, stock 658.9g, assay 98.8%, MWt 204.18, Formula C10H8N2O3, Purity >98%, SMILES OC(=O)CC1=NNC(=O)C2=CC=CC=C12, MDL NA |
| Drug_Names: 1-Phenylcyclopropane-1-sulfonyl chloride, CAS: 1359655-41-6, stock 372.3g, assay 98.6%, MWt 216.68, Formula C9H9ClO2S, Purity >98%, SMILES ClS(=O)(=O)C1(CC1)C1=CC=CC=C1, MDL NA |
| Drug_Names: 1-Phenylazetidin-3-ol, CAS: 857280-53-6, stock 757.6g, assay 98.7%, MWt 149.19, Formula C9H11NO, Purity >98%, SMILES OC1CN(C1)C1=CC=CC=C1, MDL NA |
| Drug_Names: 1-Phenyl-1,6-diazaspiro[3.3]heptane hemioxalate, CAS: 1523617-89-1, stock 876.6g, assay 98.4%, MWt 438.52, Formula C24H30N4O4, Purity >98%, SMILES OC(=O)C(O)=O.C1CC2(CNC2)N1C1=CC=CC=C1.C1CC2(CNC2)N1C1=CC=CC=C1, MDL NA |
| Drug_Names: 1-Phenyl-1,6-diazaspiro[3.3]heptane, CAS: 1363383-39-4, stock 568.2g, assay 99%, MWt 174.24, Formula C11H14N2, Purity >98%, SMILES C1CC2(CNC2)N1C1=CC=CC=C1, MDL NA |
| Drug_Names: 1-Oxaspiro[4.4]nonan-3-ol, CAS: 1331825-49-0, stock 541.7g, assay 98.1%, MWt 142.20, Formula C8H14O2, Purity >98%, SMILES OC1COC2(CCCC2)C1, MDL NA |
| Drug_Names: 1-Oxaspiro[3.5]nonan-7-one, CAS: 1823366-07-9, stock 72g, assay 98.9%, MWt 140.18, Formula C8H12O2, Purity >98%, SMILES O=C1CCC2(CCO2)CC1, MDL NA |
| Drug_Names: 1-Oxa-8-azaspiro[4.5]decane oxalate(2:1), CAS: 1523606-45-2, stock 423.3g, assay 99%, MWt 372.46, Formula C18H32N2O6, Purity >98%, SMILES OC(=O)C(O)=O.C1COC2(C1)CCNCC2.C1COC2(C1)CCNCC2, MDL NA |
| Drug_Names: 1-Oxa-7-azaspiro[4.4]nonane hydrochloride, CAS: 1419590-81-0, stock 268g, assay 98.2%, MWt 163.65, Formula C7H14ClNO, Purity >98%, SMILES Cl.C1COC2(C1)CCNC2, MDL NA |
| Drug_Names: 1-Oxa-7-azaspiro[3.5]nonane oxalate(2:1), CAS: 1523617-84-6, stock 882.3g, assay 98.9%, MWt 344.40, Formula C16H28N2O6, Purity >98%, SMILES OC(=O)C(O)=O.C1CC2(CCNCC2)O1.C1CC2(CCNCC2)O1, MDL NA |
| Drug_Names: 1-Oxa-6-azaspiro[3.5]nonane oxalate(2:1), CAS: 1523606-44-1, stock 294.1g, assay 98.9%, MWt 344.40, Formula C16H28N2O6, Purity >98%, SMILES OC(=O)C(O)=O.C1CC2(CCCNC2)O1.C1CC2(CCCNC2)O1, MDL NA |
| Drug_Names: 1-Methylpiperidine-4-sulfonamide, CAS: 929632-63-3, stock 764.9g, assay 98.7%, MWt 178.25, Formula C6H14N2O2S, Purity >98%, SMILES CN1CCC(CC1)S(N)(=O)=O, MDL NA |
| Drug_Names: 1-Methylpiperidine-3-carboxylic acid, CAS: 5657-70-5, stock 121.3g, assay 99%, MWt 143.18, Formula C7H13NO2, Purity >98%, SMILES CN1CCCC(C1)C(O)=O, MDL NA |
| Drug_Names: 1-Methylpiperazin-2-one hydrochloride, CAS: 109384-27-2, stock 143.4g, assay 99%, MWt 150.61, Formula C5H11ClN2O, Purity >98%, SMILES Cl.CN1CCNCC1=O, MDL NA |
| Drug_Names: 1-Methyl-octahydro-1H-pyrrolo[3,2-c]pyridine dihydrochloride, CAS: 172281-71-9, stock 266.8g, assay 98.1%, MWt 213.15, Formula C8H18Cl2N2, Purity >98%, SMILES Cl.Cl.CN1CCC2CNCCC12, MDL NA |
| Drug_Names: 1-Methyl-octahydro-1H-pyrrolo[2,3-c]pyridine dihydrochloride, CAS: 2126177-49-7, stock 591.7g, assay 98.2%, MWt 213.15, Formula C8H18Cl2N2, Purity >98%, SMILES Cl.Cl.CN1CCC2CCNCC12, MDL NA |
| Drug_Names: 1-Methylazepan-4-amine, CAS: 933741-93-6, stock 359.2g, assay 98.1%, MWt 128.22, Formula C7H16N2, Purity >98%, SMILES CN1CCCC(N)CC1, MDL NA |
| Drug_Names: 1-Methyl-7-nitro-1H-indazole, CAS: 58706-36-8, stock 22.8g, assay 98.5%, MWt 177.16, Formula C8H7N3O2, Purity >98%, SMILES O=[N+](C1=CC=CC2=C1N(C)N=C2)[O-], MDL NA |
| Drug_Names: 1-Methyl-7-(tetramethyl-1,3,2-dioxaborolan-2-yl)-1h-indazole, CAS: 1313738-64-5, stock 60.1g, assay 98.7%, MWt 258.12, Formula C14H19BN2O2, Purity >98%, SMILES CN1N=CC2=CC=CC(B3OC(C)(C)C(C)(C)O3)=C12, MDL NA |
| Drug_Names: 1-Methyl-6-oxopiperidine-3-carboxylic acid, CAS: 22540-51-8, stock 784.5g, assay 98.6%, MWt 157.17, Formula C7H11NO3, Purity >98%, SMILES O=C(C(CC1)CN(C)C1=O)O, MDL MFCD09701684 |
| Drug_Names: 1-Methyl-6-nitro-2,3-dihydro-1H-indol-2-one, CAS: 1374423-01-4, stock 28.8g, assay 98.8%, MWt 192.17, Formula C9H8N2O3, Purity >98%, SMILES O=C1N(C)C2=C(C=CC([N+]([O-])=O)=C2)C1, MDL NA |
| Drug_Names: 1-Methyl-6-nitro-1H-indazole, CAS: 6850-23-3, stock 527.6g, assay 98.4%, MWt 177.16, Formula C8H7N3O2, Purity >98%, SMILES O=[N+](C1=CC2=C(C=C1)C=NN2C)[O-], MDL NA |
| Drug_Names: 1-Methyl-6-(tetramethyl-1,3,2-dioxaborolan-2-yl)-2,3-dihydro-1H-indol-2-one, CAS: 1428666-17-4, stock 388.4g, assay 98.9%, MWt 273.14, Formula C15H20BNO3, Purity >98%, SMILES CN1C(=O)CC2=C1C=C(C=C2)B1OC(C)(C)C(C)(C)O1, MDL NA |
| Drug_Names: 1-Methyl-5-nitro-1H-indazole-3-carboxylic acid, CAS: 1363382-25-5, stock 231.4g, assay 98.8%, MWt 221.17, Formula C9H7N3O4, Purity >98%, SMILES CN1N=C(C(O)=O)C2=C1C=CC(=C2)[N+]([O-])=O, MDL NA |
| Drug_Names: 1-Methyl-5-(trifluoromethyl)-1H-indole-2-carboxylic acid, CAS: 1257092-36-6, stock 149.5g, assay 98.3%, MWt 243.18, Formula C11H8F3NO2, Purity >98%, SMILES CN1C(=CC2=C1C=CC(=C2)C(F)(F)F)C(O)=O, MDL NA |
| Drug_Names: 1-Methyl-4-nitro-1H-pyrazole-3-carboxylic acid, CAS: 4598-86-1, stock 497.5g, assay 98.5%, MWt 171.11, Formula C5H5N3O4, Purity >98%, SMILES CN1C=C(C(=N1)C(O)=O)[N+]([O-])=O, MDL NA |
| Drug_Names: 1-Methyl-4-{1-[4-(tetramethyl-1,3,2-dioxaborolan-2-yl)phenyl]cyclopropyl}piperazine, CAS: 1643923-77-6, stock 139.7g, assay 98.6%, MWt 342.28, Formula C20H31BN2O2, Purity >98%, SMILES CN1CCN(CC1)C1(CC1)C1=CC=C(C=C1)B1OC(C)(C)C(C)(C)O1, MDL NA |
| Drug_Names: 1-Methyl-4-[4-(tetramethyl-1,3,2-dioxaborolan-2-yl)-1H-pyrazol-1-yl]piperidine, CAS: 1323919-64-7, stock 770.9g, assay 98.4%, MWt 291.20, Formula C15H26BN3O2, Purity >98%, SMILES CN1CCC(CC1)N1C=C(C=N1)B1OC(C)(C)C(C)(C)O1, MDL NA |
| Drug_Names: 1-Methyl-4-(tetramethyl-1,3,2-dioxaborolan-2-yl)-3-(trifluoromethyl)-1H-pyrazole, CAS: 1218790-53-4, stock 318.5g, assay 98.6%, MWt 276.06, Formula C11H16BF3N2O2, Purity >98%, SMILES CN1C=C(B2OC(C)(C)C(C)(C)O2)C(=N1)C(F)(F)F, MDL NA |
| Drug_Names: 1-Methyl-4-(tetramethyl-1,3,2-dioxaborolan-2-yl)-1H-pyrrolo[2,3-b]pyridine, CAS: 1644629-23-1, stock 777.8g, assay 98.7%, MWt 258.12, Formula C14H19BN2O2, Purity >98%, SMILES CN1C=CC2=C(C=CN=C12)B1OC(C)(C)C(C)(C)O1, MDL NA |
| Drug_Names: 1-Methyl-4-(tetramethyl-1,3,2-dioxaborolan-2-yl)-1H-indazole, CAS: 885698-94-2, stock 52.9g, assay 98.9%, MWt 258.12, Formula C14H19BN2O2, Purity >98%, SMILES CN1N=CC2=C(C=CC=C12)B1OC(C)(C)C(C)(C)O1, MDL NA |
| Drug_Names: 1-Methyl-4-(piperidin-4-yloxy)piperidine dihydrochloride, CAS: 635699-23-9, stock 338.9g, assay 98.4%, MWt 271.23, Formula C11H24Cl2N2O, Purity >98%, SMILES Cl.Cl.CN1CCC(CC1)OC1CCNCC1, MDL NA |
| Drug_Names: 1-Methyl-3-oxocyclobutane-1-carboxylic acid, CAS: 286442-89-5, stock 128.2g, assay 98.8%, MWt 128.13, Formula C6H8O3, Purity >98%, SMILES CC1(CC(=O)C1)C(O)=O, MDL NA |
| Drug_Names: 1-Methyl-3-oxocyclobutane-1-carbonitrile, CAS: 32082-17-0, stock 380.5g, assay 98.8%, MWt 109.13, Formula C6H7NO, Purity >98%, SMILES CC1(CC(=O)C1)C#N, MDL NA |
| Drug_Names: 1-Methyl-3-methylidenecyclobutane-1-carboxylic acid, CAS: 286442-86-2, stock 462.4g, assay 98.1%, MWt 126.15, Formula C7H10O2, Purity >98%, SMILES CC1(CC(=C)C1)C(O)=O, MDL NA |
| Drug_Names: 1-Methyl-3-(tetramethyl-1,3,2-dioxaborolan-2-yl)-1H-pyrrolo[2,3-c]pyridine, CAS: 1501153-45-2, stock 760.5g, assay 98.7%, MWt 258.12, Formula C14H19BN2O2, Purity >98%, SMILES CN1C=C(B2OC(C)(C)C(C)(C)O2)C2=C1C=NC=C2, MDL NA |
| Drug_Names: 1-Methyl-3-(tetramethyl-1,3,2-dioxaborolan-2-yl)-1H-pyrrolo[2,3-b]pyridine, CAS: 1185427-32-0, stock 335.9g, assay 98.8%, MWt 258.12, Formula C14H19BN2O2, Purity >98%, SMILES CN1C=C(B2OC(C)(C)C(C)(C)O2)C2=CC=CN=C12, MDL NA |
| Drug_Names: 1-Methyl-2-oxopiperidine-4-carboxylic acid, CAS: 1000932-09-1, stock 490.3g, assay 98.7%, MWt 157.17, Formula C7H11NO3, Purity >98%, SMILES CN1CCC(CC1=O)C(O)=O, MDL NA |
| Drug_Names: 1-Methyl-2-oxo-2,3-dihydro-1H-indole-6-carboxylic acid, CAS: 138328-27-5, stock 257.6g, assay 98.2%, MWt 191.18, Formula C10H9NO3, Purity >98%, SMILES CN1C(=O)CC2=CC=C(C=C12)C(O)=O, MDL NA |
| Drug_Names: 1-Methyl-2-oxo-2,3-dihydro-1H-indole-5-carboxylic acid, CAS: 167627-05-6, stock 355.7g, assay 98.1%, MWt 191.18, Formula C10H9NO3, Purity >98%, SMILES CN1C(=O)CC2=CC(=CC=C12)C(O)=O, MDL NA |
| Drug_Names: 1-Methyl-2-cyanoimidazole, CAS: 45515-45-5, stock 154g, assay 98.8%, MWt 107.11, Formula C5H5N3, Purity >98%, SMILES CN1C=CN=C1C#N, MDL NA |
| Drug_Names: 1-Methyl-1H-pyrrolo[3,2-b]pyridine-3-carboxylic acid, CAS: 1346608-64-7, stock 6.7g, assay 98.6%, MWt 176.17, Formula C9H8N2O2, Purity >98%, SMILES CN1C=C(C(O)=O)C2=C1C=CC=N2, MDL NA |
| Drug_Names: 1-Methyl-1H-pyrrolo[2,3-b]pyridine-4-carboxylic acid, CAS: 1147753-38-5, stock 104.6g, assay 98.9%, MWt 176.17, Formula C9H8N2O2, Purity >98%, SMILES CN1C=CC2=C(C=CN=C12)C(O)=O, MDL NA |
| Drug_Names: 1-Methyl-1H-pyrrolo[2,3-b]pyridine-2-carboxylic acid, CAS: 1251165-53-3, stock 21.3g, assay 98.6%, MWt 176.17, Formula C9H8N2O2, Purity >98%, SMILES CN1C(=CC2=CC=CN=C12)C(O)=O, MDL NA |
| Drug_Names: 1-Methyl-1H-pyrrolo[2,3-b]pyridine-2-carbaldehyde, CAS: 1368111-06-1, stock 713.6g, assay 98.6%, MWt 160.17, Formula C9H8N2O, Purity >98%, SMILES O=CC1=CC2=CC=CN=C2N1C, MDL NA |
| Drug_Names: 1-Methyl-1H-pyrazolo[4,3-c]pyridin-4-amine, CAS: 494767-19-0, stock 261.2g, assay 98.3%, MWt 148.17, Formula C7H8N4, Purity >98%, SMILES CN1N=CC2=C1C=CN=C2N, MDL NA |
| Drug_Names: 1-Methyl-1H-pyrazolo[3,4-d]pyrimidine-4-carboxylic acid, CAS: 1095822-30-2, stock 745.2g, assay 98.4%, MWt 178.15, Formula C7H6N4O2, Purity >98%, SMILES CN1N=CC2=C(N=CN=C12)C(O)=O, MDL NA |
| Drug_Names: 1-Methyl-1H-pyrazolo[3,4-b]pyridine-3-carboxylic acid, CAS: 116855-09-5, stock 65.6g, assay 98.9%, MWt 177.16, Formula C8H7N3O2, Purity >98%, SMILES CN1N=C(C(O)=O)C2=CC=CN=C12, MDL NA |
| Drug_Names: 1-Methyl-1H-pyrazolo[3,4-b]pyridine-3-carbaldehyde, CAS: 1511782-19-6, stock 363.9g, assay 98.2%, MWt 161.16, Formula C8H7N3O, Purity >98%, SMILES O=CC1=NN(C)C2=NC=CC=C21, MDL NA |
| Drug_Names: 1-Methyl-1H-pyrazolo[3,4-b]pyridin-5-amine, CAS: 1190380-60-9, stock 272.6g, assay 98.8%, MWt 148.17, Formula C7H8N4, Purity >98%, SMILES CN1N=CC2=CC(N)=CN=C12, MDL NA |
| Drug_Names: 1-Methyl-1H-indazole-5-carboxylic acid, CAS: 1176754-31-6, stock 518.6g, assay 98.4%, MWt 176.17, Formula C9H8N2O2, Purity >98%, SMILES CN1N=CC2=CC(=CC=C12)C(O)=O, MDL NA |
| Drug_Names: 1-Methyl-1H-indazole-4-carboxylic acid, CAS: 1071433-05-0, stock 83.5g, assay 98.7%, MWt 176.17, Formula C9H8N2O2, Purity >98%, SMILES CN1N=CC2=C(C=CC=C12)C(O)=O, MDL NA |
| Drug_Names: 1-Methyl-1H-imidazole-5-carbonitrile, CAS: 66121-66-2, stock 165.5g, assay 98.3%, MWt 107.11, Formula C5H5N3, Purity >98%, SMILES CN1C=NC=C1C#N, MDL NA |
| Drug_Names: 1-Methyl-1H-imidazole-4-carbaldehyde, CAS: 17289-26-8, stock 837.1g, assay 98.1%, MWt 110.11, Formula C5H6N2O, Purity >98%, SMILES O=CC1=CN(C)C=N1, MDL NA |
| Drug_Names: 1-Methyl-1H-imidazole-2-carboximidamide hydrochloride, CAS: 849600-64-2, stock 402.6g, assay 98.2%, MWt 160.60, Formula C5H9ClN4, Purity >98%, SMILES Cl.CN1C=CN=C1C(N)=N, MDL NA |
| Drug_Names: 1-Methyl-1H,4H,5H,6H-cyclopenta[b]pyrrol-4-one, CAS: 67838-94-2, stock 522.9g, assay 98.9%, MWt 135.16, Formula C8H9NO, Purity >98%, SMILES CN1C=CC2=C1CCC2=O, MDL NA |
| Drug_Names: 1-Methyl-1H,2H,3H-pyrrolo[2,3-b]pyridin-2-one, CAS: 156136-84-4, stock 882.1g, assay 98.9%, MWt 148.16, Formula C8H8N2O, Purity >98%, SMILES CN1C(=O)CC2=CC=CN=C12, MDL NA |
| Drug_Names: 1-Methyl-1,3,8-triazaspiro[4.5]decan-4-one, CAS: 701897-99-6, stock 433.2g, assay 98.2%, MWt 169.22, Formula C8H15N3O, Purity >98%, SMILES CN1CNC(=O)C11CCNCC1, MDL NA |
| Drug_Names: 1-Methyl-1,2,3,6-tetrahydropyridin-4-yl trifluoromethanesulfonate, CAS: 180692-27-7, stock 94.3g, assay 98.8%, MWt 245.22, Formula C7H10F3NO3S, Purity >98%, SMILES CN1CCC(OS(=O)(=O)C(F)(F)F)=CC1, MDL NA |
| Drug_Names: 1-Methanesulfonylazetidine-3-carboxylic acid, CAS: 1219828-27-9, stock 839.2g, assay 98.3%, MWt 179.19, Formula C5H9NO4S, Purity >98%, SMILES CS(=O)(=O)N1CC(C1)C(O)=O, MDL NA |
| Drug_Names: 1-Methanesulfonylazetidin-3-ol, CAS: 1344068-80-9, stock 342.5g, assay 98.7%, MWt 151.18, Formula C4H9NO3S, Purity >98%, SMILES CS(=O)(=O)N1CC(O)C1, MDL NA |
| Drug_Names: 1-Methanesulfonylazetidin-3-amine, CAS: 1340300-17-5, stock 853.9g, assay 98.2%, MWt 150.20, Formula C4H10N2O2S, Purity >98%, SMILES CS(=O)(=O)N1CC(N)C1, MDL NA |
| Drug_Names: 1-Methanesulfonyl-4-(tetramethyl-1,3,2-dioxaborolan-2-yl)-1H-pyrazole, CAS: 944994-03-0, stock 354.8g, assay 99%, MWt 272.13, Formula C10H17BN2O4S, Purity >98%, SMILES CC1(C)OB(OC1(C)C)C1=CN(N=C1)S(C)(=O)=O, MDL NA |
| Drug_Names: 1-Methanesulfonyl-4-(tetramethyl-1,3,2-dioxaborolan-2-yl)-1,2,3,6-tetrahydropyridine, CAS: 1382137-67-8, stock 264.5g, assay 98%, MWt 287.18, Formula C12H22BNO4S, Purity >98%, SMILES CC1(C)OB(OC1(C)C)C1=CCN(CC1)S(C)(=O)=O, MDL NA |
| Drug_Names: 1H-Pyrrolo[3,2-c]pyridine-7-carboxylic acid, CAS: 1082040-92-3, stock 443.7g, assay 98.7%, MWt 162.15, Formula C8H6N2O2, Purity >98%, SMILES OC(=O)C1=C2NC=CC2=CN=C1, MDL NA |
| Drug_Names: 1H-Pyrrolo[3,2-c]pyridine-4-carbonitrile, CAS: 1040682-68-5, stock 156.2g, assay 98.4%, MWt 143.15, Formula C8H5N3, Purity >98%, SMILES N#CC1=C2C=CNC2=CC=N1, MDL NA |
| Drug_Names: 1H-Pyrrolo[3,2-c]pyridine-3-carbonitrile, CAS: 1260385-57-6, stock 465.1g, assay 98.4%, MWt 143.15, Formula C8H5N3, Purity >98%, SMILES N#CC1=CNC2=C1C=NC=C2, MDL NA |
| Drug_Names: 1H-Pyrrolo[3,2-b]pyridine-5-carboxylic acid, CAS: 872355-64-1, stock 303.9g, assay 98.3%, MWt 162.15, Formula C8H6N2O2, Purity >98%, SMILES OC(=O)C1=CC=C2NC=CC2=N1, MDL NA |
| Drug_Names: Ethyl 7-chloro-1H-pyrrolo[3,2-b]pyridine-3-carboxylate, CAS: 1419101-46-4, stock 667.8g, assay 98.4%, MWt 224.64, Formula C10H9ClN2O2, Purity >98%, SMILES CCOC(=O)C1=CNC2=C(Cl)C=CN=C12, MDL NA |
| Drug_Names: 1H-Pyrrolo[3,2-b]pyridin-6-amine hydrochloride, CAS: 1354940-93-4, stock 850g, assay 98%, MWt 169.61, Formula C7H8ClN3, Purity >98%, SMILES Cl.NC1=CN=C2C=CNC2=C1, MDL NA |
| Drug_Names: 1H-Pyrrolo[2,3-c]pyridine-5-carbonitrile, CAS: 1082041-09-5, stock 865.7g, assay 98.1%, MWt 143.15, Formula C8H5N3, Purity >98%, SMILES N#CC1=NC=C2NC=CC2=C1, MDL NA |
| Drug_Names: 1H-Pyrrolo[2,3-c]pyridine-4-carbonitrile, CAS: 1190319-59-5, stock 564.6g, assay 98.4%, MWt 143.15, Formula C8H5N3, Purity >98%, SMILES N#CC1=C2C=CNC2=CN=C1, MDL MFCD12963363 |
| Drug_Names: 1H-Pyrrolo[2,3-b]pyridine-2-carboxamide, CAS: 223376-47-4, stock 799g, assay 99%, MWt 161.16, Formula C8H7N3O, Purity >98%, SMILES NC(=O)C1=CC2=C(N1)N=CC=C2, MDL NA |
| Drug_Names: 1H-Pyrrolo[2,3-b]pyridine-2-carbonitrile, CAS: 1261627-31-9, stock 292.2g, assay 98.6%, MWt 143.15, Formula C8H5N3, Purity >98%, SMILES N#CC1=CC2=C(N1)N=CC=C2, MDL NA |
| Drug_Names: 1H-Pyrrolo[2,3-b]pyridin-5-ylmethanamine hydrochloride, CAS: 1432754-52-3, stock 717g, assay 98.9%, MWt 183.64, Formula C8H10ClN3, Purity >98%, SMILES Cl.NCC1=CN=C2NC=CC2=C1, MDL NA |
| Drug_Names: 1H-Pyrrolo[2,3-b]pyridin-4-ylmethanol, CAS: 936549-95-0, stock 521.4g, assay 98.8%, MWt 148.16, Formula C8H8N2O, Purity >98%, SMILES OCC1=C2C=CNC2=NC=C1, MDL NA |
| Drug_Names: 1H-Pyrrolo[2,3-b]pyridin-3-ylmethanamine dihydrochloride, CAS: 1523618-08-7, stock 804.3g, assay 98%, MWt 220.10, Formula C8H11Cl2N3, Purity >98%, SMILES Cl.Cl.NCC1=CNC2=NC=CC=C12, MDL NA |
| Drug_Names: 1H-Pyrrolo[2,3-b]pyridin-2-ylmethanamine hydrochloride, CAS: 1788054-88-5, stock 211.9g, assay 99%, MWt 183.64, Formula C8H10ClN3, Purity >98%, SMILES Cl.NCC1=CC2=CC=CN=C2N1, MDL NA |
| Drug_Names: 1H-Pyrazolo[4,3-c]pyridine-7-carboxylic acid, CAS: 1363383-10-1, stock 824.8g, assay 98.1%, MWt 163.13, Formula C7H5N3O2, Purity >98%, SMILES OC(=O)C1=C2NN=CC2=CN=C1, MDL NA |
| Drug_Names: 1H-Pyrazolo[4,3-c]pyridine-6-carboxylic acid, CAS: 1256802-03-5, stock 174.2g, assay 98.1%, MWt 163.13, Formula C7H5N3O2, Purity >98%, SMILES OC(=O)C1=NC=C2C=NNC2=C1, MDL NA |
| Drug_Names: 1H-Pyrazolo[4,3-c]pyridine-4-carboxylic acid, CAS: 1140239-94-6, stock 715.5g, assay 98.6%, MWt 163.13, Formula C7H5N3O2, Purity >98%, SMILES OC(=O)C1=C2C=NNC2=CC=N1, MDL NA |
| Drug_Names: 1H-Pyrazolo[4,3-b]pyridine-7-carboxylic acid, CAS: 1363383-15-6, stock 553.7g, assay 99%, MWt 163.13, Formula C7H5N3O2, Purity >98%, SMILES OC(=O)C1=C2NN=CC2=NC=C1, MDL NA |
| Drug_Names: 1H-Pyrazolo[4,3-b]pyridine-6-carboxylic acid, CAS: 1256807-59-6, stock 563.6g, assay 98.7%, MWt 163.13, Formula C7H5N3O2, Purity >98%, SMILES OC(=O)C1=CN=C2C=NNC2=C1, MDL NA |
| Drug_Names: 1H-Pyrazolo[4,3-b]pyridine-6-carbonitrile, CAS: 1352395-13-1, stock 475g, assay 98.5%, MWt 144.13, Formula C7H4N4, Purity >98%, SMILES N#CC1=CC2=C(C=NN2)N=C1, MDL NA |
| Drug_Names: 1H-Pyrazolo[4,3-b]pyridin-6-amine, CAS: 1352397-37-5, stock 239.5g, assay 98.8%, MWt 134.14, Formula C6H6N4, Purity >98%, SMILES NC1=CN=C2C=NNC2=C1, MDL NA |
| Drug_Names: 1H-Pyrazolo[4,3-b]pyridin-5-amine, CAS: 1206974-46-0, stock 492.8g, assay 98.4%, MWt 134.14, Formula C6H6N4, Purity >98%, SMILES NC1=CC=C2NN=CC2=N1, MDL NA |
| Drug_Names: 1H-Pyrazolo[3,4-c]pyridine-7-carboxylic acid, CAS: 1140239-98-0, stock 171.4g, assay 98.4%, MWt 163.13, Formula C7H5N3O2, Purity >98%, SMILES OC(=O)C1=C2NN=CC2=CC=N1, MDL NA |
| Drug_Names: 1H-Pyrazolo[3,4-c]pyridine-5-carboxylic acid, CAS: 1256824-45-9, stock 416g, assay 98.5%, MWt 163.13, Formula C7H5N3O2, Purity >98%, SMILES OC(=O)C1=NC=C2NN=CC2=C1, MDL NA |
| Drug_Names: 1H-Pyrazolo[3,4-c]pyridine-5-carbonitrile, CAS: 633328-50-4, stock 139.6g, assay 98.5%, MWt 144.13, Formula C7H4N4, Purity >98%, SMILES N#CC1=CC2=C(NN=C2)C=N1, MDL NA |
| Drug_Names: 1H-Pyrazolo[3,4-c]pyridin-5-amine, CAS: 1049672-75-4, stock 829.4g, assay 99%, MWt 134.14, Formula C6H6N4, Purity >98%, SMILES NC1=NC=C2NN=CC2=C1, MDL NA |
| Drug_Names: 1H-Pyrazolo[3,4-b]pyridine-6-carboxylic acid, CAS: 1251111-24-6, stock 731.1g, assay 98.5%, MWt 163.13, Formula C7H5N3O2, Purity >98%, SMILES OC(=O)C1=NC2=C(C=NN2)C=C1, MDL NA |
| Drug_Names: 1H-Pyrazolo[3,4-b]pyridine-3-carbaldehyde, CAS: 1010073-87-6, stock 716.1g, assay 98.9%, MWt 147.13, Formula C7H5N3O, Purity >98%, SMILES O=CC1=NNC2=NC=CC=C12, MDL NA |
| Drug_Names: 1H-Pyrazolo[3,4-b]pyridin-5-ol, CAS: 1256818-99-1, stock 317.4g, assay 98.5%, MWt 135.12, Formula C6H5N3O, Purity >98%, SMILES OC1=CC2=C(NN=C2)N=C1, MDL NA |
| Drug_Names: 1H-Pyrazolo[3,4-b]pyridin-3-ylmethanamine, CAS: 1155846-90-4, stock 811.2g, assay 98.1%, MWt 148.17, Formula C7H8N4, Purity >98%, SMILES NCC1=NNC2=NC=CC=C12, MDL NA |
| Drug_Names: 1H-Pyrazolo[3,4-b]pyrazine-3-carboxylic acid, CAS: 1286754-47-9, stock 876.2g, assay 98%, MWt 164.12, Formula C6H4N4O2, Purity >98%, SMILES OC(=O)C1=NNC2=C1N=CC=N2, MDL NA |
| Drug_Names: 1H-Pyrazolo[3,4-b]pyrazine, CAS: 272-60-6, stock 26.6g, assay 98.3%, MWt 120.11, Formula C5H4N4, Purity >98%, SMILES N1N=CC2=C1N=CC=N2, MDL NA |
| Drug_Names: 3-Amino-5-methoxy-1H-pyrazole-4-carboxamide, CAS: 111375-25-8, stock 669.1g, assay 98.8%, MWt 156.14, Formula C5H8N4O2, Purity >98%, SMILES COC1=C(C(N)=O)C(N)=NN1, MDL NA |
| Drug_Names: 1H-Pyrazole-3,4-diamine sulfate, CAS: 16258-80-3, stock 147.7g, assay 98.9%, MWt 196.19, Formula C3H8N4O4S, Purity >98%, SMILES OS(O)(=O)=O.NC1=CNN=C1N, MDL NA |
| Drug_Names: 3,4-Dinitro-1H-pyrazole, CAS: 38858-92-3, stock 25.2g, assay 98.9%, MWt 158.07, Formula C3H2N4O4, Purity >98%, SMILES [O-][N+](=O)C1=CNN=C1[N+]([O-])=O, MDL MFCD00159604 |
| Drug_Names: (1H-Pyrazol-4-yl)methanamine dihydrochloride, CAS: 1172862-88-2, stock 356.1g, assay 98.9%, MWt 170.04, Formula C4H9Cl2N3, Purity >98%, SMILES NCC1=CNN=C1.[H]Cl.[H]Cl, MDL MFCD09971517 |
| Drug_Names: (1H-Pyrazol-3-yl)methanol, CAS: 23585-49-1, stock 770.3g, assay 98.7%, MWt 98.10, Formula C4H6N2O, Purity >98%, SMILES OCC1=NNC=C1, MDL NA |
| Drug_Names: 1H-Pyrazol-1-ol, CAS: 81945-73-5, stock 341.4g, assay 98.4%, MWt 84.08, Formula C3H4N2O, Purity >98%, SMILES ON1C=CC=N1, MDL NA |
| Drug_Names: 1H-Indole-5-sulfonyl chloride, CAS: 1094209-33-2, stock 875.4g, assay 98.9%, MWt 215.66, Formula C8H6ClNO2S, Purity >98%, SMILES ClS(=O)(=O)C1=CC2=C(NC=C2)C=C1, MDL NA |
| Drug_Names: 2-Oxoindoline-4-carbonitrile, CAS: 214759-51-0, stock 581.7g, assay 98.9%, MWt 158.16, Formula C9H6N2O, Purity >98%, SMILES O=C1CC2=C(C=CC=C2N1)C#N, MDL NA |
| Drug_Names: (1H-Indol-7-yl)methanol, CAS: 1074-87-9, stock 58.3g, assay 98.2%, MWt 147.17, Formula C9H9NO, Purity >98%, SMILES OCC1=CC=CC2=C1NC=C2, MDL NA |
| Drug_Names: (1H-Indol-7-yl)methanamine, CAS: 408356-52-5, stock 794.6g, assay 98%, MWt 146.19, Formula C9H10N2, Purity >98%, SMILES NCC1=CC=CC2=C1NC=C2, MDL NA |
| Drug_Names: 4-Bromo-1H-indol-7-ol, CAS: 1167056-91-8, stock 419.5g, assay 98.9%, MWt 212.04, Formula C8H6BrNO, Purity >98%, SMILES OC1=CC=C(Br)C2=C1NC=C2, MDL NA |
| Drug_Names: 1H-Indazole-5-carbohydrazide, CAS: 1005205-25-3, stock 622g, assay 98.9%, MWt 176.18, Formula C8H8N4O, Purity >98%, SMILES NNC(=O)C1=CC=C2NN=CC2=C1, MDL NA |
| Drug_Names: Methyl 6-fluoro-1H-indazole-4-carboxylate, CAS: 697739-05-2, stock 537.3g, assay 98.7%, MWt 194.16, Formula C9H7FN2O2, Purity >98%, SMILES COC(=O)C1=CC(F)=CC2=C1C=NN2, MDL NA |
| Drug_Names: 4,5,6,7-Tetrahydro-1H-indazole, CAS: 2305-79-5, stock 183.2g, assay 98.3%, MWt 122.17, Formula C7H10N2, Purity >98%, SMILES C1CCC2=C(C1)NN=C2, MDL NA |
| Drug_Names: 3-Bromo-5-(trifluoromethyl)-1H-indazole, CAS: 1086378-32-6, stock 678.5g, assay 98.8%, MWt 265.03, Formula C8H4BrF3N2, Purity >98%, SMILES FC(F)(F)C1=CC2=C(NN=C2Br)C=C1, MDL NA |
| Drug_Names: (1H-Indazol-7-yl)methanol, CAS: 1092961-09-5, stock 613.7g, assay 98%, MWt 148.16, Formula C8H8N2O, Purity >98%, SMILES OCC1=C2NN=CC2=CC=C1, MDL NA |
| Drug_Names: (1H-Indazol-7-yl)methanamine, CAS: 944904-20-5, stock 589.1g, assay 98.9%, MWt 147.18, Formula C8H9N3, Purity >98%, SMILES NCC1=C2NN=CC2=CC=C1, MDL NA |
| Drug_Names: (1H-Indazol-6-yl)methanol, CAS: 916902-55-1, stock 73.5g, assay 98.8%, MWt 148.16, Formula C8H8N2O, Purity >98%, SMILES OCC1=CC=C2C=NNC2=C1, MDL NA |
| Drug_Names: (1H-Indazol-4-yl)methanamine dihydrochloride, CAS: 1630907-20-8, stock 246.7g, assay 98.4%, MWt 220.10, Formula C8H11Cl2N3, Purity >98%, SMILES Cl.Cl.NCC1=C2C=NNC2=CC=C1, MDL NA |
| Drug_Names: (1H-Indazol-3-yl)methanol, CAS: 64132-13-4, stock 296.7g, assay 98.7%, MWt 148.16, Formula C8H8N2O, Purity >98%, SMILES OCC1=NNC2=CC=CC=C12, MDL NA |
| Drug_Names: 1H-Imidazole-2-carboximidamide dihydrochloride, CAS: 1788054-71-6, stock 550.5g, assay 98.6%, MWt 183.04, Formula C4H8Cl2N4, Purity >98%, SMILES Cl.Cl.NC(=N)C1=NC=CN1, MDL NA |
| Drug_Names: 1H-Imidazole-2-carbonitrile hydrochloride, CAS: 1392803-62-1, stock 542.3g, assay 98.6%, MWt 129.55, Formula C4H4ClN3, Purity >98%, SMILES Cl.N#CC1=NC=CN1, MDL NA |
| Drug_Names: 2-(tert-Butyl)-1H-imidazole, CAS: 36947-69-0, stock 775.4g, assay 98.8%, MWt 124.18, Formula C7H12N2, Purity >98%, SMILES CC(C)(C)C1=NC=CN1, MDL NA |
| Drug_Names: 3H-Imidazo[4,5-c]pyridine-4-carboxylic acid, CAS: 933728-33-7, stock 483.6g, assay 98.8%, MWt 163.13, Formula C7H5N3O2, Purity >98%, SMILES OC(=O)C1=C2N=CNC2=CC=N1, MDL NA |
| Drug_Names: (1H-Benzo[d]imidazol-4-yl)methanol, CAS: 65658-13-1, stock 799.5g, assay 98.8%, MWt 148.16, Formula C8H8N2O, Purity >98%, SMILES OCC1=C2N=CNC2=CC=C1, MDL NA |
| Drug_Names: (1H-Benzo[d]imidazol-4-yl)methanamine hydrochloride, CAS: 1788044-02-9, stock 105.8g, assay 98.7%, MWt 183.64, Formula C8H10ClN3, Purity >98%, SMILES Cl.NCC1=CC=CC2=C1N=CN2, MDL NA |
| Drug_Names: 1H-1,2,4-Triazole-5-sulfonamide, CAS: 89517-96-4, stock 17g, assay 98.8%, MWt 148.14, Formula C2H4N4O2S, Purity >98%, SMILES NS(=O)(=O)C1=NNC=N1, MDL NA |
| Drug_Names: Pyrrolo[1,2-b]pyridazin-4(1H)-one, CAS: 888720-26-1, stock 761.9g, assay 98%, MWt 134.14, Formula C7H6N2O, Purity >98%, SMILES O=C1C=CNN2C=CC=C12, MDL NA |
| Drug_Names: 1H,4H,5H,6H,7H-Pyrrolo[3,2-c]pyridin-4-one, CAS: 736990-65-1, stock 608g, assay 98.7%, MWt 136.15, Formula C7H8N2O, Purity >98%, SMILES O=C1NCCC2=C1C=CN2, MDL NA |
| Drug_Names: 1H-Pyrazolo[4,3-d]pyrimidine-5,7(4H,6H)-dione, CAS: 40769-81-1, stock 846.7g, assay 99%, MWt 152.11, Formula C5H4N4O2, Purity >98%, SMILES O=C1NC2=C(NN=C2)C(=O)N1, MDL NA |
| Drug_Names: 1H-Pyrrolo[3,4-c]pyridin-3(2H)-one, CAS: 40107-95-7, stock 521g, assay 98.7%, MWt 134.14, Formula C7H6N2O, Purity >98%, SMILES O=C1NCC2=CC=NC=C12, MDL NA |
| Drug_Names: 1H-Pyrrolo[2,3-c]pyridin-2(3H)-one hydrochloride, CAS: 295327-22-9, stock 212.2g, assay 98.9%, MWt 170.60, Formula C7H7ClN2O, Purity >98%, SMILES Cl.O=C1CC2=CC=NC=C2N1, MDL NA |
| Drug_Names: 4,5,6,7-Tetrahydro-3-(trifluoromethyl)-1H-pyrazolo[4,3-c]pyridine dihydrochloride, CAS: 2102410-08-0, stock 883.2g, assay 99%, MWt 264.08, Formula C7H10Cl2F3N3, Purity >98%, SMILES Cl.Cl.FC(F)(F)C1=NNC2=C1CNCC2, MDL NA |
| Drug_Names: 3-(4,4,5,5-Tetramethyl-1,3,2-dioxaborolan-2-yl)-1-((2-(trimethylsilyl)ethoxy)methyl)-1H-pyrazole, CAS: 1146162-54-0, stock 583.8g, assay 98.7%, MWt 324.30, Formula C15H29BN2O3Si, Purity >98%, SMILES CC1(C)OB(OC1(C)C)C1=NN(COCC[Si](C)(C)C)C=C1, MDL NA |
| Drug_Names: 1-Ethynyladamantane, CAS: 40430-66-8, stock 674.4g, assay 98%, MWt 160.26, Formula C12H16, Purity >98%, SMILES C#CC12C[C@H]3C[C@@H](C2)C[C@@H](C1)C3, MDL NA |
| Drug_Names: 1-Ethylpyrrolidin-3-amine dihydrochloride, CAS: 1337882-63-9, stock 511.2g, assay 98.6%, MWt 187.11, Formula C6H16Cl2N2, Purity >98%, SMILES Cl.Cl.CCN1CCC(N)C1, MDL NA |
| Drug_Names: 1-Ethylazetidin-3-ol hydrochloride, CAS: 1354940-66-1, stock 503.9g, assay 98.1%, MWt 137.61, Formula C5H12ClNO, Purity >98%, SMILES Cl.CCN1CC(O)C1, MDL NA |
| Drug_Names: 1-Ethylazetidin-3-amine, CAS: 55438-58-9, stock 575.8g, assay 98.2%, MWt 100.16, Formula C5H12N2, Purity >98%, SMILES CCN1CC(N)C1, MDL MFCD18817602 |
| Drug_Names: 1-Ethyl-4-methyl-2,3-dihydro-1H-indole, CAS: 86911-83-3, stock 697.8g, assay 98.7%, MWt 161.24, Formula C11H15N, Purity >98%, SMILES CCN1CCC2=C1C=CC=C2C, MDL NA |
| Drug_Names: 1-Ethyl-4-methyl-1H-pyrazol-3-amine, CAS: 1174882-85-9, stock 736.5g, assay 99%, MWt 125.17, Formula C6H11N3, Purity >98%, SMILES CCN1C=C(C)C(N)=N1, MDL NA |
| Drug_Names: 1-Ethyl-3-methyl-1H-pyrazol-4-amine, CAS: 947763-34-0, stock 423.4g, assay 98.4%, MWt 125.17, Formula C6H11N3, Purity >98%, SMILES CCN1C=C(N)C(C)=N1, MDL NA |
| Drug_Names: 1-Ethyl-1H-pyrazol-4-amine, CAS: 876343-24-7, stock 152.2g, assay 98.3%, MWt 111.15, Formula C5H9N3, Purity >98%, SMILES CCN1C=C(N)C=N1, MDL NA |
| Drug_Names: 1-Cyclopropylpropan-1-amine hydrochloride, CAS: 677743-70-3, stock 41.1g, assay 98.4%, MWt 135.64, Formula C6H14ClN, Purity >98%, SMILES Cl.CCC(N)C1CC1, MDL NA |
| Drug_Names: 1-Cyclopropyl-2,2,2-trifluoroethan-1-ol, CAS: 1993-77-7, stock 765.9g, assay 98.6%, MWt 140.10, Formula C5H7F3O, Purity >98%, SMILES OC(C1CC1)C(F)(F)F, MDL NA |
| Drug_Names: 1-Cyclopropyl-1H-pyrazole-5-carboxylic acid, CAS: 1393532-43-8, stock 487.4g, assay 98.4%, MWt 152.15, Formula C7H8N2O2, Purity >98%, SMILES OC(=O)C1=CC=NN1C1CC1, MDL NA |
| Drug_Names: 1-Cyclopropyl-1H-pyrazole-4-carboxylic acid, CAS: 1622883-44-6, stock 283.5g, assay 98.5%, MWt 152.15, Formula C7H8N2O2, Purity >98%, SMILES OC(=O)C1=CN(N=C1)C1CC1, MDL NA |
| Drug_Names: 1-Cyclopropyl-1H-pyrazole-3-carboxylic acid, CAS: 1403333-94-7, stock 518.4g, assay 98.7%, MWt 152.15, Formula C7H8N2O2, Purity >98%, SMILES OC(=O)C1=NN(C=C1)C1CC1, MDL NA |
| Drug_Names: 1-Cyclopentylethan-1-amine hydrochloride, CAS: 150812-09-2, stock 180.8g, assay 98.6%, MWt 149.66, Formula C7H16ClN, Purity >98%, SMILES Cl.CC(N)C1CCCC1, MDL NA |
| Drug_Names: 1-Cyclobutylpiperidin-4-ol, CAS: 869224-62-4, stock 101.5g, assay 98.5%, MWt 155.24, Formula C9H17NO, Purity >98%, SMILES OC1CCN(CC1)C1CCC1, MDL NA |
| Drug_Names: 1-Cyclobutylpiperazine dihydrochloride, CAS: 799557-65-6, stock 561.6g, assay 98.1%, MWt 213.15, Formula C8H18Cl2N2, Purity >98%, SMILES Cl.Cl.C1CC(C1)N1CCNCC1, MDL NA |
| Drug_Names: 1-Cyclobutylethan-1-amine hydrochloride, CAS: 904733-73-9, stock 5.4g, assay 98.3%, MWt 135.64, Formula C6H14ClN, Purity >98%, SMILES Cl.CC(N)C1CCC1, MDL NA |
| Drug_Names: 1-Cyanocyclobutanecarboxylic acid, CAS: 30491-91-9, stock 719.6g, assay 98.7%, MWt 125.13, Formula C6H7NO2, Purity >98%, SMILES OC(=O)C1(CCC1)C#N, MDL NA |
| Drug_Names: 1-Chloro-6-methyl-5-nitroisoquinoline, CAS: 943606-84-6, stock 694.4g, assay 98.2%, MWt 222.63, Formula C10H7ClN2O2, Purity >98%, SMILES CC1=C(C2=CC=NC(Cl)=C2C=C1)[N+]([O-])=O, MDL MFCD09264575 |
| Drug_Names: 1-Bromo-5,6,7,8-tetrahydroisoquinoline, CAS: 50388-18-6, stock 288g, assay 98.1%, MWt 212.09, Formula C9H10BrN, Purity >98%, SMILES BrC1=C2CCCCC2=CC=N1, MDL NA |
| Drug_Names: 1-Bromo-4-(4-bromonaphthalen-1-yl)naphthalene, CAS: 49610-35-7, stock 24.5g, assay 98.3%, MWt 412.12, Formula C20H12Br2, Purity >98%, SMILES BrC1=CC=C(C2=CC=CC=C12)C1=C2C=CC=CC2=C(Br)C=C1, MDL NA |
| Drug_Names: 1-Bromo-2-methoxy-4-methyl-5-nitrobenzene, CAS: 861076-28-0, stock 291.5g, assay 98.5%, MWt 246.06, Formula C8H8BrNO3, Purity >98%, SMILES COC1=CC(C)=C(C=C1Br)[N+]([O-])=O, MDL NA |
| Drug_Names: 1-Bromo-2-fluoro-5-methyl-4-nitrobenzene, CAS: 948294-26-6, stock 537.3g, assay 98.3%, MWt 234.02, Formula C7H5BrFNO2, Purity >98%, SMILES CC1=CC(Br)=C(F)C=C1[N+]([O-])=O, MDL NA |
| Drug_Names: tert-Butyl 8-(hydroxymethyl)-3-azabicyclo[3.2.1]octane-3-carboxylate, CAS: 637301-16-7, stock 723.8g, assay 98.4%, MWt 241.33, Formula C13H23NO3, Purity >98%, SMILES O=C(N1CC(C2CO)CCC2C1)OC(C)(C)C, MDL NA |
| Drug_Names: tert-Butyl 4-(hydroxymethyl)-2,6-dimethylpiperidine-1-carboxylate, CAS: 1934594-38-3, stock 180g, assay 98.6%, MWt 243.34, Formula C13H25NO3, Purity >98%, SMILES O=C(N1C(C)CC(CO)CC1C)OC(C)(C)C, MDL NA |
| Drug_Names: tert-Butyl 4-(2-hydroxypropan-2-yl)piperidine-1-carboxylate, CAS: 1935325-64-6, stock 87.4g, assay 98%, MWt 243.34, Formula C13H25NO3, Purity >98%, SMILES O=C(N1CCC(C(C)(O)C)CC1)OC(C)(C)C, MDL NA |
| Drug_Names: 1-Benzylazetidin-3-amine, CAS: 223381-58-6, stock 441g, assay 98.7%, MWt 162.23, Formula C10H14N2, Purity >98%, SMILES NC1CN(CC2=CC=CC=C2)C1, MDL NA |
| Drug_Names: 1-Benzyl-5-oxopyrrolidine-3-carboxylic acid, CAS: 5733-86-8, stock 682.9g, assay 98.1%, MWt 219.24, Formula C12H13NO3, Purity >98%, SMILES OC(=O)C1CN(CC2=CC=CC=C2)C(=O)C1, MDL NA |
| Drug_Names: 1-Benzyl-5-nitro-1H-imidazole, CAS: 159790-78-0, stock 750.9g, assay 98.9%, MWt 203.20, Formula C10H9N3O2, Purity >98%, SMILES [O-][N+](=O)C1=CN=CN1CC1=CC=CC=C1, MDL NA |
| Drug_Names: 1-Benzyl-5-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)-1,2,3,6-tetrahydropyridine, CAS: 1313738-80-5, stock 538.9g, assay 98.9%, MWt 299.22, Formula C18H26BNO2, Purity >98%, SMILES CC1(C)OB(OC1(C)C)C1=CCCN(CC2=CC=CC=C2)C1, MDL NA |
| Drug_Names: 1-Benzyl-4-oxopyrrolidine-3-carboxylic acid, CAS: 94577-77-2, stock 98.5g, assay 98.4%, MWt 219.24, Formula C12H13NO3, Purity >98%, SMILES OC(=O)C1CN(CC2=CC=CC=C2)CC1=O, MDL NA |
| Drug_Names: 1-Benzyl-4-methylpiperidin-3-one hydrochloride, CAS: 1303968-15-1, stock 602.1g, assay 98.8%, MWt 239.74, Formula C13H18ClNO, Purity >98%, SMILES Cl.CC1CCN(CC2=CC=CC=C2)CC1=O, MDL NA |
| Drug_Names: 1-Benzyl-3,3-dimethylpiperidin-4-ol, CAS: 324769-02-0, stock 457.5g, assay 98.3%, MWt 219.32, Formula C14H21NO, Purity >98%, SMILES CC1(C)CN(CC2=CC=CC=C2)CCC1O, MDL NA |
| Drug_Names: 1-Benzyl-3,3-dimethylpiperidin-4-amine, CAS: 473838-36-7, stock 383.4g, assay 98%, MWt 218.34, Formula C14H22N2, Purity >98%, SMILES CC1(C)CN(CC2=CC=CC=C2)CCC1N, MDL NA |
| Drug_Names: 1-Benzyl-2-methylpiperidin-4-one, CAS: 203661-73-8, stock 565.1g, assay 98.3%, MWt 203.28, Formula C13H17NO, Purity >98%, SMILES CC1CC(=O)CCN1CC1=CC=CC=C1, MDL NA |
| Drug_Names: 1-Benzyl-2-methylpiperidin-4-amine, CAS: 321345-30-6, stock 27.8g, assay 98.1%, MWt 204.31, Formula C13H20N2, Purity >98%, SMILES CC1CC(N)CCN1CC1=CC=CC=C1, MDL NA |
| Drug_Names: 1-Benzyl-1H-pyrazolo[3,4-d]pyrimidin-4-amine, CAS: 5444-61-1, stock 657.2g, assay 99%, MWt 225.25, Formula C12H11N5, Purity >98%, SMILES NC1=NC=NC2=C1C=NN2CC1=CC=CC=C1, MDL NA |
| Drug_Names: 1-Benzyl-1H,4H,5H-pyrazolo[4,3-c]pyridin-4-one, CAS: 41372-93-4, stock 485.7g, assay 98.6%, MWt 225.25, Formula C13H11N3O, Purity >98%, SMILES O=C1NC=CC2=C1C=NN2CC1=CC=CC=C1, MDL NA |
| Drug_Names: 1-Benzyl-1,6-diazaspiro[3.4]octane, CAS: 1363381-74-1, stock 92.3g, assay 98.9%, MWt 202.30, Formula C13H18N2, Purity >98%, SMILES C(N1CCC11CCNC1)C1=CC=CC=C1, MDL NA |
| Drug_Names: 1-Benzyl-1,6-diazaspiro[3.3]heptane oxalate, CAS: 1374659-14-9, stock 579.9g, assay 98.5%, MWt 278.30, Formula C14H18N2O4, Purity >98%, SMILES OC(=O)C(O)=O.C(N1CCC11CNC1)C1=CC=CC=C1, MDL NA |
| Drug_Names: 1-Benzylpyridin-2(1H)-one, CAS: 1753-62-4, stock 34.2g, assay 98.3%, MWt 185.22, Formula C12H11NO, Purity >98%, SMILES O=C1C=CC=CN1CC1=CC=CC=C1, MDL NA |
| Drug_Names: 1-Benzyl 7-tert-butyl 1,7-diazaspiro[4.5]decane-1,7-dicarboxylate, CAS: 1523571-86-9, stock 523.4g, assay 98.2%, MWt 374.47, Formula C21H30N2O4, Purity >98%, SMILES CC(C)(C)OC(=O)N1CCCC2(CCCN2C(=O)OCC2=CC=CC=C2)C1, MDL NA |
| Drug_Names: 1-Benzyl 4-methyl piperidine-1,4-dicarboxylate, CAS: 138163-07-2, stock 786.2g, assay 98.1%, MWt 277.32, Formula C15H19NO4, Purity >98%, SMILES COC(=O)C1CCN(CC1)C(=O)OCC1=CC=CC=C1, MDL NA |
| Drug_Names: 1-Benzyl 4-methyl 4-aminopiperidine-1,4-dicarboxylate, CAS: 115655-42-0, stock 401.2g, assay 98.1%, MWt 292.33, Formula C15H20N2O4, Purity >98%, SMILES COC(=O)C1(N)CCN(CC1)C(=O)OCC1=CC=CC=C1, MDL NA |
| Drug_Names: 1-Benzyl 3-methyl pyrrolidine-1,3-dicarboxylate, CAS: 188847-00-9, stock 301.4g, assay 98.1%, MWt 263.29, Formula C14H17NO4, Purity >98%, SMILES COC(=O)C1CCN(C1)C(=O)OCC1=CC=CC=C1, MDL MFCD06410557 |
| Drug_Names: Methyl N-Cbz-piperidine-3-carboxylate, CAS: 174543-74-9, stock 779.4g, assay 98.1%, MWt 277.32, Formula C15H19NO4, Purity >98%, SMILES COC(=O)C1CCCN(C1)C(=O)OCC1=CC=CC=C1, MDL NA |
| Drug_Names: 1-Benzyl 3-methyl 5-oxopiperidine-1,3-dicarboxylate, CAS: 1956365-99-3, stock 174.9g, assay 98.9%, MWt 291.30, Formula C15H17NO5, Purity >98%, SMILES COC(=O)C1CN(CC(=O)C1)C(=O)OCC1=CC=CC=C1, MDL NA |
| Drug_Names: 1-Benzyl 3-methyl 5-hydroxypiperidine-1,3-dicarboxylate, CAS: 1095010-45-9, stock 381.5g, assay 98.6%, MWt 293.32, Formula C15H19NO5, Purity >98%, SMILES COC(=O)C1CC(O)CN(C1)C(=O)OCC1=CC=CC=C1, MDL NA |
| Drug_Names: 1-Benzyl 3-methyl 3-methylpiperidine-1,3-dicarboxylate, CAS: 174543-82-9, stock 246.9g, assay 98.2%, MWt 291.34, Formula C16H21NO4, Purity >98%, SMILES COC(=O)C1(C)CCCN(C1)C(=O)OCC1=CC=CC=C1, MDL NA |
| Drug_Names: 1-Benzyl 3-methyl 3-methylazetidine-1,3-dicarboxylate, CAS: 912444-78-1, stock 25.8g, assay 98.7%, MWt 263.29, Formula C14H17NO4, Purity >98%, SMILES COC(=O)C1(C)CN(C1)C(=O)OCC1=CC=CC=C1, MDL NA |
| Drug_Names: 1-Benzyl 3-methyl (S)-pyrrolidine-1,3-dicarboxylate, CAS: 313706-14-8, stock 381.5g, assay 98.4%, MWt 263.29, Formula C14H17NO4, Purity >98%, SMILES O=C(N1C[C@@H](C(OC)=O)CC1)OCC2=CC=CC=C2, MDL NA |
| Drug_Names: 1-Benzyl 3-methyl (3R,6R)-rel-6-methylpiperidine-1,3-dicarboxylate, CAS: 1269755-57-8, stock 285.1g, assay 98.4%, MWt 291.34, Formula C16H21NO4, Purity >98%, SMILES COC(=O)[C@@H]1CC[C@@H](C)N(C1)C(=O)OCC1=CC=CC=C1, MDL NA |
| Drug_Names: 1-Benzyl 3-methyl (R)-pyrrolidine-1,3-dicarboxylate, CAS: 1217655-90-7, stock 767.5g, assay 98.5%, MWt 263.29, Formula C14H17NO4, Purity >98%, SMILES O=C(N1C[C@H](C(OC)=O)CC1)OCC2=CC=CC=C2, MDL NA |
| Drug_Names: 1-Benzyl 3-ethyl 3-aminoazetidine-1,3-dicarboxylate, CAS: 1434142-16-1, stock 462.8g, assay 98%, MWt 278.30, Formula C14H18N2O4, Purity >98%, SMILES CCOC(=O)C1(N)CN(C1)C(=O)OCC1=CC=CC=C1, MDL NA |
| Drug_Names: 1-Benzyl 2-methyl (2S,4S)-4-{[(tert-butoxy)carbonyl]amino}pyrrolidine-1,2-dicarboxylate, CAS: 168263-80-7, stock 634.4g, assay 98.3%, MWt 378.42, Formula C19H26N2O6, Purity >98%, SMILES COC(=O)[C@@H]1C[C@@H](CN1C(=O)OCC1=CC=CC=C1)NC(=O)OC(C)(C)C, MDL NA |
| Drug_Names: 1-Benzyl 2-methyl (2S)-5-oxopiperidine-1,2-dicarboxylate, CAS: 117836-13-2, stock 513.4g, assay 98.8%, MWt 291.30, Formula C15H17NO5, Purity >98%, SMILES COC(=O)[C@@H]1CCC(=O)CN1C(=O)OCC1=CC=CC=C1, MDL NA |
| Drug_Names: 1-Benzyl 2-methyl (2S)-4-methylidenepyrrolidine-1,2-dicarboxylate, CAS: 200184-60-7, stock 861.5g, assay 98.8%, MWt 275.30, Formula C15H17NO4, Purity >98%, SMILES COC(=O)[C@@H]1CC(=C)CN1C(=O)OCC1=CC=CC=C1, MDL NA |
| Drug_Names: 1-Benzyl 2-methyl (2S)-2,3-dihydro-1H-pyrrole-1,2-dicarboxylate, CAS: 856781-81-2, stock 267.5g, assay 98.9%, MWt 261.27, Formula C14H15NO4, Purity >98%, SMILES COC(=O)[C@@H]1CC=CN1C(=O)OCC1=CC=CC=C1, MDL NA |
| Drug_Names: 1-Benzyl 2-methyl (2R,4R)-4-hydroxypyrrolidine-1,2-dicarboxylate, CAS: 155075-23-3, stock 634.3g, assay 98%, MWt 279.29, Formula C14H17NO5, Purity >98%, SMILES COC(=O)[C@H]1C[C@@H](O)CN1C(=O)OCC1=CC=CC=C1, MDL NA |
| Drug_Names: 1-Benzoylpyrrolidin-2-one, CAS: 2399-66-8, stock 589.3g, assay 98.6%, MWt 189.21, Formula C11H11NO2, Purity >98%, SMILES O=C(N1CCCC1=O)C1=CC=CC=C1, MDL NA |
| Drug_Names: Benzo[b]thiophen-5-ylmethanol, CAS: 20532-34-7, stock 154.8g, assay 98.6%, MWt 164.22, Formula C9H8OS, Purity >98%, SMILES OCC1=CC=C2SC=CC2=C1, MDL NA |
| Drug_Names: 1-Azaspiro[4.5]decan-8-amine hydrochloride, CAS: 1823898-56-1, stock 412.2g, assay 98.2%, MWt 190.71, Formula C9H19ClN2, Purity >98%, SMILES Cl.NC1CCC2(CCCN2)CC1, MDL NA |
| Drug_Names: 1-Azaspiro[3.4]octane, CAS: 57174-62-6, stock 255.7g, assay 98.4%, MWt 111.18, Formula C7H13N, Purity >98%, SMILES C1CC2(CCCC2)N1, MDL NA |
| Drug_Names: 1-Azabicyclo[2.2.2]octane-4-carboxylic acid hydrochloride, CAS: 40117-63-3, stock 421.8g, assay 98.1%, MWt 191.66, Formula C8H14ClNO2, Purity >98%, SMILES Cl.OC(=O)C12CCN(CC1)CC2, MDL NA |
| Drug_Names: 1-Aminocyclopropane-1-carboxamide hydrochloride, CAS: 324796-27-2, stock 270.2g, assay 98.8%, MWt 136.58, Formula C4H9ClN2O, Purity >98%, SMILES Cl.NC(=O)C1(N)CC1, MDL NA |
| Drug_Names: 1-Aminoazetidin-3-ol dihydrochloride, CAS: 2007919-87-9, stock 243.7g, assay 98.7%, MWt 161.03, Formula C3H10Cl2N2O, Purity >98%, SMILES Cl.Cl.NN1CC(O)C1, MDL NA |
| Drug_Names: 1-Amino-3-fluorocyclobutane-1-carboxylic acid, CAS: 1033700-92-3, stock 183.7g, assay 98.6%, MWt 133.12, Formula C5H8FNO2, Purity >98%, SMILES NC1(CC(F)C1)C(O)=O, MDL NA |
| Drug_Names: 1-Amino-3-bromopyridin-1-ium 2,4,6-trimethylbenzene-1-sulfonate, CAS: 55899-13-3, stock 670.3g, assay 98.9%, MWt 373.27, Formula C14H17BrN2O3S, Purity >98%, SMILES N[N+]1=CC(Br)=CC=C1.CC1=CC(C)=C(C(C)=C1)S([O-])(=O)=O, MDL NA |
| Drug_Names: 1-Amino-3,3-dimethylbutan-2-one hydrochloride, CAS: 33119-72-1, stock 754.5g, assay 98.4%, MWt 151.63, Formula C6H14ClNO, Purity >98%, SMILES Cl.CC(C)(C)C(=O)CN, MDL NA |
| Drug_Names: 1-Amino-3,3-difluorocyclobutane-1-carboxylic acid, CAS: 1225532-86-4, stock 129.9g, assay 98.1%, MWt 151.11, Formula C5H7F2NO2, Purity >98%, SMILES NC1(CC(F)(F)C1)C(O)=O, MDL NA |
| Drug_Names: 1-Amino-3-(hydroxymethyl)cyclobutane-1-carboxylic acid, CAS: 1555492-59-5, stock 711.5g, assay 98.3%, MWt 145.16, Formula C6H11NO3, Purity >98%, SMILES NC1(CC(CO)C1)C(O)=O, MDL NA |
| Drug_Names: 1-Amino-1H-pyrrole-2-carboxamide hydrochloride, CAS: 1630906-75-0, stock 100.6g, assay 98.5%, MWt 161.59, Formula C5H8ClN3O, Purity >98%, SMILES Cl.NN1C=CC=C1C(N)=O, MDL NA |
| Drug_Names: 1-Amino-1H-pyrrole-2-carbonitrile hydrochloride, CAS: 937046-97-4, stock 89g, assay 98.6%, MWt 143.57, Formula C5H6ClN3, Purity >98%, SMILES Cl.NN1C=CC=C1C#N, MDL NA |
| Drug_Names: 1-Acetyl-6-methyl-1H-indazole-3-carbonitrile, CAS: 1788043-95-7, stock 179.8g, assay 98.4%, MWt 199.21, Formula C11H9N3O, Purity >98%, SMILES CC(=O)N1N=C(C#N)C2=C1C=C(C)C=C2, MDL NA |
| Drug_Names: 1-{3-Hydroxybicyclo[1.1.1]pentan-1-yl}ethan-1-one, CAS: 2055839-77-3, stock 113.8g, assay 98.5%, MWt 126.15, Formula C7H10O2, Purity >98%, SMILES CC(=O)C12CC(O)(C1)C2, MDL NA |
| Drug_Names: 1-{3H-Imidazo[4,5-b]pyridin-7-yl}methanamine dihydrochloride, CAS: 2102412-95-1, stock 677.1g, assay 98.4%, MWt 221.09, Formula C7H10Cl2N4, Purity >98%, SMILES Cl.Cl.NCC1=CC=NC2=C1N=CN2, MDL NA |
| Drug_Names: 1-{3-[(3,5-Dihydroxyphenyl)methyl]azetidin-1-yl}ethan-1-one, CAS: 1801243-46-8, stock 874.5g, assay 98.9%, MWt 221.25, Formula C12H15NO3, Purity >98%, SMILES CC(=O)N1CC(CC2=CC(O)=CC(O)=C2)C1, MDL NA |
| Drug_Names: 1-{2-[4-(Tetramethyl-1,3,2-dioxaborolan-2-yl)-1H-pyrazol-1-yl]ethyl}pyrrolidin-2-one, CAS: 1342834-87-0, stock 433.1g, assay 98%, MWt 305.18, Formula C15H24BN3O3, Purity >98%, SMILES CC1(C)OB(OC1(C)C)C1=CN(CCN2CCCC2=O)N=C1, MDL NA |
| Drug_Names: 1-{2,6-Diazaspiro[3.3]heptan-2-yl}ethan-1-one; trifluoroacetic acid, CAS: 2055839-78-4, stock 88.6g, assay 98.3%, MWt 254.21, Formula C9H13F3N2O3, Purity >98%, SMILES OC(=O)C(F)(F)F.CC(=O)N1CC2(CNC2)C1, MDL NA |
| Drug_Names: 1-(2,6-Diazaspiro[3.3]heptan-2-yl)ethanone hydrochloride, CAS: 1349875-74-6, stock 484.7g, assay 98.2%, MWt 176.64, Formula C7H13ClN2O, Purity >98%, SMILES Cl.CC(=O)N1CC2(CNC2)C1, MDL NA |
| Drug_Names: 1-(1H-Pyrrolo[2,3-b]pyridin-5-yl)ethanone, CAS: 944937-14-8, stock 665.7g, assay 98.6%, MWt 160.17, Formula C9H8N2O, Purity >98%, SMILES CC(=O)C1=CN=C2NC=CC2=C1, MDL NA |
| Drug_Names: 1-(1H-Pyrrolo[2,3-b]pyridin-4-yl)ethanone, CAS: 915415-16-6, stock 160.3g, assay 98.5%, MWt 160.17, Formula C9H8N2O, Purity >98%, SMILES CC(=O)C1=C2C=CNC2=NC=C1, MDL NA |
| Drug_Names: 1-{1-[(tert-Butoxy)carbonyl]piperidin-4-yl}methyl 4-methyl 4-fluoropiperidine-1,4-dicarboxylate, CAS: 2055839-71-7, stock 410.4g, assay 98.8%, MWt 402.46, Formula C19H31FN2O6, Purity >98%, SMILES COC(=O)C1(F)CCN(CC1)C(=O)OCC1CCN(CC1)C(=O)OC(C)(C)C, MDL NA |
| Drug_Names: 1-(3-(Trifluoromethyl)benzyl)-1H-pyrazole-4-carboxylic acid, CAS: 752222-88-1, stock 738.2g, assay 99%, MWt 270.21, Formula C12H9F3N2O2, Purity >98%, SMILES OC(=O)C1=CN(CC2=CC=CC(=C2)C(F)(F)F)N=C1, MDL NA |
| Drug_Names: 1-(2-Fluoro-6-(trifluoromethyl)benzyl)-5-iodo-6-methylpyrimidine-2,4(1H,3H)-dione, CAS: 1150560-54-5, stock 212.8g, assay 98.8%, MWt 428.12, Formula C13H9F4IN2O2, Purity >98%, SMILES CC1=C(I)C(=O)NC(=O)N1CC1=C(C=CC=C1F)C(F)(F)F, MDL NA |
| Drug_Names: 1-((2-(Trimethylsilyl)ethoxy)methyl)-1H-pyrrolo[2,3-b]pyridine-5-carbonitrile, CAS: 1203953-27-8, stock 102.3g, assay 98.4%, MWt 273.41, Formula C14H19N3OSi, Purity >98%, SMILES C[Si](C)(C)CCOCN1C=CC2=C1N=CC(=C2)C#N, MDL NA |
| Drug_Names: 1-{[(tert-Butoxy)carbonyl]amino}-3-methoxycyclobutane-1-carboxylic acid, CAS: 1700442-25-6, stock 620.1g, assay 98.5%, MWt 245.27, Formula C11H19NO5, Purity >98%, SMILES COC1CC(C1)(NC(=O)OC(C)(C)C)C(O)=O, MDL NA |
| Drug_Names: 1-{[(tert-Butoxy)carbonyl]amino}-3-hydroxycyclobutane-1-carboxylic acid, CAS: 1262141-51-4, stock 589.6g, assay 99%, MWt 231.25, Formula C10H17NO5, Purity >98%, SMILES CC(C)(C)OC(=O)NC1(CC(O)C1)C(O)=O, MDL NA |
| Drug_Names: 1-{[(tert-Butoxy)carbonyl]amino}-3-fluorocyclobutane-1-carboxylic acid, CAS: 1363381-27-4, stock 18.5g, assay 98.3%, MWt 233.24, Formula C10H16FNO4, Purity >98%, SMILES CC(C)(C)OC(=O)NC1(CC(F)C1)C(O)=O, MDL NA |
| Drug_Names: 1-((tert-Butoxycarbonyl)amino)-3,3-difluorocyclobutanecarboxylic acid, CAS: 1363380-83-9, stock 46.5g, assay 98.4%, MWt 251.23, Formula C10H15F2NO4, Purity >98%, SMILES CC(C)(C)OC(=O)NC1(CC(F)(F)C1)C(O)=O, MDL NA |
| Drug_Names: 1-[Tris(propan-2-yl)silyl]-1H-indole-6-sulfonyl chloride, CAS: 912846-33-4, stock 760.8g, assay 98.5%, MWt 372.00, Formula C17H26ClNO2SSi, Purity >98%, SMILES CC(C)[Si](C(C)C)(C(C)C)N1C=CC2=C1C=C(C=C2)S(Cl)(=O)=O, MDL NA |
| Drug_Names: 1-(4-Amino-2-(methylthio)pyrimidin-5-yl)ethanone, CAS: 352328-55-3, stock 347.6g, assay 98.1%, MWt 183.23, Formula C7H9N3OS, Purity >98%, SMILES CSC1=NC=C(C(C)=O)C(N)=N1, MDL NA |
| Drug_Names: 1-(4-(4,4,5,5-Tetramethyl-1,3,2-dioxaborolan-2-yl)-1H-pyrazol-1-yl)propan-2-ol, CAS: 1346819-38-2, stock 764.8g, assay 98.9%, MWt 252.12, Formula C12H21BN2O3, Purity >98%, SMILES CC(O)CN1C=C(C=N1)B1OC(C)(C)C(C)(C)O1, MDL NA |
| Drug_Names: 1-[4-(Hydroxymethyl)piperidin-1-yl]ethan-1-one, CAS: 846057-27-0, stock 295.8g, assay 98.8%, MWt 157.21, Formula C8H15NO2, Purity >98%, SMILES CC(=O)N1CCC(CO)CC1, MDL NA |
| Drug_Names: 1-[4-(4-Amino-3-methoxyphenyl)piperazin-1-yl]ethan-1-one, CAS: 1021426-42-5, stock 6.1g, assay 98%, MWt 249.31, Formula C13H19N3O2, Purity >98%, SMILES COC1=CC(=CC=C1N)N1CCN(CC1)C(C)=O, MDL NA |
| Drug_Names: 1-(3-Hydroxymethyl-pyrrolidin-1-yl)-ethanone, CAS: 191347-96-3, stock 651g, assay 98.4%, MWt 143.18, Formula C7H13NO2, Purity >98%, SMILES CC(=O)N1CCC(CO)C1, MDL NA |
| Drug_Names: 1-(2-Bromo-4-(trifluoromethyl)phenyl)ethanone, CAS: 1131605-31-6, stock 802.6g, assay 98.9%, MWt 267.04, Formula C9H6BrF3O, Purity >98%, SMILES CC(=O)C1=C(Br)C=C(C=C1)C(F)(F)F, MDL NA |
| Drug_Names: 1-[2-(Benzyloxy)ethyl]cyclopropane-1-carboxylic acid, CAS: 1803599-29-2, stock 435.2g, assay 98.5%, MWt 220.26, Formula C13H16O3, Purity >98%, SMILES OC(=O)C1(CCOCC2=CC=CC=C2)CC1, MDL NA |
| Drug_Names: 1-(2-(Azetidin-1-yl)ethyl)-4-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)-1H-pyrazole, CAS: 1422126-12-2, stock 549g, assay 99%, MWt 277.17, Formula C14H24BN3O2, Purity >98%, SMILES CC1(C)OB(OC1(C)C)C1=CN(CCN2CCC2)N=C1, MDL NA |
| Drug_Names: 1-(2-(2-Aminoethoxy)ethyl)-1H-pyrrole-2,5-dione 2,2,2-trifluoroacetate, CAS: 131274-17-4, stock 614.2g, assay 98.2%, MWt 298.22, Formula C10H13F3N2O5, Purity >98%, SMILES OC(=O)C(F)(F)F.NCCOCCN1C(=O)C=CC1=O, MDL NA |
| Drug_Names: 1-[1-(Propan-2-yl)piperidin-4-yl]ethan-1-ol, CAS: 1699407-61-8, stock 621.5g, assay 98.7%, MWt 171.28, Formula C10H21NO, Purity >98%, SMILES CC(C)N1CCC(CC1)C(C)O, MDL NA |
| Drug_Names: 1-[1-(Bromomethyl)cyclopropyl]methanamine hydrobromide, CAS: 1232676-97-9, stock 815g, assay 98.9%, MWt 244.96, Formula C5H11Br2N, Purity >98%, SMILES NCC1(CC1)CBr.Br, MDL NA |
| Drug_Names: 1-[(Tert-butoxy)carbonyl]-5-methylpiperidine-3-carboxylic acid, CAS: 1365887-45-1, stock 53g, assay 98.2%, MWt 243.30, Formula C12H21NO4, Purity >98%, SMILES CC1CC(CN(C1)C(=O)OC(C)(C)C)C(O)=O, MDL NA |
| Drug_Names: 1-[(Tert-butoxy)carbonyl]-4-methoxypiperidine-4-carboxylic acid, CAS: 1082042-29-2, stock 823.3g, assay 98.3%, MWt 259.30, Formula C12H21NO5, Purity >98%, SMILES COC1(CCN(CC1)C(=O)OC(C)(C)C)C(O)=O, MDL NA |
| Drug_Names: 1-[(Tert-butoxy)carbonyl]-4,4-difluoropyrrolidine-3-carboxylic acid, CAS: 1196145-11-5, stock 490.7g, assay 98.9%, MWt 251.23, Formula C10H15F2NO4, Purity >98%, SMILES CC(C)(C)OC(=O)N1CC(C(O)=O)C(F)(F)C1, MDL NA |
| Drug_Names: 1-[(Tert-butoxy)carbonyl]-4-(methoxycarbonyl)piperidine-4-carboxylic acid, CAS: 1005738-45-3, stock 406g, assay 98.7%, MWt 287.31, Formula C13H21NO6, Purity >98%, SMILES COC(=O)C1(CCN(CC1)C(=O)OC(C)(C)C)C(O)=O, MDL NA |
| Drug_Names: 1-[(Tert-butoxy)carbonyl]-3-hydroxyazetidine-3-carboxylic acid, CAS: 1035351-06-4, stock 566.6g, assay 98.7%, MWt 217.22, Formula C9H15NO5, Purity >98%, SMILES CC(C)(C)OC(=O)N1CC(O)(C1)C(O)=O, MDL NA |
| Drug_Names: 1-[(Tert-butoxy)carbonyl]-3-hydroxyazetidine-2-carboxylic acid, CAS: 1822531-69-0, stock 842.1g, assay 98.6%, MWt 217.22, Formula C9H15NO5, Purity >98%, SMILES CC(C)(C)OC(=O)N1CC(O)C1C(O)=O, MDL NA |
| Drug_Names: 1-[(Tert-butoxy)carbonyl]-3-ethylazetidine-3-carboxylic acid, CAS: 610791-06-5, stock 171.2g, assay 98%, MWt 229.27, Formula C11H19NO4, Purity >98%, SMILES CCC1(CN(C1)C(=O)OC(C)(C)C)C(O)=O, MDL NA |
| Drug_Names: 1-[(Tert-butoxy)carbonyl]-3-cyanopyrrolidine-3-carboxylic acid, CAS: 1158759-28-4, stock 387.9g, assay 98.5%, MWt 240.26, Formula C11H16N2O4, Purity >98%, SMILES CC(C)(C)OC(=O)N1CCC(C1)(C#N)C(O)=O, MDL NA |
| Drug_Names: 1-[(Tert-butoxy)carbonyl]-3-cyanoazetidine-3-carboxylic acid, CAS: 1158759-45-5, stock 538.8g, assay 98.7%, MWt 226.23, Formula C10H14N2O4, Purity >98%, SMILES CC(C)(C)OC(=O)N1CC(C1)(C#N)C(O)=O, MDL NA |
| Drug_Names: 1-[(Tert-butoxy)carbonyl]-3-{[(tert-butoxy)carbonyl]amino}azetidine-3-carboxylic acid, CAS: 1363382-07-3, stock 806.1g, assay 98.7%, MWt 316.35, Formula C14H24N2O6, Purity >98%, SMILES CC(C)(C)OC(=O)NC1(CN(C1)C(=O)OC(C)(C)C)C(O)=O, MDL NA |
| Drug_Names: 1-[(Tert-butoxy)carbonyl]-3,3-dimethylpiperidine-4-carboxylic acid, CAS: 1638771-27-3, stock 896.1g, assay 98.3%, MWt 257.33, Formula C13H23NO4, Purity >98%, SMILES CC(C)(C)OC(=O)N1CCC(C(O)=O)C(C)(C)C1, MDL NA |
| Drug_Names: 1-[(Tert-butoxy)carbonyl]-3-(prop-2-en-1-yl)piperidine-3-carboxylic acid, CAS: 959236-11-4, stock 688.8g, assay 98.2%, MWt 269.34, Formula C14H23NO4, Purity >98%, SMILES CC(C)(C)OC(=O)N1CCCC(CC=C)(C1)C(O)=O, MDL NA |
| Drug_Names: 1-[(Tert-butoxy)carbonyl]-3-(ethoxycarbonyl)azetidine-3-carboxylic acid, CAS: 1011479-76-7, stock 242.9g, assay 98.6%, MWt 273.28, Formula C12H19NO6, Purity >98%, SMILES CCOC(=O)C1(CN(C1)C(=O)OC(C)(C)C)C(O)=O, MDL NA |
| Drug_Names: 1-[(Tert-butoxy)carbonyl]-2-methylazetidine-3-carboxylic acid, CAS: 1638760-82-3, stock 525.5g, assay 98.4%, MWt 215.25, Formula C10H17NO4, Purity >98%, SMILES CC1C(CN1C(=O)OC(C)(C)C)C(O)=O, MDL NA |
| Drug_Names: 1-[(Tert-butoxy)carbonyl]-1-azaspiro[3.3]heptane-6-carboxylic acid, CAS: 1374659-11-6, stock 604.2g, assay 98.1%, MWt 241.28, Formula C12H19NO4, Purity >98%, SMILES CC(C)(C)OC(=O)N1CCC11CC(C1)C(O)=O, MDL NA |
| Drug_Names: 1-[(Diphenylmethylidene)amino]cyclopropane-1-carbonitrile, CAS: 89985-88-6, stock 867.7g, assay 98.2%, MWt 246.31, Formula C17H14N2, Purity >98%, SMILES N#CC1(CC1)N=C(C1=CC=CC=C1)C1=CC=CC=C1, MDL NA |
| Drug_Names: 1-[(Benzyloxy)carbonyl]azepane-4-carboxylic acid, CAS: 1195256-01-9, stock 414.9g, assay 98.5%, MWt 277.32, Formula C15H19NO4, Purity >98%, SMILES OC(=O)C1CCCN(CC1)C(=O)OCC1=CC=CC=C1, MDL NA |
| Drug_Names: 1-[(Benzyloxy)carbonyl]-5,5-difluoropiperidine-3-carboxylic acid, CAS: 1356338-81-2, stock 348.1g, assay 98.4%, MWt 299.27, Formula C14H15F2NO4, Purity >98%, SMILES OC(=O)C1CN(CC(F)(F)C1)C(=O)OCC1=CC=CC=C1, MDL NA |
| Drug_Names: 1-[(Benzyloxy)carbonyl]-4-methylpiperidine-4-carboxylic acid, CAS: 203522-12-7, stock 262.4g, assay 98.8%, MWt 277.32, Formula C15H19NO4, Purity >98%, SMILES CC1(CCN(CC1)C(=O)OCC1=CC=CC=C1)C(O)=O, MDL NA |
| Drug_Names: 1-[(Benzyloxy)carbonyl]-3-methylpiperidine-3-carboxylic acid, CAS: 174543-78-3, stock 13.1g, assay 98%, MWt 277.32, Formula C15H19NO4, Purity >98%, SMILES CC1(CCCN(C1)C(=O)OCC1=CC=CC=C1)C(O)=O, MDL NA |
| Drug_Names: 1-[(Benzyloxy)carbonyl]-3-methylazetidine-3-carboxylic acid, CAS: 1143525-35-2, stock 772.3g, assay 98.2%, MWt 249.26, Formula C13H15NO4, Purity >98%, SMILES CC1(CN(C1)C(=O)OCC1=CC=CC=C1)C(O)=O, MDL NA |
| Drug_Names: 1-[(Benzyloxy)carbonyl]-3-hydroxyazetidine-3-carboxylic acid, CAS: 70767-64-5, stock 855g, assay 98.8%, MWt 251.24, Formula C12H13NO5, Purity >98%, SMILES OC(=O)C1(O)CN(C1)C(=O)OCC1=CC=CC=C1, MDL NA |
| Drug_Names: 1-[(5-Chloro-1H-indol-3-yl)methyl]piperidine-4-carboxylic acid, CAS: 1170595-16-0, stock 200.4g, assay 98.3%, MWt 292.76, Formula C15H17ClN2O2, Purity >98%, SMILES OC(=O)C1CCN(CC2=CNC3=C2C=C(Cl)C=C3)CC1, MDL NA |
| Drug_Names: (R)-1-(3-Hydroxypyrrolidin-1-yl)ethanone, CAS: 916733-17-0, stock 412.8g, assay 98.3%, MWt 129.16, Formula C6H11NO2, Purity >98%, SMILES CC(=O)N1CC[C@@H](O)C1, MDL NA |
| Drug_Names: 1-[(3,3-Difluorocyclobutyl)methyl]-4-(tetramethyl-1,3,2-dioxaborolan-2-yl)-1H-pyrazole, CAS: 2101934-11-4, stock 82.8g, assay 98.9%, MWt 298.14, Formula C14H21BF2N2O2, Purity >98%, SMILES CC1(C)OB(OC1(C)C)C1=CN(CC2CC(F)(F)C2)N=C1, MDL NA |
| Drug_Names: 1-(2,4-Dimethoxybenzyl)-5-oxopyrrolidine-3-carboxylic acid, CAS: 304858-45-5, stock 218.3g, assay 98.5%, MWt 279.29, Formula C14H17NO5, Purity >98%, SMILES COC1=CC=C(CN2CC(CC2=O)C(O)=O)C(OC)=C1, MDL NA |
| Drug_Names: 1,9-Diazaspiro[5.5]undecan-2-one hydrochloride, CAS: 1171417-47-2, stock 265.2g, assay 98.8%, MWt 204.70, Formula C9H17ClN2O, Purity >98%, SMILES Cl.O=C1CCCC2(CCNCC2)N1, MDL NA |
| Drug_Names: 1,8-Diazaspiro[4.5]decan-2-one hydrochloride, CAS: 1389313-57-8, stock 577.5g, assay 98.3%, MWt 190.67, Formula C8H15ClN2O, Purity >98%, SMILES Cl.O=C1CCC2(CCNCC2)N1, MDL NA |
| Drug_Names: 1,7-Naphthyridine-4-carboxylic acid, CAS: 1378260-92-4, stock 829.7g, assay 98.8%, MWt 174.16, Formula C9H6N2O2, Purity >98%, SMILES OC(=O)C1=CC=NC2=CN=CC=C12, MDL NA |
| Drug_Names: 2-Chloro-1,7-naphthyridine, CAS: 35192-05-3, stock 174.3g, assay 98.5%, MWt 164.59, Formula C8H5ClN2, Purity >98%, SMILES ClC1=NC2=C(C=CN=C2)C=C1, MDL NA |
| Drug_Names: 1,7-Diazaspiro[4.4]nonan-2-one 2,2,2-trifluoroacetate, CAS: 1566649-47-5, stock 1.2g, assay 98.8%, MWt 254.21, Formula C9H13F3N2O3, Purity >98%, SMILES OC(=O)C(F)(F)F.O=C1CCC2(CCNC2)N1, MDL NA |
| Drug_Names: 1,6-Diazaspiro[3.5]nonan-2-one, CAS: 1567085-15-7, stock 297.3g, assay 98.6%, MWt 140.18, Formula C7H12N2O, Purity >98%, SMILES O=C1CC2(CCCNC2)N1, MDL NA |
| Drug_Names: 1,5-Dimethyl-1H-pyrazole-4-sulfonamide, CAS: 88398-55-4, stock 626.1g, assay 98.6%, MWt 175.21, Formula C5H9N3O2S, Purity >98%, SMILES CN1N=CC(=C1C)S(N)(=O)=O, MDL NA |
| Drug_Names: Dimethyl bicyclo[3.2.2]nonane-1,5-dicarboxylate, CAS: 942999-92-0, stock 889.6g, assay 98.4%, MWt 240.30, Formula C13H20O4, Purity >98%, SMILES COC(=O)C12CCC(CC1)(CCC2)C(=O)OC, MDL NA |
| Drug_Names: Di-tert-butyl 2-(aminomethyl)piperazine-1,4-dicarboxylate, CAS: 1256815-07-2, stock 613.6g, assay 98.4%, MWt 315.41, Formula C15H29N3O4, Purity >98%, SMILES CC(C)(C)OC(=O)N1CCN(C(CN)C1)C(=O)OC(C)(C)C, MDL NA |
| Drug_Names: 1,4-Dioxaspiro[4.5]decan-7-ol, CAS: 73223-83-3, stock 633g, assay 98.7%, MWt 158.19, Formula C8H14O3, Purity >98%, SMILES OC1CCCC2(C1)OCCO2, MDL NA |
| Drug_Names: 1,4-Dimethyl-1H-pyrrolo[2,3-b]pyridine-3-carbaldehyde, CAS: 27284-69-1, stock 706.3g, assay 98.2%, MWt 174.20, Formula C10H10N2O, Purity >98%, SMILES O=CC1=CN(C)C2=NC=CC(C)=C21, MDL NA |
| Drug_Names: 1,7-Naphthyridin-4(1H)-one, CAS: 60122-51-2, stock 53.6g, assay 98.7%, MWt 146.15, Formula C8H6N2O, Purity >98%, SMILES O=C1C=CNC2=C1C=CN=C2, MDL MFCD11501460 |
| Drug_Names: 1,4-Diazabicyclo[3.2.1]octane dihydrochloride, CAS: 5492-61-5, stock 46g, assay 98.6%, MWt 185.09, Formula C6H14Cl2N2, Purity >98%, SMILES Cl.Cl.C1CN2CC1NCC2, MDL NA |
| Drug_Names: 1,4-Dicarboxycubane, CAS: 32846-66-5, stock 670.2g, assay 98.6%, MWt 192.17, Formula C10H8O4, Purity >98%, SMILES OC(=O)C12C3C4C1C1C2C3C41C(O)=O, MDL NA |
| Drug_Names: 1,4,8-Trioxaspiro[4.5]decan-6-amine oxalate, CAS: 1392803-05-2, stock 54g, assay 98.7%, MWt 249.22, Formula C9H15NO7, Purity >98%, SMILES OC(=O)C(O)=O.NC1COCCC11OCCO1, MDL NA |
| Drug_Names: 2,3,5,6,8,9-Hexahydro-[1,4,7,10]tetraoxacyclododecino[2,3-g]quinolin-15(12H)-one, CAS: 1355620-88-0, stock 206.2g, assay 98.4%, MWt 291.30, Formula C15H17NO5, Purity >98%, SMILES OC1=CC=NC2=C1C=C1OCCOCCOCCOC1=C2, MDL NA |
| Drug_Names: 1,3-Dimethylpiperidin-3-amine, CAS: 1236348-35-8, stock 529.6g, assay 98.3%, MWt 128.22, Formula C7H16N2, Purity >98%, SMILES CN1CCCC(C)(N)C1, MDL NA |
| Drug_Names: 1,3-Dimethyl-1H-pyrazole-4-sulfonamide, CAS: 88398-53-2, stock 868.9g, assay 98.4%, MWt 175.21, Formula C5H9N3O2S, Purity >98%, SMILES CN1C=C(C(C)=N1)S(N)(=O)=O, MDL NA |
| Drug_Names: 1,3-Dimethyl-1H-indol-6-amine, CAS: 1499852-30-0, stock 208.2g, assay 98.5%, MWt 160.22, Formula C10H12N2, Purity >98%, SMILES CN1C=C(C)C2=C1C=C(N)C=C2, MDL NA |
| Drug_Names: 1,3-Dimethyl 5-hydroxycyclohexane-1,3-dicarboxylate, CAS: 113474-25-2, stock 138.8g, assay 98.7%, MWt 216.23, Formula C10H16O5, Purity >98%, SMILES COC(=O)C1CC(O)CC(C1)C(=O)OC, MDL NA |
| Drug_Names: Dimethyl 2-aminoisophthalate, CAS: 57053-02-8, stock 898.6g, assay 99%, MWt 209.20, Formula C10H11NO4, Purity >98%, SMILES COC(=O)C1=CC=CC(C(=O)OC)=C1N, MDL MFCD18431747 |
| Drug_Names: 1,3-Dimethyl 2-(4-methoxyphenyl)propanedioate, CAS: 71146-13-9, stock 171.2g, assay 98.9%, MWt 238.24, Formula C12H14O5, Purity >98%, SMILES COC(=O)C(C(=O)OC)C1=CC=C(OC)C=C1, MDL NA |
| Drug_Names: 1,3-Dihydro-2,1-benzoxaborole-1,5-diol, CAS: 1187190-70-0, stock 138.4g, assay 98.5%, MWt 149.94, Formula C7H7BO3, Purity >98%, SMILES OB1OCC2=C1C=CC(O)=C2, MDL NA |
| Drug_Names: Diethyl 2-(3,5-dichlorophenyl)malonate, CAS: 1186194-50-2, stock 525.1g, assay 98.4%, MWt 305.15, Formula C13H14Cl2O4, Purity >98%, SMILES O=C(OCC)C(C1=CC(Cl)=CC(Cl)=C1)C(OCC)=O, MDL NA |
| Drug_Names: 1,3-Dibromo-2-methoxy-4-methyl-5-nitrobenzene, CAS: 62265-99-0, stock 72.2g, assay 98.2%, MWt 324.95, Formula C8H7Br2NO3, Purity >98%, SMILES O=[N+](C1=C(C)C(Br)=C(OC)C(Br)=C1)[O-], MDL NA |
| Drug_Names: 1,3,3-Trimethylindolin-5-amine, CAS: 848047-45-0, stock 102.6g, assay 99%, MWt 176.26, Formula C11H16N2, Purity >98%, SMILES CN1CC(C)(C)C2=CC(N)=CC=C12, MDL NA |
| Drug_Names: (R)-di-tert-Butyl 4-oxopyrrolidine-1,2-dicarboxylate, CAS: 1260591-66-9, stock 312.5g, assay 98.5%, MWt 285.34, Formula C14H23NO5, Purity >98%, SMILES CC(C)(C)OC(=O)[C@H]1CC(=O)CN1C(=O)OC(C)(C)C, MDL NA |
| Drug_Names: Dimethyl 4-oxocyclopentane-1,2-dicarboxylate, CAS: 6453-07-2, stock 42.9g, assay 98.8%, MWt 200.19, Formula C9H12O5, Purity >98%, SMILES COC(=O)C1CC(=O)CC1C(=O)OC, MDL NA |
| Drug_Names: Dimethyl 3-bromophthalate, CAS: 58749-33-0, stock 233.3g, assay 98.3%, MWt 273.08, Formula C10H9BrO4, Purity >98%, SMILES COC(=O)C1=CC=CC(Br)=C1C(=O)OC, MDL NA |
| Drug_Names: Spiro[cyclopropane-1,3'-indoline] hydrochloride, CAS: 1788041-56-4, stock 678.1g, assay 98.4%, MWt 181.66, Formula C10H12ClN, Purity >98%, SMILES Cl.C1CC11CNC2=C1C=CC=C2, MDL NA |
| Drug_Names: Spiro[cyclohexane-1,3'-pyrrolo[2,3-b]pyridine]-2',4(1'H)-dione, CAS: 1638768-64-5, stock 543.6g, assay 98.4%, MWt 216.24, Formula C12H12N2O2, Purity >98%, SMILES O=C1NC2=NC=CC=C2C11CCC(=O)CC1, MDL NA |
| Drug_Names: 1,8-Naphthyridin-2(1H)-one, CAS: 15936-09-1, stock 720.9g, assay 98.3%, MWt 146.15, Formula C8H6N2O, Purity >98%, SMILES O=C1NC2=C(C=CC=N2)C=C1, MDL NA |
| Drug_Names: 1,2-Dicyclopropylethan-1-one, CAS: 14113-96-3, stock 785.9g, assay 98.5%, MWt 124.18, Formula C8H12O, Purity >98%, SMILES O=C(CC1CC1)C1CC1, MDL NA |
| Drug_Names: 3,8-Dimethyl-6-nitro-[1,2,4]triazolo[4,3-a]pyridine, CAS: 1639115-99-3, stock 756.4g, assay 98.1%, MWt 192.17, Formula C8H8N4O2, Purity >98%, SMILES CC1=NN=C2N1C=C(C=C2C)[N+]([O-])=O, MDL NA |
| Drug_Names: 5-Chloro-1,2,4-triazolo[4,3-a]pyridin-3-amine, CAS: 66999-63-1, stock 74.3g, assay 98%, MWt 168.58, Formula C6H5ClN4, Purity >98%, SMILES NC1=NN=C2C=CC=C(Cl)N12, MDL NA |
| Drug_Names: 1,2,3-Oxathiazolidine,3-ethyl-,2,2-dioxide, CAS: 153631-34-6, stock 206g, assay 98.4%, MWt 151.18, Formula C4H9NO3S, Purity >98%, SMILES CCN1CCOS1(=O)=O, MDL NA |
| Drug_Names: 3,4-Dihydro-1,8-naphthyridin-2(1H)-one, CAS: 40000-79-1, stock 712.1g, assay 98.3%, MWt 148.16, Formula C8H8N2O, Purity >98%, SMILES O=C1CCC2=CC=CN=C2N1, MDL NA |
| Drug_Names: 1,2,3,4-Tetrahydro-1,6-naphthyridin-2-one, CAS: 14757-41-6, stock 529.1g, assay 98.6%, MWt 148.16, Formula C8H8N2O, Purity >98%, SMILES O=C1CCC2=CN=CC=C2N1, MDL NA |
| Drug_Names: 1,1-Dimethylisoindoline, CAS: 712262-06-1, stock 498.4g, assay 98.1%, MWt 147.22, Formula C10H13N, Purity >98%, SMILES CC1(C)NCC2=CC=CC=C12, MDL NA |
| Drug_Names: Dimethyl 3-oxocyclobutane-1,1-dicarboxylate, CAS: 1486409-21-5, stock 879.6g, assay 98.1%, MWt 186.16, Formula C8H10O5, Purity >98%, SMILES COC(=O)C1(CC(=O)C1)C(=O)OC, MDL NA |
| Drug_Names: 1,1-Difluoro-6-azaspiro[2.5]octane hydrochloride, CAS: 1263132-31-5, stock 669g, assay 98%, MWt 183.63, Formula C7H12ClF2N, Purity >98%, SMILES Cl.FC1(F)CC11CCNCC1, MDL NA |
| Drug_Names: 1,1-Difluoro-5-azaspiro[2.5]octane hydrochloride, CAS: 1630906-35-2, stock 808.9g, assay 98.9%, MWt 183.63, Formula C7H12ClF2N, Purity >98%, SMILES Cl.FC1(F)CC11CCCNC1, MDL NA |
| Drug_Names: 1,1-Difluoro-5-azaspiro[2.4]heptane hydrochloride, CAS: 1215071-12-7, stock 651.6g, assay 98.2%, MWt 169.60, Formula C6H10ClF2N, Purity >98%, SMILES Cl.FC1(F)CC11CCNC1, MDL NA |
| Drug_Names: 1,1-Difluoro-5-azaspiro[2.3]hexane hydrochloride, CAS: 1630906-91-0, stock 17.6g, assay 98.7%, MWt 155.57, Formula C5H8ClF2N, Purity >98%, SMILES Cl.FC1(F)CC11CNC1, MDL NA |
| Drug_Names: 1,1-Difluoro-3-(iodomethyl)cyclobutane, CAS: 1434142-22-9, stock 501g, assay 98.6%, MWt 232.01, Formula C5H7F2I, Purity >98%, SMILES FC1(F)CC(CI)C1, MDL NA |
| Drug_Names: 1,1-Diethyl 3-oxocyclobutane-1,1-dicarboxylate, CAS: 99173-61-2, stock 213g, assay 98.5%, MWt 214.22, Formula C10H14O5, Purity >98%, SMILES CCOC(=O)C1(CC(=O)C1)C(=O)OCC, MDL NA |
| Drug_Names: Diethyl 3-(benzyloxy)cyclobutane-1,1-dicarboxylate, CAS: 54166-15-3, stock 635.6g, assay 98.1%, MWt 306.35, Formula C17H22O5, Purity >98%, SMILES CCOC(=O)C1(CC(C1)OCC1=CC=CC=C1)C(=O)OCC, MDL NA |
| Drug_Names: Diisopropyl 3-fluorocyclobutane-1,1-dicarboxylate, CAS: 1403767-29-2, stock 713.8g, assay 98.7%, MWt 246.28, Formula C12H19FO4, Purity >98%, SMILES CC(C)OC(=O)C1(CC(F)C1)C(=O)OC(C)C, MDL NA |
| Drug_Names: Diisopropyl 3-((tert-butoxycarbonyl)amino)cyclobutane-1,1-dicarboxylate, CAS: 1363382-20-0, stock 810.2g, assay 98.9%, MWt 343.42, Formula C17H29NO6, Purity >98%, SMILES CC(C)OC(=O)C1(CC(C1)NC(=O)OC(C)(C)C)C(=O)OC(C)C, MDL NA |
| Drug_Names: Diisopropyl 3,3-dimethoxycyclobutane-1,1-dicarboxylate, CAS: 115118-68-8, stock 360.7g, assay 98.1%, MWt 288.34, Formula C14H24O6, Purity >98%, SMILES COC1(CC(C1)(C(=O)OC(C)C)C(=O)OC(C)C)OC, MDL NA |
| Drug_Names: Diisopropyl 3-(benzyloxy)cyclobutane-1,1-dicarboxylate, CAS: 869109-30-8, stock 624.9g, assay 98.1%, MWt 334.41, Formula C19H26O5, Purity >98%, SMILES CC(C)OC(=O)C1(CC(C1)OCC1=CC=CC=C1)C(=O)OC(C)C, MDL NA |
| Drug_Names: 1,1,1-Trifluoro-2-(piperidin-4-yl)propan-2-ol, CAS: 1227068-37-2, stock 446.8g, assay 98.7%, MWt 197.20, Formula C8H14F3NO, Purity >98%, SMILES CC(O)(C1CCNCC1)C(F)(F)F, MDL NA |
| Drug_Names: (2S,4S)-1-(tert-butoxycarbonyl)-2-methylpiperidine-4-carboxylic acid, CAS: 1820583-83-2, stock 431.3g, assay 98.9%, MWt 243.30, Formula C12H21NO4, Purity >98%, SMILES C[C@H]1C[C@H](CCN1C(=O)OC(C)(C)C)C(O)=O, MDL NA |
| Drug_Names: 1-(tert-Butyl) 3-methyl 3-aminopiperidine-1,3-dicarboxylate, CAS: 1779450-04-2, stock 242.7g, assay 98%, MWt 258.31, Formula C12H22N2O4, Purity >98%, SMILES COC(=O)C1(N)CCCN(C1)C(=O)OC(C)(C)C, MDL NA |
| Drug_Names: 1-(tert-Butyl) 3-methyl 3-aminoazetidine-1,3-dicarboxylate, CAS: 1782647-31-7, stock 783.6g, assay 98.5%, MWt 230.26, Formula C10H18N2O4, Purity >98%, SMILES COC(=O)C1(N)CN(C1)C(=O)OC(C)(C)C, MDL NA |
| Drug_Names: 1-(tert-Butyl) 2-methyl 5-hydroxypiperidine-1,2-dicarboxylate, CAS: 1822538-74-8, stock 221.8g, assay 98.9%, MWt 259.30, Formula C12H21NO5, Purity >98%, SMILES COC(=O)C1CCC(O)CN1C(=O)OC(C)(C)C, MDL NA |
| Drug_Names: 1,1-Di(aminomethyl)cyclobutane, CAS: 38932-71-7, stock 579.5g, assay 99%, MWt 114.19, Formula C6H14N2, Purity >98%, SMILES NCC1(CN)CCC1, MDL NA |
| Drug_Names: 1-(Trimethylsilyl)cyclopropane-1-carboxylic acid, CAS: 31469-29-1, stock 442.6g, assay 98.2%, MWt 158.27, Formula C7H14O2Si, Purity >98%, SMILES C[Si](C)(C)C1(CC1)C(O)=O, MDL NA |
| Drug_Names: 1-(Trifluoromethyl)cyclopropane-1-carboxamide, CAS: 1628184-67-7, stock 815.1g, assay 98.5%, MWt 153.10, Formula C5H6F3NO, Purity >98%, SMILES NC(=O)C1(CC1)C(F)(F)F, MDL NA |
| Drug_Names: 1-(Trifluoromethyl)-1H-pyrazole-4-carboxylic acid, CAS: 1402664-77-0, stock 203.6g, assay 98.2%, MWt 180.08, Formula C5H3F3N2O2, Purity >98%, SMILES OC(=O)C1=CN(N=C1)C(F)(F)F, MDL NA |
| Drug_Names: 1-(Trifluoromethyl)-1H-pyrazol-4-amine, CAS: 1706447-99-5, stock 741.4g, assay 98.3%, MWt 151.09, Formula C4H4F3N3, Purity >98%, SMILES NC1=CN(N=C1)C(F)(F)F, MDL NA |
| Drug_Names: 1-(Trifluoromethyl)-1H-pyrazol-3-amine, CAS: 1995071-75-4, stock 215g, assay 98.7%, MWt 151.09, Formula C4H4F3N3, Purity >98%, SMILES NC1=NN(C=C1)C(F)(F)F, MDL NA |
| Drug_Names: 1-(Tetrahydro-2H-pyran-2-yl)-3-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)-1H-pyrazole, CAS: 1279088-80-0, stock 341.9g, assay 98.6%, MWt 278.16, Formula C14H23BN2O3, Purity >98%, SMILES CC1(C)OB(OC1(C)C)C1=NN(C=C1)C1CCCCO1, MDL NA |
| Drug_Names: 3-(4-(4,4,5,5-Tetramethyl-1,3,2-dioxaborolan-2-yl)-1H-pyrazol-1-yl)tetrahydrothiophene 1,1-dioxide, CAS: 1233526-31-2, stock 235.1g, assay 98.3%, MWt 312.19, Formula C13H21BN2O4S, Purity >98%, SMILES CC1(C)OB(OC1(C)C)C1=CN(N=C1)C1CCS(=O)(=O)C1, MDL NA |
| Drug_Names: 1-(Pyrimidin-4-yl)pyrrolidin-3-amine dihydrochloride, CAS: 2098048-58-7, stock 724.4g, assay 98.2%, MWt 237.13, Formula C8H14Cl2N4, Purity >98%, SMILES Cl.Cl.NC1CCN(C1)C1=CC=NC=N1, MDL NA |
| Drug_Names: 1-(Pyrimidin-2-yl)cyclopropane-1-carboxylic acid, CAS: 1427022-89-6, stock 800.8g, assay 98.3%, MWt 164.16, Formula C8H8N2O2, Purity >98%, SMILES OC(=O)C1(CC1)C1=NC=CC=N1, MDL NA |
| Drug_Names: 1-(Pyrimidin-2-yl)cyclopropan-1-amine dihydrochloride, CAS: 1159734-42-5, stock 597.7g, assay 98.9%, MWt 208.09, Formula C7H11Cl2N3, Purity >98%, SMILES Cl.Cl.NC1(CC1)C1=NC=CC=N1, MDL NA |
| Drug_Names: 1-(Pyrimidin-2-yl)cyclopropan-1-amine, CAS: 1159878-06-4, stock 557.6g, assay 98.3%, MWt 135.17, Formula C7H9N3, Purity >98%, SMILES NC1(CC1)C1=NC=CC=N1, MDL NA |
| Drug_Names: 1-(Pyrimidin-2-yl)azetidin-3-amine dihydrochloride, CAS: 1365968-57-5, stock 678.9g, assay 98%, MWt 223.10, Formula C7H12Cl2N4, Purity >98%, SMILES Cl.Cl.NC1CN(C1)C1=NC=CC=N1, MDL NA |
| Drug_Names: 1-(Pyridin-3-yl)-1H-pyrazole-4-carboxylic acid, CAS: 1014631-89-0, stock 595.1g, assay 98.7%, MWt 189.17, Formula C9H7N3O2, Purity >98%, SMILES OC(=O)C1=CN(N=C1)C1=CN=CC=C1, MDL NA |
| Drug_Names: 1-(Pyrazin-2-yl)cyclopropanecarboxylic acid, CAS: 1159734-52-7, stock 175.4g, assay 98.6%, MWt 164.16, Formula C8H8N2O2, Purity >98%, SMILES OC(=O)C1(CC1)C1=CN=CC=N1, MDL NA |
| Drug_Names: 1-Isopropylpiperidine-2,4-dione, CAS: 904301-91-3, stock 147.5g, assay 98.4%, MWt 155.19, Formula C8H13NO2, Purity >98%, SMILES CC(C)N1CCC(=O)CC1=O, MDL NA |
| Drug_Names: 1-(Propan-2-yl)azetidin-3-amine dihydrochloride, CAS: 117546-56-2, stock 779.5g, assay 99%, MWt 187.11, Formula C6H16Cl2N2, Purity >98%, SMILES Cl.Cl.CC(C)N1CC(N)C1, MDL NA |
| Drug_Names: 1-(Propan-2-yl)-1H-pyrazol-3-amine, CAS: 857267-04-0, stock 798.6g, assay 98.1%, MWt 125.17, Formula C6H11N3, Purity >98%, SMILES CC(C)N1C=CC(N)=N1, MDL NA |
| Drug_Names: 1-(Prop-2-en-1-yl)cyclopropane-1-carboxylic acid, CAS: 80360-57-2, stock 737.3g, assay 98.4%, MWt 126.15, Formula C7H10O2, Purity >98%, SMILES OC(=O)C1(CC=C)CC1, MDL NA |
| Drug_Names: 1-(Oxolan-3-yl)-1H-pyrazol-4-amine, CAS: 1311369-72-8, stock 51.4g, assay 99%, MWt 153.18, Formula C7H11N3O, Purity >98%, SMILES NC1=CN(N=C1)C1CCOC1, MDL NA |
| Drug_Names: 1-(Oxetan-3-ylmethyl)-4-(tetramethyl-1,3,2-dioxaborolan-2-yl)-1H-pyrazole, CAS: 1578484-07-7, stock 70.4g, assay 98.1%, MWt 264.13, Formula C13H21BN2O3, Purity >98%, SMILES CC1(C)OB(OC1(C)C)C1=CN(CC2COC2)N=C1, MDL NA |
| Drug_Names: 1-(Oxetan-3-yl)piperidin-4-amine oxalate, CAS: 1523571-88-1, stock 563.7g, assay 99%, MWt 246.26, Formula C10H18N2O5, Purity >98%, SMILES OC(=O)C(O)=O.NC1CCN(CC1)C1COC1, MDL NA |
| Drug_Names: 1-(Oxetan-3-yl)piperazine oxalate(2:1), CAS: 1523571-19-8, stock 3.8g, assay 98.9%, MWt 374.43, Formula C16H30N4O6, Purity >98%, SMILES OC(=O)C(O)=O.C1OCC1N1CCNCC1.C1OCC1N1CCNCC1, MDL NA |
| Drug_Names: 1-(Oxetan-3-yl)ethan-1-amine, CAS: 1544892-89-8, stock 547.4g, assay 98.7%, MWt 101.15, Formula C5H11NO, Purity >98%, SMILES CC(N)C1COC1, MDL MFCD26406835 |
| Drug_Names: 1-(Oxetan-3-yl)azetidin-3-amine; oxalic acid, CAS: 1630907-32-2, stock 131.2g, assay 98.1%, MWt 218.21, Formula C8H14N2O5, Purity >98%, SMILES OC(=O)C(O)=O.NC1CN(C1)C1COC1, MDL NA |
| Drug_Names: 1-(Oxetan-3-yl)-5-(tetramethyl-1,3,2-dioxaborolan-2-yl)-1H-pyrazole, CAS: 1876473-44-7, stock 512.4g, assay 98.1%, MWt 250.10, Formula C12H19BN2O3, Purity >98%, SMILES CC1(C)OB(OC1(C)C)C1=CC=NN1C1COC1, MDL NA |
| Drug_Names: 1-(Oxetan-3-yl)-1H-pyrazol-5-amine, CAS: 1349708-97-9, stock 822.8g, assay 98.8%, MWt 139.16, Formula C6H9N3O, Purity >98%, SMILES NC1=CC=NN1C1COC1, MDL NA |
| Drug_Names: 1-(Oxetan-3-yl)-1H-pyrazol-4-amine, CAS: 1338719-26-8, stock 148g, assay 98.3%, MWt 139.16, Formula C6H9N3O, Purity >98%, SMILES NC1=CN(N=C1)C1COC1, MDL NA |
| Drug_Names: 1-(Methanesulfonylmethyl)-4-(tetramethyl-1,3,2-dioxaborolan-2-yl)-1H-pyrazole, CAS: 1282530-99-7, stock 102.8g, assay 98%, MWt 286.16, Formula C11H19BN2O4S, Purity >98%, SMILES CC1(C)OB(OC1(C)C)C1=CN(CS(C)(=O)=O)N=C1, MDL NA |
| Drug_Names: 1-(Imidazo[1,2-a]pyridin-7-yl)ethanone, CAS: 1036991-50-0, stock 164.6g, assay 98.9%, MWt 160.17, Formula C9H8N2O, Purity >98%, SMILES CC(=O)C1=CC2=NC=CN2C=C1, MDL NA |
| Drug_Names: 1-(Ethylsulfonyl)piperazine hydrochloride, CAS: 859525-16-9, stock 551.3g, assay 98.1%, MWt 214.71, Formula C6H15ClN2O2S, Purity >98%, SMILES Cl.CCS(=O)(=O)N1CCNCC1, MDL NA |
| Drug_Names: 1-Benzhydryl-N-methylazetidin-3-amine, CAS: 69159-49-5, stock 243.9g, assay 98.2%, MWt 252.35, Formula C17H20N2, Purity >98%, SMILES CNC1CN(C1)C(C1=CC=CC=C1)C1=CC=CC=C1, MDL NA |
| Drug_Names: 1-Benzhydryl-3-methyleneazetidine, CAS: 40569-55-9, stock 316.3g, assay 98.8%, MWt 235.32, Formula C17H17N, Purity >98%, SMILES C=C1CN(C1)C(C1=CC=CC=C1)C1=CC=CC=C1, MDL NA |
| Drug_Names: 1-(Diphenylmethyl)-3-methylazetidin-3-ol hydrochloride, CAS: 133891-86-8, stock 142.2g, assay 98.8%, MWt 289.80, Formula C17H20ClNO, Purity >98%, SMILES Cl.CC1(O)CN(C1)C(C1=CC=CC=C1)C1=CC=CC=C1, MDL NA |
| Drug_Names: 1-(Diphenylmethyl)-3,3-difluoroazetidine, CAS: 288315-02-6, stock 365.9g, assay 98.6%, MWt 259.29, Formula C16H15F2N, Purity >98%, SMILES FC1(F)CN(C1)C(C1=CC=CC=C1)C1=CC=CC=C1, MDL NA |
| Drug_Names: 1-(Diphenylmethyl)-2-methylazetidin-3-one, CAS: 959062-84-1, stock 850.9g, assay 98.8%, MWt 251.32, Formula C17H17NO, Purity >98%, SMILES CC1N(CC1=O)C(C1=CC=CC=C1)C1=CC=CC=C1, MDL NA |
| Drug_Names: 1-(Diphenylmethyl)-2,2-dimethylazetidin-3-ol, CAS: 159556-73-7, stock 825.8g, assay 98.6%, MWt 267.37, Formula C18H21NO, Purity >98%, SMILES CC1(C)C(O)CN1C(C1=CC=CC=C1)C1=CC=CC=C1, MDL NA |
| Drug_Names: 1-(Diphenylmethyl)-2,2-dimethylazetidin-3-amine, CAS: 133891-73-3, stock 134.7g, assay 98.4%, MWt 266.38, Formula C18H22N2, Purity >98%, SMILES CC1(C)C(N)CN1C(C1=CC=CC=C1)C1=CC=CC=C1, MDL NA |
| Drug_Names: 1-(Difluoromethyl)-1H-pyrazol-4-amine, CAS: 1174309-16-0, stock 140.9g, assay 98.1%, MWt 133.10, Formula C4H5F2N3, Purity >98%, SMILES NC1=CN(N=C1)C(F)F, MDL NA |
| Drug_Names: 1-(Cyclopropanesulfonyl)-4-(tetramethyl-1,3,2-dioxaborolan-2-yl)-1H-pyrazole, CAS: 1612172-62-9, stock 437.4g, assay 98.3%, MWt 298.17, Formula C12H19BN2O4S, Purity >98%, SMILES CC1(C)OB(OC1(C)C)C1=CN(N=C1)S(=O)(=O)C1CC1, MDL NA |
| Drug_Names: 1-(Cyclobutylmethyl)-4-(tetramethyl-1,3,2-dioxaborolan-2-yl)-1H-pyrazole, CAS: 1233526-47-0, stock 881.2g, assay 98.4%, MWt 262.16, Formula C14H23BN2O2, Purity >98%, SMILES CC1(C)OB(OC1(C)C)C1=CN(CC2CCC2)N=C1, MDL NA |
| Drug_Names: 1-(Bromomethyl)cyclopent-1-ene, CAS: 69543-15-3, stock 289.8g, assay 98.3%, MWt 161.04, Formula C6H9Br, Purity >98%, SMILES BrCC1=CCCC1, MDL NA |
| Drug_Names: 1-(Bromomethyl)cyclohex-1-ene, CAS: 37677-17-1, stock 139.6g, assay 98.8%, MWt 175.07, Formula C7H11Br, Purity >98%, SMILES BrCC1=CCCCC1, MDL NA |
| Drug_Names: 1-(Bromomethyl)bicyclo[1.1.1]pentane, CAS: 161043-38-5, stock 59.8g, assay 98.3%, MWt 161.04, Formula C6H9Br, Purity >98%, SMILES BrCC12CC(C1)C2, MDL NA |
| Drug_Names: 1-(Benzenesulfonyl)-6-iodo-2-methyl-1H-indole, CAS: 1818847-55-0, stock 78.1g, assay 98.4%, MWt 397.23, Formula C15H12INO2S, Purity >98%, SMILES CC1=CC2=C(C=C(I)C=C2)N1S(=O)(=O)C1=CC=CC=C1, MDL NA |
| Drug_Names: 1-(Benzenesulfonyl)-6-chloro-2-iodo-1H-pyrrolo[3,2-c]pyridine, CAS: 1227267-17-5, stock 499.5g, assay 99%, MWt 418.64, Formula C13H8ClIN2O2S, Purity >98%, SMILES ClC1=NC=C2C=C(I)N(C2=C1)S(=O)(=O)C1=CC=CC=C1, MDL NA |
| Drug_Names: 1-(Benzenesulfonyl)-4-chloro-5-nitro-1H-pyrrolo[2,3-b]pyridine, CAS: 1245649-52-8, stock 510.2g, assay 98.9%, MWt 337.74, Formula C13H8ClN3O4S, Purity >98%, SMILES [O-][N+](=O)C1=CN=C2N(C=CC2=C1Cl)S(=O)(=O)C1=CC=CC=C1, MDL NA |
| Drug_Names: 1-(Benzenesulfonyl)-4-bromo-6-fluoro-1H-indole, CAS: 1001394-95-1, stock 343.6g, assay 98.5%, MWt 354.19, Formula C14H9BrFNO2S, Purity >98%, SMILES FC1=CC2=C(C=CN2S(=O)(=O)C2=CC=CC=C2)C(Br)=C1, MDL NA |
| Drug_Names: 1-(Benzenesulfonyl)-4-bromo-1H-indazole, CAS: 1001415-32-2, stock 663g, assay 98.8%, MWt 337.19, Formula C13H9BrN2O2S, Purity >98%, SMILES BrC1=CC=CC2=C1C=NN2S(=O)(=O)C1=CC=CC=C1, MDL NA |
| Drug_Names: 1-(Benzenesulfonyl)-4,6-dichloro-3-iodo-1H-pyrrolo[2,3-b]pyridine, CAS: 2055841-50-2, stock 141.8g, assay 98.4%, MWt 453.08, Formula C13H7Cl2IN2O2S, Purity >98%, SMILES ClC1=NC2=C(C(I)=CN2S(=O)(=O)C2=CC=CC=C2)C(Cl)=C1, MDL NA |
| Drug_Names: 1-(Benzenesulfonyl)-3-bromo-6-chloro-1H-pyrrolo[2,3-b]pyridine, CAS: 1638761-42-8, stock 716.7g, assay 98.2%, MWt 371.64, Formula C13H8BrClN2O2S, Purity >98%, SMILES ClC1=CC=C2C(Br)=CN(C2=N1)S(=O)(=O)C1=CC=CC=C1, MDL NA |
| Drug_Names: 1-(Benzenesulfonyl)-3-bromo-1H-pyrrole, CAS: 1192217-75-6, stock 138.7g, assay 98.2%, MWt 286.15, Formula C10H8BrNO2S, Purity >98%, SMILES BrC1=CN(C=C1)S(=O)(=O)C1=CC=CC=C1, MDL NA |
| Drug_Names: 1-(Benzenesulfonyl)-3-bromo-1h-indazole, CAS: 1788041-55-3, stock 642.2g, assay 98.1%, MWt 337.19, Formula C13H9BrN2O2S, Purity >98%, SMILES BrC1=NN(C2=C1C=CC=C2)S(=O)(=O)C1=CC=CC=C1, MDL NA |
| Drug_Names: 1-(Benzenesulfonyl)-3-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)-1H-pyrrolo[2,3-c]pyridine, CAS: 1174038-65-3, stock 570.3g, assay 98.9%, MWt 384.26, Formula C19H21BN2O4S, Purity >98%, SMILES CC1(C)OB(OC1(C)C)C1=CN(C2=CN=CC=C12)S(=O)(=O)C1=CC=CC=C1, MDL NA |
| Drug_Names: 1-(Benzenesulfonyl)-2-iodo-1H-pyrrolo[3,2-c]pyridine, CAS: 877060-44-1, stock 142.7g, assay 98.3%, MWt 384.19, Formula C13H9IN2O2S, Purity >98%, SMILES IC1=CC2=CN=CC=C2N1S(=O)(=O)C1=CC=CC=C1, MDL NA |
| Drug_Names: 1-(Benzenesulfonyl)-2-(difluoromethyl)-1H-pyrrolo[2,3-b]pyridine, CAS: 1363381-32-1, stock 89.1g, assay 98.5%, MWt 308.30, Formula C14H10F2N2O2S, Purity >98%, SMILES FC(F)C1=CC2=C(N=CC=C2)N1S(=O)(=O)C1=CC=CC=C1, MDL NA |
| Drug_Names: 1-(Benzenesulfonyl)-1H-pyrrolo[2,3-c]pyridine, CAS: 867034-27-3, stock 344.4g, assay 98.6%, MWt 258.30, Formula C13H10N2O2S, Purity >98%, SMILES O=S(=O)(N1C=CC2=CC=NC=C12)C1=CC=CC=C1, MDL NA |
| Drug_Names: 1-(Benzenesulfonyl)-1H-indole-2-carbaldehyde, CAS: 80360-23-2, stock 423.1g, assay 98.4%, MWt 285.32, Formula C15H11NO3S, Purity >98%, SMILES [H]C(=O)C1=CC2=CC=CC=C2N1S(=O)(=O)C1=CC=CC=C1, MDL NA |
| Drug_Names: 1-(Azetidin-3-yl)pyrrolidine dihydrochloride, CAS: 1024589-68-1, stock 767.7g, assay 98.9%, MWt 199.12, Formula C7H16Cl2N2, Purity >98%, SMILES Cl.Cl.C1NCC1N1CCCC1, MDL NA |
| Drug_Names: 1-(Azetidin-3-yl)ethan-1-ol hydrochloride, CAS: 2068152-34-9, stock 183.4g, assay 98.1%, MWt 137.61, Formula C5H12ClNO, Purity >98%, SMILES Cl.CC(O)C1CNC1, MDL NA |
| Drug_Names: 1-(Azetidin-3-yl)-3-methylazetidin-3-ol dihydrochloride, CAS: 1403766-73-3, stock 782.5g, assay 98.1%, MWt 215.12, Formula C7H16Cl2N2O, Purity >98%, SMILES Cl.Cl.CC1(O)CN(C1)C1CNC1, MDL NA |
| Drug_Names: 1-(Azetidin-3-yl)-3-fluoropyrrolidine dihydrochloride, CAS: 1403766-81-3, stock 768.9g, assay 98.4%, MWt 217.11, Formula C7H15Cl2FN2, Purity >98%, SMILES Cl.Cl.FC1CCN(C1)C1CNC1, MDL NA |
| Drug_Names: 3-Fluoro-1,3'-biazetidine hydrochloride, CAS: 1426290-05-2, stock 295.9g, assay 98.9%, MWt 166.62, Formula C6H12ClFN2, Purity >98%, SMILES FC1CN(C2CNC2)C1.[H]Cl, MDL NA |
| Drug_Names: 1-(Azetidin-3-yl)-3,3-difluoropyrrolidine dihydrochloride, CAS: 1403766-97-1, stock 798.2g, assay 98.8%, MWt 235.10, Formula C7H14Cl2F2N2, Purity >98%, SMILES Cl.Cl.FC1(F)CCN(C1)C1CNC1, MDL NA |
| Drug_Names: 1-(Aminomethyl)cyclobutane-1-carboxylic acid hydrochloride, CAS: 1360547-44-9, stock 201.1g, assay 98.5%, MWt 165.62, Formula C6H12ClNO2, Purity >98%, SMILES Cl.NCC1(CCC1)C(O)=O, MDL NA |
| Drug_Names: 1-(6-Chloropyridazin-3-yl)ethanone, CAS: 214701-31-2, stock 799.3g, assay 98.9%, MWt 156.57, Formula C6H5ClN2O, Purity >98%, SMILES CC(=O)C1=CC=C(Cl)N=N1, MDL NA |
| Drug_Names: 1-(6-Bromo-1H-indol-4-yl)ethan-1-one, CAS: 2055841-48-8, stock 31.2g, assay 98%, MWt 238.08, Formula C10H8BrNO, Purity >98%, SMILES CC(=O)C1=CC(Br)=CC2=C1C=CN2, MDL NA |
| Drug_Names: 1-(5-Fluoropyridin-2-yl)ethanamine, CAS: 915720-57-9, stock 697.4g, assay 98.9%, MWt 140.16, Formula C7H9FN2, Purity >98%, SMILES CC(N)C1=NC=C(F)C=C1, MDL NA |
| Drug_Names: 1-(5-Chlorothiophen-3-yl)ethanone, CAS: 58119-67-8, stock 32.2g, assay 98.6%, MWt 160.62, Formula C6H5ClOS, Purity >98%, SMILES CC(=O)C1=CSC(Cl)=C1, MDL NA |
| Drug_Names: 1-(5-Chlorothiophen-3-yl)ethanol, CAS: 1363383-08-7, stock 340.8g, assay 98.8%, MWt 162.64, Formula C6H7ClOS, Purity >98%, SMILES CC(O)C1=CSC(Cl)=C1, MDL NA |
| Drug_Names: 1-(5-Bromopyrimidin-2-yl)cyclopropan-1-amine hydrochloride, CAS: 2055841-13-7, stock 75.2g, assay 99%, MWt 250.52, Formula C7H9BrClN3, Purity >98%, SMILES Cl.NC1(CC1)C1=NC=C(Br)C=N1, MDL NA |
| Drug_Names: 1-(5-Bromopyridin-3-yl)cyclopropane-1-carboxylic acid, CAS: 1256038-40-0, stock 254.3g, assay 98.6%, MWt 242.07, Formula C9H8BrNO2, Purity >98%, SMILES OC(=O)C1(CC1)C1=CC(Br)=CN=C1, MDL NA |
| Drug_Names: 1-(5-Bromopyridin-3-yl)cyclopropan-1-amine hydrochloride, CAS: 1993189-05-1, stock 11.8g, assay 98.2%, MWt 249.54, Formula C8H10BrClN2, Purity >98%, SMILES Cl.NC1(CC1)C1=CC(Br)=CN=C1, MDL NA |
| Drug_Names: 1-(5-Bromo-3-iodo-6-methyl-1h-indazol-1-yl)ethan-1-one, CAS: 1788054-76-1, stock 762.6g, assay 98.7%, MWt 378.99, Formula C10H8BrIN2O, Purity >98%, SMILES CC(=O)N1N=C(I)C2=C1C=C(C)C(Br)=C2, MDL NA |
| Drug_Names: 1-(5-Bromo-1,3-thiazol-2-yl)ethan-1-one, CAS: 774230-98-7, stock 275.7g, assay 98.4%, MWt 206.06, Formula C5H4BrNOS, Purity >98%, SMILES CC(=O)C1=NC=C(Br)S1, MDL NA |
| Drug_Names: 1-(4-Methyltetrahydro-2H-pyran-4-yl)ethanone, CAS: 887481-28-9, stock 816.3g, assay 98.5%, MWt 142.20, Formula C8H14O2, Purity >98%, SMILES CC(=O)C1(C)CCOCC1, MDL NA |
| Drug_Names: 1-[(4-Methylphenyl)sulfonyl]-3-azetidinone, CAS: 76543-27-6, stock 24.9g, assay 98.6%, MWt 225.26, Formula C10H11NO3S, Purity >98%, SMILES CC1=CC=C(C=C1)S(=O)(=O)N1CC(=O)C1, MDL NA |
| Drug_Names: 1-Tosyl-2,5-dihydro-1H-pyrrole, CAS: 16851-72-2, stock 162g, assay 98.4%, MWt 223.29, Formula C11H13NO2S, Purity >98%, SMILES CC1=CC=C(C=C1)S(=O)(=O)N1CC=CC1, MDL NA |
| Drug_Names: 1-(4-Methoxypyridin-3-yl)ethanone, CAS: 191725-82-3, stock 826.8g, assay 98.1%, MWt 151.16, Formula C8H9NO2, Purity >98%, SMILES COC1=C(C=NC=C1)C(C)=O, MDL NA |
| Drug_Names: 1-(3-Methyloxetan-3-yl)ethanone, CAS: 1363381-04-7, stock 328.3g, assay 98%, MWt 114.14, Formula C6H10O2, Purity >98%, SMILES CC(=O)C1(C)COC1, MDL NA |
| Drug_Names: 1-(3-Methoxypropyl)piperidin-4-amine, CAS: 179474-79-4, stock 581.5g, assay 99%, MWt 172.27, Formula C9H20N2O, Purity >98%, SMILES COCCCN1CCC(N)CC1, MDL NA |
| Drug_Names: 1-(3-Hydroxypropyl)cyclobutan-1-ol, CAS: 1584139-24-1, stock 349.4g, assay 98.9%, MWt 130.18, Formula C7H14O2, Purity >98%, SMILES OCCCC1(O)CCC1, MDL NA |
| Drug_Names: 1-(3-Hydroxycyclobutyl)ethan-1-one, CAS: 30494-01-0, stock 334g, assay 98.7%, MWt 114.14, Formula C6H10O2, Purity >98%, SMILES CC(=O)C1CC(O)C1, MDL NA |
| Drug_Names: 1-(3-Fluoropyridin-2-yl)-3-oxocyclobutane-1-carbonitrile, CAS: 1344145-36-3, stock 599.6g, assay 98.7%, MWt 190.17, Formula C10H7FN2O, Purity >98%, SMILES FC1=CC=CN=C1C1(CC(=O)C1)C#N, MDL NA |
| Drug_Names: 1-(3-Fluoro-4-methoxyphenyl)cyclopropanamine hydrochloride, CAS: 1860028-22-3, stock 100.3g, assay 98.9%, MWt 217.67, Formula C10H13ClFNO, Purity >98%, SMILES Cl.COC1=C(F)C=C(C=C1)C1(N)CC1, MDL NA |
| Drug_Names: 1-(3-Chloropyridin-2-yl)ethanone, CAS: 131109-75-6, stock 896.8g, assay 98.7%, MWt 155.58, Formula C7H6ClNO, Purity >98%, SMILES CC(=O)C1=NC=CC=C1Cl, MDL NA |
| Drug_Names: 1-(3-Chloropyrazin-2-yl)ethanone, CAS: 121246-90-0, stock 193.1g, assay 99%, MWt 156.57, Formula C6H5ClN2O, Purity >98%, SMILES CC(=O)C1=NC=CN=C1Cl, MDL NA |
| Drug_Names: 1-(3-Chloropropyl)pyrrolidine oxalate(1:?), CAS: 1022112-22-6, stock 423.8g, assay 98.3%, MWt 237.68, Formula C9H16ClNO4, Purity >98%, SMILES OC(=O)C(O)=O.ClCCCN1CCCC1, MDL NA |
| Drug_Names: 1-(3-Chloro-2-hydroxyphenyl)propan-1-one, CAS: 938-67-0, stock 16.5g, assay 98.7%, MWt 184.62, Formula C9H9ClO2, Purity >98%, SMILES CCC(=O)C1=C(O)C(Cl)=CC=C1, MDL NA |
| Drug_Names: 1-(3-Bromo-4-chlorophenyl)cyclopropan-1-ol, CAS: 1691720-00-9, stock 898.2g, assay 98.3%, MWt 247.52, Formula C9H8BrClO, Purity >98%, SMILES OC1(CC1)C1=CC=C(Cl)C(Br)=C1, MDL NA |
| Drug_Names: 1-(3-Aminoazetidin-1-yl)ethanone hydrochloride, CAS: 1462921-50-1, stock 150.2g, assay 98.6%, MWt 150.61, Formula C5H11ClN2O, Purity >98%, SMILES Cl.CC(=O)N1CC(N)C1, MDL NA |
| Drug_Names: 1-(5-Amino-1H-pyrazol-3-yl)ethanone, CAS: 1373267-26-5, stock 147.6g, assay 98.6%, MWt 125.13, Formula C5H7N3O, Purity >98%, SMILES CC(C1=NNC(N)=C1)=O, MDL NA |
| Drug_Names: 1-(3,4-Dichlorophenyl)-3-azabicyclo[3.1.0]hexane hydrochloride, CAS: 86215-36-3, stock 629.8g, assay 98.8%, MWt 264.58, Formula C11H12Cl3N, Purity >98%, SMILES Cl.ClC1=C(Cl)C=C(C=C1)C12CC1CNC2, MDL NA |
| Drug_Names: 1-(3,3-Difluorocyclobutyl)ethan-1-one, CAS: 1621223-57-1, stock 355.3g, assay 98.3%, MWt 134.12, Formula C6H8F2O, Purity >98%, SMILES CC(=O)C1CC(F)(F)C1, MDL NA |
| Drug_Names: 1-(3,3-Difluorocyclobutyl)ethan-1-ol, CAS: 1784303-38-3, stock 326.5g, assay 98.7%, MWt 136.14, Formula C6H10F2O, Purity >98%, SMILES CC(O)C1CC(F)(F)C1, MDL NA |
| Drug_Names: 1-(2-Methyl-2H-indazol-7-yl)ethan-1-one, CAS: 1159511-30-4, stock 412.9g, assay 98.4%, MWt 174.20, Formula C10H10N2O, Purity >98%, SMILES CN1C=C2C=CC=C(C(C)=O)C2=N1, MDL NA |
| Drug_Names: 1-(2-Methoxyethyl)piperidin-4-ol, CAS: 512778-95-9, stock 869.3g, assay 98.9%, MWt 159.23, Formula C8H17NO2, Purity >98%, SMILES COCCN1CCC(O)CC1, MDL NA |
| Drug_Names: 1-(2-Methanesulfonylethyl)-4-(tetramethyl-1,3,2-dioxaborolan-2-yl)-1H-pyrazole, CAS: 1339892-52-2, stock 124.7g, assay 98.6%, MWt 300.18, Formula C12H21BN2O4S, Purity >98%, SMILES CC1(C)OB(OC1(C)C)C1=CN(CCS(C)(=O)=O)N=C1, MDL NA |
| Drug_Names: 1-(2-Hydroxyethyl)cyclopropane-1-carbonitrile, CAS: 1849196-57-1, stock 118.1g, assay 98.1%, MWt 111.14, Formula C6H9NO, Purity >98%, SMILES OCCC1(CC1)C#N, MDL NA |
| Drug_Names: 1-(2-Hydroxyethyl)cyclopropan-1-ol, CAS: 128312-78-7, stock 57.1g, assay 98.2%, MWt 102.13, Formula C5H10O2, Purity >98%, SMILES OCCC1(O)CC1, MDL NA |
| Drug_Names: 1-(2-Fluoroethyl)-4-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)-1H-pyrazole, CAS: 1049730-39-3, stock 213.8g, assay 98.8%, MWt 240.08, Formula C11H18BFN2O2, Purity >98%, SMILES CC1(C)OB(OC1(C)C)C1=CN(CCF)N=C1, MDL NA |
| Drug_Names: 1-(2-Fluorobenzyl)-1H-pyrazolo[3,4-b]pyridine-3-carboximidamide hydrochloride, CAS: 256499-19-1, stock 202.4g, assay 98.8%, MWt 305.74, Formula C14H13ClFN5, Purity >98%, SMILES Cl.NC(=N)C1=NN(CC2=CC=CC=C2F)C2=C1C=CC=N2, MDL NA |
| Drug_Names: 1-(2-Chloropyrimidin-5-yl)ethan-1-ol, CAS: 1279822-48-8, stock 633.4g, assay 98.3%, MWt 158.59, Formula C6H7ClN2O, Purity >98%, SMILES CC(O)C1=CN=C(Cl)N=C1, MDL NA |
| Drug_Names: 1-(2-Chloroethyl)cyclopropane-1-carboxylic acid, CAS: 1849381-55-0, stock 698.8g, assay 98.2%, MWt 148.59, Formula C6H9ClO2, Purity >98%, SMILES OC(=O)C1(CCCl)CC1, MDL NA |
| Drug_Names: 1-(2-Bromoethyl)-4-methylpiperazine dihydrobromide, CAS: 5845-28-3, stock 899.7g, assay 98.9%, MWt 368.94, Formula C7H17Br3N2, Purity >98%, SMILES CN1CCN(CCBr)CC1.[H]Br.[H]Br, MDL NA |
| Drug_Names: 1-(2-Bromoethyl)-2,3,4-trifluorobenzene, CAS: 887586-25-6, stock 188.2g, assay 98.4%, MWt 239.03, Formula C8H6BrF3, Purity >98%, SMILES FC1=C(F)C(F)=C(CCBr)C=C1, MDL NA |
| Drug_Names: 1'-(2-Bromoethyl)-1',2'-dihydrospiro[cyclopropane-1,3'-pyrrolo[2,3-b]pyridine]-2'-one, CAS: 1818847-40-3, stock 34.9g, assay 98.1%, MWt 267.12, Formula C11H11BrN2O, Purity >98%, SMILES BrCCN1C(=O)C2(CC2)C2=C1N=CC=C2, MDL NA |
| Drug_Names: 1-(2-Aminoethyl)cyclopropane-1-carboxylic acid hydrochloride, CAS: 1421602-17-6, stock 504.1g, assay 98.3%, MWt 165.62, Formula C6H12ClNO2, Purity >98%, SMILES Cl.NCCC1(CC1)C(O)=O, MDL NA |
| Drug_Names: 1-(2-Aminoethyl)cyclopropanecarboxylic acid, CAS: 126822-37-5, stock 430.7g, assay 98.4%, MWt 129.16, Formula C6H11NO2, Purity >98%, SMILES NCCC1(CC1)C(O)=O, MDL NA |
| Drug_Names: 1-(2-Aminothiazol-5-yl)ethanone, CAS: 53159-71-0, stock 112.6g, assay 98.9%, MWt 142.18, Formula C5H6N2OS, Purity >98%, SMILES CC(=O)C1=CN=C(N)S1, MDL MFCD00775044 |
| Drug_Names: 1-(2,4-Dichloropyrimidin-5-yl)ethanone, CAS: 871254-62-5, stock 88.3g, assay 98.7%, MWt 191.01, Formula C6H4Cl2N2O, Purity >98%, SMILES CC(=O)C1=CN=C(Cl)N=C1Cl, MDL NA |
| Drug_Names: 1-(2,2-Difluoroethyl)azetidin-3-amine; bis(trifluoroacetic acid), CAS: 2102412-76-8, stock 748.2g, assay 98.1%, MWt 364.19, Formula C9H12F8N2O4, Purity >98%, SMILES OC(=O)C(F)(F)F.OC(=O)C(F)(F)F.NC1CN(CC(F)F)C1, MDL NA |
| Drug_Names: 1-(2,2-Difluoroethyl)-4-(tetramethyl-1,3,2-dioxaborolan-2-yl)-1H-pyrazole, CAS: 1049730-40-6, stock 568.6g, assay 98.2%, MWt 258.07, Formula C11H17BF2N2O2, Purity >98%, SMILES CC1(C)OB(OC1(C)C)C1=CN(CC(F)F)N=C1, MDL NA |
| Drug_Names: 1-(2,2-Difluoroethyl)-1H-pyrazol-3-amine, CAS: 1006462-38-9, stock 369.4g, assay 98.7%, MWt 147.13, Formula C5H7F2N3, Purity >98%, SMILES NC1=NN(CC(F)F)C=C1, MDL NA |
| Drug_Names: 1-(2,2,2-Trifluoroethyl)azetidin-3-amine, CAS: 1339236-05-3, stock 196.2g, assay 98.1%, MWt 154.13, Formula C5H9F3N2, Purity >98%, SMILES NC1CN(CC(F)(F)F)C1, MDL NA |
| Drug_Names: 1-(1-Methyl-1H-pyrazol-4-yl)cyclopropanamine dihydrochloride, CAS: 1401426-05-8, stock 804g, assay 98.4%, MWt 210.10, Formula C7H13Cl2N3, Purity >98%, SMILES Cl.Cl.CN1C=C(C=N1)C1(N)CC1, MDL NA |
| Drug_Names: 1-(1-Methoxypropan-2-yl)piperazine dihydrochloride, CAS: 1258640-14-0, stock 846.5g, assay 98.2%, MWt 231.16, Formula C8H20Cl2N2O, Purity >98%, SMILES Cl.Cl.COCC(C)N1CCNCC1, MDL NA |
| Drug_Names: 1-((Tetrahydro-2H-pyran-4-yl)methyl)-4-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)-1H-pyrazole, CAS: 1220635-60-8, stock 208.8g, assay 98.4%, MWt 292.18, Formula C15H25BN2O3, Purity >98%, SMILES CC1(C)OB(OC1(C)C)C1=CN(CC2CCOCC2)N=C1, MDL NA |
| Drug_Names: cis-tert-Butyl 4-hydroxy-3-methylpiperidine-1-carboxylate, CAS: 955028-93-0, stock 79.1g, assay 98.8%, MWt 215.29, Formula C11H21NO3, Purity >98%, SMILES C[C@H]1CN(CC[C@H]1O)C(=O)OC(C)(C)C, MDL NA |
| Drug_Names: (2R,6R)-rel-1-Boc-2,6-dimethyl-4-hydroxypiperidine, CAS: 146337-39-5, stock 785.9g, assay 98.8%, MWt 229.32, Formula C12H23NO3, Purity >98%, SMILES C[C@@H]1CC(O)C[C@@H](C)N1C(=O)OC(C)(C)C, MDL NA |
| Drug_Names: tert-Butyl 4-bromo-3-methylpiperidine-1-carboxylate, CAS: 1281712-14-8, stock 57.6g, assay 98.6%, MWt 278.19, Formula C11H20BrNO2, Purity >98%, SMILES CC1CN(CCC1Br)C(=O)OC(C)(C)C, MDL NA |
| Drug_Names: tert-Butyl 4-bromo-3-fluoropiperidine-1-carboxylate, CAS: 1359944-91-4, stock 630.1g, assay 98.7%, MWt 282.15, Formula C10H17BrFNO2, Purity >98%, SMILES CC(C)(C)OC(=O)N1CCC(Br)C(F)C1, MDL NA |
| Drug_Names: tert-Butyl 4-bromo-2-methylpiperidine-1-carboxylate, CAS: 1281576-23-5, stock 813.6g, assay 98.3%, MWt 278.19, Formula C11H20BrNO2, Purity >98%, SMILES CC1CC(Br)CCN1C(=O)OC(C)(C)C, MDL NA |
| Drug_Names: tert-Butyl (3R,4S)-4-amino-3-hydroxypiperidine-1-carboxylate, CAS: 1821799-48-7, stock 795.8g, assay 98.4%, MWt 216.28, Formula C10H20N2O3, Purity >98%, SMILES CC(C)(C)OC(=O)N1CC[C@H](N)[C@H](O)C1, MDL NA |
| Drug_Names: Benzyl 3-methylenepiperidine-1-carboxylate, CAS: 138163-15-2, stock 468.2g, assay 98.3%, MWt 231.29, Formula C14H17NO2, Purity >98%, SMILES C=C1CCCN(C1)C(=O)OCC1=CC=CC=C1, MDL NA |
| Drug_Names: tert-Butyl 3-hydroxy-4,4-dimethylpiperidine-1-carboxylate, CAS: 955028-71-4, stock 596.1g, assay 98.1%, MWt 229.32, Formula C12H23NO3, Purity >98%, SMILES CC(C)(C)OC(=O)N1CCC(C)(C)C(O)C1, MDL NA |
| Drug_Names: (3S,4R)-tert-Butyl 3-amino-4-fluoropiperidine-1-carboxylate, CAS: 1290191-73-9, stock 300.6g, assay 98.9%, MWt 218.27, Formula C10H19FN2O2, Purity >98%, SMILES CC(C)(C)OC(=O)N1CC[C@@H](F)[C@@H](N)C1, MDL NA |
| Drug_Names: Benzyl 3-amino-3-methylpiperidine-1-carboxylate, CAS: 174543-80-7, stock 637.8g, assay 98.5%, MWt 248.32, Formula C14H20N2O2, Purity >98%, SMILES CC1(N)CCCN(C1)C(=O)OCC1=CC=CC=C1, MDL NA |
| Drug_Names: Benzyl 3-((tert-Butoxycarbonyl)amino)-5-hydroxypiperidine-1-carboxylate, CAS: 1785642-46-7, stock 548.5g, assay 98.4%, MWt 350.41, Formula C18H26N2O5, Purity >98%, SMILES CC(C)(C)OC(=O)NC1CC(O)CN(C1)C(=O)OCC1=CC=CC=C1, MDL NA |
| Drug_Names: Benzyl 3-carbamoyl-3-methylpiperidine-1-carboxylate, CAS: 174543-79-4, stock 637.4g, assay 98.9%, MWt 276.33, Formula C15H20N2O3, Purity >98%, SMILES CC1(CCCN(C1)C(=O)OCC1=CC=CC=C1)C(N)=O, MDL NA |
| Drug_Names: (R)-1-Boc-2-Cyanopiperidine, CAS: 940000-26-0, stock 761.9g, assay 98.8%, MWt 210.27, Formula C11H18N2O2, Purity >98%, SMILES CC(C)(C)OC(=O)N1CCCC[C@@H]1C#N, MDL NA |
| Drug_Names: tert-Butyl 3-(thiophen-2-yl)piperazine-1-carboxylate, CAS: 886771-38-6, stock 661.7g, assay 98.1%, MWt 268.38, Formula C13H20N2O2S, Purity >98%, SMILES CC(C)(C)OC(=O)N1CCNC(C1)C1=CC=CS1, MDL MFCD06660372 |
| Drug_Names: 1-Hydroxycyclobutanecarboxylic acid, CAS: 41248-13-9, stock 680.8g, assay 98.6%, MWt 116.12, Formula C5H8O3, Purity >98%, SMILES OC(=O)C1(O)CCC1, MDL NA |
| Drug_Names: 1-(Ethanesulfonyl)piperidin-4-one, CAS: 476373-84-9, stock 179.3g, assay 98.7%, MWt 191.25, Formula C7H13NO3S, Purity >98%, SMILES O=C1CCN(S(=O)(CC)=O)CC1, MDL NA |
| Drug_Names: Bicyclo[2.2.2]octan-1-ylmethanol, CAS: 2574-42-7, stock 895.5g, assay 98.2%, MWt 140.22, Formula C9H16O, Purity >98%, SMILES OCC12CCC(CC1)CC2, MDL NA |
| Drug_Names: (7-Methyl-7-azaspiro[3.5]nonan-2-yl)methanol, CAS: 1363360-02-4, stock 61.4g, assay 98.2%, MWt 169.26, Formula C10H19NO, Purity >98%, SMILES CN1CCC2(CC(CO)C2)CC1, MDL NA |
| Drug_Names: {4-Fluoro-1H-pyrrolo[2,3-b]pyridin-5-yl}boronic acid, CAS: 1626336-01-3, stock 273.7g, assay 98.3%, MWt 179.94, Formula C7H6BFN2O2, Purity >98%, SMILES OB(O)C1=C(F)C2=C(NC=C2)N=C1, MDL NA |
| Drug_Names: (4-Chloro-7H-pyrrolo[2,3-d]pyrimidin-5-yl)methanol, CAS: 1207543-24-5, stock 427.2g, assay 98.3%, MWt 183.60, Formula C7H6ClN3O, Purity >98%, SMILES OCC1=CNC2=NC=NC(Cl)=C12, MDL NA |
| Drug_Names: (3-Methyl-1H-pyrrolo[2,3-b]pyridin-5-yl)methanol, CAS: 1630906-52-3, stock 866.1g, assay 98.4%, MWt 162.19, Formula C9H10N2O, Purity >98%, SMILES CC1=CNC2=NC=C(CO)C=C12, MDL NA |
| Drug_Names: (3-Iodoimidazo[1,2-a]pyridin-7-yl)methanol, CAS: 1036990-66-5, stock 665.8g, assay 98.7%, MWt 274.06, Formula C8H7IN2O, Purity >98%, SMILES OCC1=CC2=NC=C(I)N2C=C1, MDL NA |
| Drug_Names: {3-Azabicyclo[3.2.1]octan-8-yl}methanol hydrochloride, CAS: 1427416-73-6, stock 635.1g, assay 98%, MWt 177.67, Formula C8H16ClNO, Purity >98%, SMILES Cl.OCC1C2CCC1CNC2, MDL NA |
| Drug_Names: {3-Aminobicyclo[1.1.1]pentan-1-yl}methanol, CAS: 1638767-26-6, stock 247.9g, assay 98.2%, MWt 113.16, Formula C6H11NO, Purity >98%, SMILES NC12CC(CO)(C1)C2, MDL NA |
| Drug_Names: {3-[(tert-Butyldimethylsilyl)oxy]cyclobutyl}methanol, CAS: 1394119-83-5, stock 355.7g, assay 98.8%, MWt 216.39, Formula C11H24O2Si, Purity >98%, SMILES CC(C)(C)[Si](C)(C)OC1CC(CO)C1, MDL NA |
| Drug_Names: {1-Methyl-1H-pyrrolo[2,3-b]pyridin-4-yl}methanol, CAS: 1268516-15-9, stock 385.3g, assay 98.7%, MWt 162.19, Formula C9H10N2O, Purity >98%, SMILES CN1C=CC2=C(CO)C=CN=C12, MDL NA |
| Drug_Names: {1-Methyl-1H-pyrazolo[3,4-b]pyridin-5-yl}methanol, CAS: 1221288-28-3, stock 25.9g, assay 98.1%, MWt 163.18, Formula C8H9N3O, Purity >98%, SMILES CN1N=CC2=CC(CO)=CN=C12, MDL NA |
| Drug_Names: (1-Methyl-1H-pyrazolo[3,4-b]pyridin-3-yl)methanamine, CAS: 1151512-20-7, stock 289.6g, assay 98.6%, MWt 162.19, Formula C8H10N4, Purity >98%, SMILES CN1N=C(CN)C2=CC=CN=C12, MDL NA |
| Drug_Names: (1H-Pyrrolo[2,3-c]pyridin-4-yl)boronic acid, CAS: 1312368-90-3, stock 631.6g, assay 98.7%, MWt 161.95, Formula C7H7BN2O2, Purity >98%, SMILES OB(O)C1=C2C=CNC2=CN=C1, MDL NA |
| Drug_Names: {1H-Pyrrolo[2,3-b]pyridin-4-yl}methanamine hydrochloride, CAS: 1860028-34-7, stock 865.5g, assay 98.5%, MWt 183.64, Formula C8H10ClN3, Purity >98%, SMILES Cl.NCC1=C2C=CNC2=NC=C1, MDL NA |
| Drug_Names: {1-[(tert-Butoxy)carbonyl]-1H-pyrrolo[2,3-c]pyridin-3-yl}boronic acid, CAS: 1326715-94-9, stock 786.7g, assay 98.1%, MWt 262.07, Formula C12H15BN2O4, Purity >98%, SMILES CC(C)(C)OC(=O)N1C=C(B(O)O)C2=CC=NC=C12, MDL NA |
| Drug_Names: {1-[(tert-Butoxy)carbonyl]-1H-pyrrolo[2,3-b]pyridin-3-yl}boronic acid, CAS: 1425334-89-9, stock 736.5g, assay 98.4%, MWt 262.07, Formula C12H15BN2O4, Purity >98%, SMILES CC(C)(C)OC(=O)N1C=C(B(O)O)C2=C1N=CC=C2, MDL NA |
| Drug_Names: {1-[(Acetyloxy)methyl]cyclopropyl}methyl acetate, CAS: 148420-14-8, stock 535.4g, assay 98.3%, MWt 186.21, Formula C9H14O4, Purity >98%, SMILES CC(=O)OCC1(COC(C)=O)CC1, MDL NA |
| Drug_Names: (4-(Trifluoromethyl)benzyl)hydrazine hydrochloride, CAS: 74195-71-4, stock 301.7g, assay 98.9%, MWt 226.63, Formula C8H10ClF3N2, Purity >98%, SMILES Cl.NNCC1=CC=C(C=C1)C(F)(F)F, MDL NA |
| Drug_Names: (3-(Trifluoromethoxy)benzyl)hydrazine dihydrochloride, CAS: 1427396-65-3, stock 867.1g, assay 98.9%, MWt 279.09, Formula C8H11Cl2F3N2O, Purity >98%, SMILES Cl.Cl.NNCC1=CC(OC(F)(F)F)=CC=C1, MDL NA |
| Drug_Names: ((3-(Bromomethyl)cyclobutoxy)methyl)benzene, CAS: 1379358-84-5, stock 720.2g, assay 98.3%, MWt 255.15, Formula C12H15BrO, Purity >98%, SMILES BrCC1CC(C1)OCC1=CC=CC=C1, MDL NA |
| Drug_Names: {[1,1'-Bi(cyclopropane)]-1-yl}methanol, CAS: 177719-30-1, stock 799.3g, assay 98.5%, MWt 112.17, Formula C7H12O, Purity >98%, SMILES OCC1(CC1)C1CC1, MDL NA |
| Drug_Names: {[(2S)-1,4-dioxan-2-yl]methyl}(methyl)amine hydrochloride, CAS: 2055848-87-6, stock 147.2g, assay 98.3%, MWt 167.63, Formula C6H14ClNO2, Purity >98%, SMILES Cl.CNC[C@H]1COCCO1, MDL NA |
| Drug_Names: {[(2R)-1,4-dioxan-2-yl]methyl}(methyl)amine hydrochloride, CAS: 917882-58-7, stock 206.1g, assay 98.2%, MWt 167.63, Formula C6H14ClNO2, Purity >98%, SMILES Cl.CNC[C@@H]1COCCO1, MDL NA |
| Drug_Names: [cis-3-Methoxycyclobutyl]methanamine hydrochloride, CAS: 2044706-13-8, stock 767.3g, assay 98.7%, MWt 151.63, Formula C6H14ClNO, Purity >98%, SMILES Cl.CO[C@@H]1C[C@H](CN)C1, MDL NA |
| Drug_Names: (6-(Trifluoromethyl)pyrimidin-4-yl)methanol, CAS: 1356111-18-6, stock 555.2g, assay 98.9%, MWt 178.11, Formula C6H5F3N2O, Purity >98%, SMILES OCC1=CC(=NC=N1)C(F)(F)F, MDL NA |
| Drug_Names: [5-Chloro-1-(4-methylbenzenesulfonyl)-1H-pyrrolo[2,3-b]pyridin-3-yl]boronic acid, CAS: 1417422-00-4, stock 156.9g, assay 98.7%, MWt 350.59, Formula C14H12BClN2O4S, Purity >98%, SMILES CC1=CC=C(C=C1)S(=O)(=O)N1C=C(B(O)O)C2=C1N=CC(Cl)=C2, MDL NA |
| Drug_Names: (5-(Methoxymethyl)-1H-pyrazol-3-yl)methanamine hydrochloride, CAS: 1297607-82-9, stock 872.3g, assay 98.3%, MWt 177.63, Formula C6H12ClN3O, Purity >98%, SMILES Cl.COCC1=CC(CN)=NN1, MDL NA |
| Drug_Names: (4-Chloro-2-(methylthio)pyrimidin-5-yl)methanol, CAS: 1044145-59-6, stock 446.8g, assay 98.7%, MWt 190.65, Formula C6H7ClN2OS, Purity >98%, SMILES OCC1=CN=C(SC)N=C1Cl, MDL NA |
| Drug_Names: (4-(Oxetan-3-yloxy)phenyl)methanamine, CAS: 1349719-23-8, stock 63g, assay 98.5%, MWt 179.22, Formula C10H13NO2, Purity >98%, SMILES NCC1=CC=C(OC2COC2)C=C1, MDL NA |
| Drug_Names: (4-(Methoxycarbonyl)-3-methylphenyl)boronic acid, CAS: 603122-81-2, stock 72.7g, assay 98.4%, MWt 193.99, Formula C9H11BO4, Purity >98%, SMILES COC(=O)C1=C(C)C=C(C=C1)B(O)O, MDL NA |
| Drug_Names: [4-(Hydroxymethyl)pyridin-3-yl]methanol hydrochloride, CAS: 53654-42-5, stock 515g, assay 98.7%, MWt 175.61, Formula C7H10ClNO2, Purity >98%, SMILES Cl.OCC1=C(CO)C=NC=C1, MDL NA |
| Drug_Names: Pyridine-3,4-diyldimethanol, CAS: 38070-80-3, stock 839.3g, assay 98.1%, MWt 139.15, Formula C7H9NO2, Purity >98%, SMILES OCC1=C(CO)C=NC=C1, MDL NA |
| Drug_Names: Piperidine-4,4-diyldimethanol hydrochloride, CAS: 884535-05-1, stock 151.5g, assay 98%, MWt 181.66, Formula C7H16ClNO2, Purity >98%, SMILES Cl.OCC1(CO)CCNCC1, MDL NA |
| Drug_Names: (3-Chloro-5-(trifluoromethyl)pyridin-2-yl)methanol, CAS: 1033463-31-8, stock 47.7g, assay 98.3%, MWt 211.57, Formula C7H5ClF3NO, Purity >98%, SMILES OCC1=NC=C(C=C1Cl)C(F)(F)F, MDL NA |
| Drug_Names: (3-Aminocyclobutane-1,1-diyl)dimethanol, CAS: 1208989-40-5, stock 839g, assay 98.2%, MWt 131.17, Formula C6H13NO2, Purity >98%, SMILES NC1CC(CO)(CO)C1, MDL NA |
| Drug_Names: (3-(Trifluoromethyl)pyridin-4-yl)boronic acid, CAS: 1204334-17-7, stock 853.3g, assay 98.9%, MWt 190.92, Formula C6H5BF3NO2, Purity >98%, SMILES OB(O)C1=C(C=NC=C1)C(F)(F)F, MDL NA |
| Drug_Names: (3-(Pyrrolidin-1-yl)oxetan-3-yl)methanamine, CAS: 1416323-30-2, stock 621.6g, assay 98%, MWt 156.23, Formula C8H16N2O, Purity >98%, SMILES NCC1(COC1)N1CCCC1, MDL NA |
| Drug_Names: [3-(Oxetan-3-yloxy)phenyl]methanamine, CAS: 1416323-28-8, stock 111.7g, assay 98%, MWt 179.22, Formula C10H13NO2, Purity >98%, SMILES NCC1=CC(OC2COC2)=CC=C1, MDL NA |
| Drug_Names: (3-(Methylamino)oxetan-3-yl)methanol, CAS: 1416323-17-5, stock 299.3g, assay 98%, MWt 117.15, Formula C5H11NO2, Purity >98%, SMILES CNC1(CO)COC1, MDL NA |
| Drug_Names: Oxetane-3,3-diyldimethanol, CAS: 2754-18-9, stock 621.5g, assay 98.4%, MWt 118.13, Formula C5H10O3, Purity >98%, SMILES OCC1(CO)COC1, MDL NA |
| Drug_Names: Azetidine-3,3-diyldimethanol hydrochloride, CAS: 1016232-92-0, stock 216.9g, assay 98.2%, MWt 153.61, Formula C5H12ClNO2, Purity >98%, SMILES Cl.OCC1(CO)CNC1, MDL NA |
| Drug_Names: [3-(Difluoromethyl)oxetan-3-yl]methanol, CAS: 1393688-82-8, stock 425.2g, assay 98.4%, MWt 138.11, Formula C5H8F2O2, Purity >98%, SMILES OCC1(COC1)C(F)F, MDL NA |
| Drug_Names: [3-(Difluoromethyl)oxetan-3-yl]methanamine, CAS: 1781121-31-0, stock 410.3g, assay 99%, MWt 137.13, Formula C5H9F2NO, Purity >98%, SMILES NCC1(COC1)C(F)F, MDL NA |
| Drug_Names: (3-(Bromomethyl)-1-tosylazetidin-3-yl)methanol, CAS: 1041026-55-4, stock 748g, assay 98.9%, MWt 334.23, Formula C12H16BrNO3S, Purity >98%, SMILES CC1=CC=C(C=C1)S(=O)(=O)N1CC(CO)(CBr)C1, MDL NA |
| Drug_Names: (3-(Benzylamino)oxetan-3-yl)methanol, CAS: 1195684-52-6, stock 283.7g, assay 98.2%, MWt 193.24, Formula C11H15NO2, Purity >98%, SMILES OCC1(COC1)NCC1=CC=CC=C1, MDL NA |
| Drug_Names: (3-(Aminomethyl)oxetan-3-yl)methanol hydrochloride, CAS: 1810070-02-0, stock 79.7g, assay 98.4%, MWt 153.61, Formula C5H12ClNO2, Purity >98%, SMILES Cl.NCC1(CO)COC1, MDL NA |
| Drug_Names: [3-(Aminomethyl)oxetan-3-yl]methanol oxalate(2:1), CAS: 1523571-98-3, stock 547.7g, assay 98.2%, MWt 324.33, Formula C12H24N2O8, Purity >98%, SMILES OC(=O)C(O)=O.NCC1(CO)COC1.NCC1(CO)COC1, MDL NA |
| Drug_Names: Oxetane-3,3-diyldimethanamine, CAS: 23500-57-4, stock 859.2g, assay 98.2%, MWt 116.16, Formula C5H12N2O, Purity >98%, SMILES NCC1(CN)COC1, MDL NA |
| Drug_Names: [3-(4-Methylphenyl)oxetan-3-yl]methanol, CAS: 1903050-29-2, stock 752.4g, assay 98.7%, MWt 178.23, Formula C11H14O2, Purity >98%, SMILES CC1=CC=C(C=C1)C1(CO)COC1, MDL NA |
| Drug_Names: (3-(4-Fluorophenyl)oxetan-3-yl)methanol, CAS: 1378472-32-2, stock 20.1g, assay 98.7%, MWt 182.19, Formula C10H11FO2, Purity >98%, SMILES OCC1(COC1)C1=CC=C(F)C=C1, MDL NA |
| Drug_Names: [3-(4-Chlorophenyl)oxetan-3-yl]methanol, CAS: 1903083-49-7, stock 734.5g, assay 98.7%, MWt 198.65, Formula C10H11ClO2, Purity >98%, SMILES OCC1(COC1)C1=CC=C(Cl)C=C1, MDL NA |
| Drug_Names: [3-(3-Methylphenyl)oxetan-3-yl]methanol, CAS: 1904269-10-8, stock 146.9g, assay 98.8%, MWt 178.23, Formula C11H14O2, Purity >98%, SMILES CC1=CC(=CC=C1)C1(CO)COC1, MDL NA |
| Drug_Names: [3-(1,1-Difluoroethyl)oxetan-3-yl]methanol, CAS: 2102412-02-0, stock 83.4g, assay 98.5%, MWt 152.14, Formula C6H10F2O2, Purity >98%, SMILES CC(F)(F)C1(CO)COC1, MDL NA |
| Drug_Names: (2-Methoxy-5-(trifluoromethyl)pyridin-3-yl)methanol, CAS: 1227581-36-3, stock 265.7g, assay 98.6%, MWt 207.15, Formula C8H8F3NO2, Purity >98%, SMILES COC1=C(CO)C=C(C=N1)C(F)(F)F, MDL NA |
| Drug_Names: (2-Chloro-5-(trifluoromethyl)pyridin-4-yl)boronic acid, CAS: 1167437-28-6, stock 728.9g, assay 98.3%, MWt 225.36, Formula C6H4BClF3NO2, Purity >98%, SMILES OB(O)C1=CC(Cl)=NC=C1C(F)(F)F, MDL NA |
| Drug_Names: [2-Amino-5-(tetramethyl-1,3,2-dioxaborolan-2-yl)phenyl]methanol, CAS: 1339927-45-5, stock 255.2g, assay 98.6%, MWt 249.11, Formula C13H20BNO3, Purity >98%, SMILES CC1(C)OB(OC1(C)C)C1=CC=C(N)C(CO)=C1, MDL NA |
| Drug_Names: (2-(Trifluoromethyl)pyrimidin-5-yl)methanamine, CAS: 608515-92-0, stock 778.4g, assay 98.3%, MWt 177.13, Formula C6H6F3N3, Purity >98%, SMILES NCC1=CN=C(N=C1)C(F)(F)F, MDL NA |
| Drug_Names: (2-(Methylthio)pyrimidin-5-yl)boronic acid, CAS: 348098-29-3, stock 142.8g, assay 98.9%, MWt 170.00, Formula C5H7BN2O2S, Purity >98%, SMILES CSC1=NC=C(C=N1)B(O)O, MDL NA |
| Drug_Names: 5,8-Dioxaspiro[3.4]octane-2,2-diyldimethanol, CAS: 1788043-96-8, stock 426.2g, assay 98.7%, MWt 174.19, Formula C8H14O4, Purity >98%, SMILES OCC1(CO)CC2(C1)OCCO2, MDL NA |
| Drug_Names: [1,2,4]Triazolo[4,3-b]pyridazine-6-carboxylic acid, CAS: 56434-29-8, stock 276.9g, assay 98.1%, MWt 164.12, Formula C6H4N4O2, Purity >98%, SMILES OC(=O)C1=NN2C=NN=C2C=C1, MDL NA |
| Drug_Names: [1,2,4]Triazolo[4,3-a]pyridine-8-carboxylic acid, CAS: 1216218-95-9, stock 136.5g, assay 98.5%, MWt 163.13, Formula C7H5N3O2, Purity >98%, SMILES OC(=O)C1=CC=CN2C=NN=C12, MDL NA |
| Drug_Names: [1,2,4]Triazolo[4,3-a]pyridine-7-carboxylic acid, CAS: 1234616-66-0, stock 617.1g, assay 98.3%, MWt 163.13, Formula C7H5N3O2, Purity >98%, SMILES OC(=O)C1=CC2=NN=CN2C=C1, MDL NA |
| Drug_Names: [1,2,4]Triazolo[4,3-a]pyridine-5-carboxylic acid, CAS: 1234615-95-2, stock 545.1g, assay 98.5%, MWt 163.13, Formula C7H5N3O2, Purity >98%, SMILES OC(=O)C1=CC=CC2=NN=CN12, MDL NA |
| Drug_Names: [1,2,4]Triazolo[1,5-a]pyridine-7-carboxylic acid, CAS: 1234616-29-5, stock 612.5g, assay 98.2%, MWt 163.13, Formula C7H5N3O2, Purity >98%, SMILES OC(=O)C1=CC2=NC=NN2C=C1, MDL NA |
| Drug_Names: [1,2,4]Triazolo[1,5-a]pyridine-6-carboxylic acid, CAS: 1043903-19-0, stock 199.7g, assay 98.3%, MWt 163.13, Formula C7H5N3O2, Purity >98%, SMILES OC(=O)C1=CN2N=CN=C2C=C1, MDL NA |
| Drug_Names: [1,2,4]Triazolo[1,5-a]pyridine-5-carboxylic acid, CAS: 1234616-38-6, stock 799.3g, assay 98.6%, MWt 163.13, Formula C7H5N3O2, Purity >98%, SMILES OC(=O)C1=CC=CC2=NC=NN12, MDL NA |
| Drug_Names: [1,1'-Bi(cyclopropane)]-1-carboxylic acid, CAS: 60629-92-7, stock 15.3g, assay 98%, MWt 126.15, Formula C7H10O2, Purity >98%, SMILES OC(=O)C1(CC1)C1CC1, MDL NA |
| Drug_Names: (1-(Trifluoromethyl)cyclopropyl)methanamine hydrochloride, CAS: 1783418-59-6, stock 783.8g, assay 99%, MWt 175.58, Formula C5H9ClF3N, Purity >98%, SMILES Cl.NCC1(CC1)C(F)(F)F, MDL NA |
| Drug_Names: [1-(Propan-2-yl)cyclopropyl]methanol, CAS: 1502415-85-1, stock 147.7g, assay 98.4%, MWt 114.19, Formula C7H14O, Purity >98%, SMILES CC(C)C1(CO)CC1, MDL NA |
| Drug_Names: (1-Benzhydrylazetidin-3-yl)methanamine dihydrochloride, CAS: 221095-77-8, stock 18.1g, assay 98.5%, MWt 325.28, Formula C17H22Cl2N2, Purity >98%, SMILES Cl.Cl.NCC1CN(C1)C(C1=CC=CC=C1)C1=CC=CC=C1, MDL NA |
| Drug_Names: 3-Aminomethyl-1-benzhydrylazetidine, CAS: 36476-88-7, stock 833.4g, assay 98.7%, MWt 252.35, Formula C17H20N2, Purity >98%, SMILES NCC1CN(C1)C(C1=CC=CC=C1)C1=CC=CC=C1, MDL NA |
| Drug_Names: (1-(Aminomethyl)cyclohexyl)methanol, CAS: 2041-57-8, stock 841.2g, assay 98.6%, MWt 143.23, Formula C8H17NO, Purity >98%, SMILES NCC1(CO)CCCCC1, MDL NA |
| Drug_Names: [1-(Aminomethyl)-3-fluorocyclobutyl]methanol, CAS: 1363380-81-7, stock 634.9g, assay 98.9%, MWt 133.16, Formula C6H12FNO, Purity >98%, SMILES NCC1(CO)CC(F)C1, MDL NA |
| Drug_Names: (1-(Aminomethyl)-3,3-difluorocyclobutyl)methanol, CAS: 1363383-40-7, stock 164.5g, assay 98.2%, MWt 151.15, Formula C6H11F2NO, Purity >98%, SMILES NCC1(CO)CC(F)(F)C1, MDL NA |
| Drug_Names: (1-Tosylpiperidine-4,4-diyl)bis(methylene) bis(4-methylbenzenesulfonate), CAS: 1523572-05-5, stock 285.9g, assay 98.9%, MWt 607.76, Formula C28H33NO8S3, Purity >98%, SMILES CC1=CC=C(C=C1)S(=O)(=O)OCC1(COS(=O)(=O)C2=CC=C(C)C=C2)CCN(CC1)S(=O)(=O)C1=CC=C(C)C=C1, MDL NA |
| Drug_Names: [1-(2-Methoxyethyl)cyclobutyl]methanol, CAS: 1483466-73-4, stock 303.2g, assay 98.3%, MWt 144.21, Formula C8H16O2, Purity >98%, SMILES COCCC1(CO)CCC1, MDL NA |
| Drug_Names: [(Adamantan-1-yl)methyl](methyl)amine hydrochloride, CAS: 1773-99-5, stock 117.3g, assay 98.2%, MWt 215.76, Formula C12H22ClN, Purity >98%, SMILES CNCC12C[C@H]3C[C@@H](C2)C[C@@H](C1)C3.Cl, MDL NA |
| Drug_Names: 2-((5-Chloropyridin-2-yl)amino)-2-oxoacetic acid, CAS: 552850-73-4, stock 583g, assay 98.1%, MWt 200.58, Formula C7H5ClN2O3, Purity >98%, SMILES OC(=O)C(=O)NC1=NC=C(Cl)C=C1, MDL NA |
| Drug_Names: [(5-Bromopyridin-2-yl)methyl]dimethylamine, CAS: 908271-69-2, stock 694.6g, assay 98.8%, MWt 215.09, Formula C8H11BrN2, Purity >98%, SMILES CN(C)CC1=NC=C(Br)C=C1, MDL NA |
| Drug_Names: (4-Fluorobenzyl)hydrazine dihydrochloride, CAS: 1000805-93-5, stock 610.5g, assay 98.4%, MWt 213.08, Formula C7H11Cl2FN2, Purity >98%, SMILES Cl.Cl.NNCC1=CC=C(F)C=C1, MDL NA |
| Drug_Names: (4-Bromobenzyl)hydrazine hydrochloride, CAS: 1727-08-8, stock 304.4g, assay 98.1%, MWt 237.52, Formula C7H10BrClN2, Purity >98%, SMILES Cl.NNCC1=CC=C(Br)C=C1, MDL NA |
| Drug_Names: (S)-(Tetrahydrofuran-3-yl)methanamine, CAS: 1048962-84-0, stock 606.3g, assay 98.3%, MWt 101.15, Formula C5H11NO, Purity >98%, SMILES NC[C@@H]1CCOC1, MDL NA |
| Drug_Names: (S)-(1-Methylpyrrolidin-3-yl)methanol, CAS: 1210934-04-5, stock 403.6g, assay 98.7%, MWt 115.17, Formula C6H13NO, Purity >98%, SMILES CN1CC[C@H](CO)C1, MDL NA |
| Drug_Names: [(3S)-1-Methylpyrrolidin-3-yl]methanamine dihydrochloride, CAS: 1860033-51-7, stock 13.9g, assay 98.5%, MWt 187.11, Formula C6H16Cl2N2, Purity >98%, SMILES Cl.Cl.CN1CC[C@@H](CN)C1, MDL NA |
| Drug_Names: (S)-(1-Methylpyrrolidin-3-yl)methanamine, CAS: 1419075-98-1, stock 340.4g, assay 98.4%, MWt 114.19, Formula C6H14N2, Purity >98%, SMILES CN1CC[C@@H](CN)C1, MDL NA |
| Drug_Names: (S)-(1-Methylpiperidin-3-yl)methanamine dihydrochloride, CAS: 1400744-19-5, stock 499.6g, assay 98.3%, MWt 201.14, Formula C7H18Cl2N2, Purity >98%, SMILES Cl.Cl.CN1CCC[C@@H](CN)C1, MDL NA |
| Drug_Names: [(3R,6S)-6-Methylpiperidin-3-yl]methanol hydrochloride, CAS: 2068138-08-7, stock 138.3g, assay 98.7%, MWt 165.66, Formula C7H16ClNO, Purity >98%, SMILES Cl.C[C@H]1CC[C@@H](CO)CN1, MDL NA |
| Drug_Names: [(3R,4R)-4-(Trifluoromethyl)pyrrolidin-3-yl]methanol hydrochloride, CAS: 2101775-10-2, stock 466g, assay 98.4%, MWt 205.61, Formula C6H11ClF3NO, Purity >98%, SMILES Cl.OC[C@H]1CNC[C@@H]1C(F)(F)F, MDL NA |
| Drug_Names: (R)-(1-Methylpyrrolidin-3-yl)methanamine, CAS: 1207541-15-8, stock 241.1g, assay 98.1%, MWt 114.19, Formula C6H14N2, Purity >98%, SMILES CN1CC[C@H](CN)C1, MDL NA |
| Drug_Names: (R)-(1-Methylpiperidin-3-yl)methanamine dihydrochloride, CAS: 1400744-18-4, stock 493.7g, assay 98.3%, MWt 201.14, Formula C7H18Cl2N2, Purity >98%, SMILES Cl.Cl.CN1CCC[C@H](CN)C1, MDL NA |
| Drug_Names: (3-Methoxybenzyl)hydrazine dihydrochloride, CAS: 849021-11-0, stock 206.9g, assay 98.5%, MWt 225.12, Formula C8H14Cl2N2O, Purity >98%, SMILES Cl.Cl.COC1=CC=CC(CNN)=C1, MDL NA |
| Drug_Names: (3-Fluorobenzyl)hydrazine dihydrochloride, CAS: 1000805-94-6, stock 172.3g, assay 98.5%, MWt 213.08, Formula C7H11Cl2FN2, Purity >98%, SMILES Cl.Cl.NNCC1=CC(F)=CC=C1, MDL NA |
| Drug_Names: (3-Chlorobenzyl)hydrazine dihydrochloride, CAS: 1260787-89-0, stock 745.5g, assay 98.1%, MWt 229.53, Formula C7H11Cl3N2, Purity >98%, SMILES Cl.Cl.NNCC1=CC(Cl)=CC=C1, MDL NA |
| Drug_Names: [(3-Bromocyclobutoxy)methyl]benzene, CAS: 1443110-01-7, stock 329.7g, assay 98.8%, MWt 241.12, Formula C11H13BrO, Purity >98%, SMILES BrC1CC(C1)OCC1=CC=CC=C1, MDL NA |
| Drug_Names: ((3aR,6S,6aR)-6-(Benzyloxy)-2,2-dimethyltetrahydrofuro[2,3-d][1,3]dioxole-5,5-diyl)dimethanol, CAS: 63593-03-3, stock 10.7g, assay 98%, MWt 310.34, Formula C16H22O6, Purity >98%, SMILES [H][C@@]12OC(C)(C)O[C@]1([H])[C@H](OCC1=CC=CC=C1)C(CO)(CO)O2, MDL NA |
| Drug_Names: ((3aR,4R,6aR)-6-Methoxy-2,2-dimethyltetrahydrofuro[3,4-d][1,3]dioxol-4-yl)methanol, CAS: 72402-14-3, stock 305.7g, assay 98.7%, MWt 204.22, Formula C9H16O5, Purity >98%, SMILES COC1O[C@H](CO)[C@H]2OC(C)(C)O[C@@H]12, MDL NA |
| Drug_Names: 1-(3,3-Difluorocyclobutyl)-N-methylmethanamine hydrochloride, CAS: 1250444-03-1, stock 335g, assay 98.6%, MWt 171.62, Formula C6H12ClF2N, Purity >98%, SMILES Cl.CNCC1CC(F)(F)C1, MDL NA |
| Drug_Names: [(2S)-4-Benzylpiperazin-2-yl]methanol dihydrochloride, CAS: 1860012-50-5, stock 618.2g, assay 98.4%, MWt 279.21, Formula C12H20Cl2N2O, Purity >98%, SMILES Cl.Cl.OC[C@@H]1CN(CC2=CC=CC=C2)CCN1, MDL NA |
| Drug_Names: (S)-(4,4-Difluoro-1-methylpyrrolidin-2-yl)methanol, CAS: 1408057-44-2, stock 231.9g, assay 98.2%, MWt 151.15, Formula C6H11F2NO, Purity >98%, SMILES CN1CC(F)(F)C[C@H]1CO, MDL NA |
| Drug_Names: [(2S)-4,4-Difluoro-1-methylpyrrolidin-2-yl]methanamine dihydrochloride, CAS: 2007919-82-4, stock 367.5g, assay 98.6%, MWt 223.09, Formula C6H14Cl2F2N2, Purity >98%, SMILES Cl.Cl.CN1CC(F)(F)C[C@H]1CN, MDL NA |
| Drug_Names: (S)-(2-Methylpyrrolidin-2-yl)methanol hydrochloride, CAS: 1523541-78-7, stock 450.8g, assay 99%, MWt 151.63, Formula C6H14ClNO, Purity >98%, SMILES Cl.C[C@@]1(CO)CCCN1, MDL NA |
| Drug_Names: [(2S)-1-Methylazetidin-2-yl]methanamine bis(trifluoroacetic acid), CAS: 2007919-76-6, stock 308g, assay 98.8%, MWt 328.21, Formula C9H14F6N2O4, Purity >98%, SMILES CN1CC[C@H]1CN.OC(=O)C(F)(F)F.OC(=O)C(F)(F)F, MDL NA |
| Drug_Names: (2R)-4-(Phenylmethyl)-2-morpholinemethanamine, CAS: 214273-17-3, stock 555.4g, assay 98.6%, MWt 206.28, Formula C12H18N2O, Purity >98%, SMILES NC[C@@H]1CN(CC2=CC=CC=C2)CCO1, MDL NA |
| Drug_Names: (R)-(4,4-Difluoropyrrolidin-2-yl)methanol hydrochloride, CAS: 1315593-71-5, stock 295.8g, assay 98.2%, MWt 173.59, Formula C5H10ClF2NO, Purity >98%, SMILES Cl.OC[C@H]1CC(F)(F)CN1, MDL NA |
| Drug_Names: (R)-(4,4-Difluoro-1-methylpyrrolidin-2-yl)methanol, CAS: 1408002-86-7, stock 890.3g, assay 98.5%, MWt 151.15, Formula C6H11F2NO, Purity >98%, SMILES CN1CC(F)(F)C[C@@H]1CO, MDL NA |
| Drug_Names: (R)-(2-Methylpyrrolidin-2-yl)methanol hydrochloride, CAS: 1523530-30-4, stock 691.6g, assay 98.8%, MWt 151.63, Formula C6H14ClNO, Purity >98%, SMILES Cl.C[C@]1(CO)CCCN1, MDL NA |
| Drug_Names: (R)-(1-Methylpyrrolidin-2-yl)methanamine, CAS: 66411-53-8, stock 241.6g, assay 98.6%, MWt 114.19, Formula C6H14N2, Purity >98%, SMILES CN1CCC[C@@H]1CN, MDL NA |
| Drug_Names: (2-Fluorobenzyl)hydrazine, CAS: 51859-98-4, stock 542.6g, assay 98.9%, MWt 140.16, Formula C7H9FN2, Purity >98%, SMILES NNCC1=C(F)C=CC=C1, MDL NA |
| Drug_Names: (2-Chlorobenzyl)hydrazine dihydrochloride, CAS: 64415-10-7, stock 126.8g, assay 98%, MWt 229.53, Formula C7H11Cl3N2, Purity >98%, SMILES Cl.Cl.NNCC1=C(Cl)C=CC=C1, MDL NA |
| Drug_Names: [(2-Chloro-4-fluorophenyl)methyl]hydrazine dihydrochloride, CAS: 2044707-02-8, stock 561.5g, assay 98.4%, MWt 247.53, Formula C7H10Cl3FN2, Purity >98%, SMILES Cl.Cl.NNCC1=CC=C(F)C=C1Cl, MDL NA |
| Drug_Names: (2-Bromobenzyl)hydrazine dihydrochloride, CAS: 1349718-46-2, stock 651.6g, assay 98.6%, MWt 273.99, Formula C7H11BrCl2N2, Purity >98%, SMILES Cl.Cl.NNCC1=C(Br)C=CC=C1, MDL NA |
| Drug_Names: 1-(2,4-Dichlorophenyl)-N-methylmethanamine hydrochloride, CAS: 90389-07-4, stock 707.1g, assay 98%, MWt 226.53, Formula C8H10Cl3N, Purity >98%, SMILES Cl.CNCC1=CC=C(Cl)C=C1Cl, MDL NA |
| Drug_Names: [(1S,2R)-rel-2-(hydroxymethyl)cyclopropyl]methanol, CAS: 2345-68-8, stock 468g, assay 98.2%, MWt 102.13, Formula C5H10O2, Purity >98%, SMILES OC[C@H]1C[C@H]1CO, MDL NA |
| Drug_Names: (S)-(3,3-Difluorocyclopentyl)methanol, CAS: 1407991-23-4, stock 789.8g, assay 98.5%, MWt 136.14, Formula C6H10F2O, Purity >98%, SMILES OC[C@H]1CCC(F)(F)C1, MDL NA |
| Drug_Names: [(1S)-3,3-difluorocyclopentyl]methanamine hydrochloride, CAS: 2007916-16-5, stock 309.4g, assay 98.9%, MWt 171.62, Formula C6H12ClF2N, Purity >98%, SMILES Cl.NC[C@H]1CCC(F)(F)C1, MDL NA |
| Drug_Names: (1R,2S,5S)-rel-3-Azabicyclo[3.1.0]hexan-2-ylmethanol hydrochloride, CAS: 1788041-43-9, stock 93g, assay 98.2%, MWt 149.62, Formula C6H12ClNO, Purity >98%, SMILES Cl.[H][C@]12C[C@@]1([H])[C@@H](CO)NC2, MDL NA |
| Drug_Names: [(1-Ethynylcyclopropyl)methyl]benzene, CAS: 2126160-12-9, stock 787.2g, assay 98.2%, MWt 156.22, Formula C12H12, Purity >98%, SMILES C#CC1(CC2=CC=CC=C2)CC1, MDL NA |
| Drug_Names: 4-(Aminomethyl)tetrahydro-2H-thiopyran 1,1-dioxide hydrochloride, CAS: 1107645-98-6, stock 849g, assay 98.8%, MWt 199.70, Formula C6H14ClNO2S, Purity >98%, SMILES Cl.NCC1CCS(=O)(=O)CC1, MDL NA |
| Drug_Names: (S)-5-Methyl-5-azaspiro[2.4]heptane-6-carboxylic acid, CAS: 1860033-47-1, stock 852.6g, assay 98.9%, MWt 155.19, Formula C8H13NO2, Purity >98%, SMILES CN1CC2(CC2)C[C@H]1C(O)=O, MDL NA |
| Drug_Names: (S)-Tetrahydro-2H-pyran-2-carboxylic acid, CAS: 105499-32-9, stock 307.3g, assay 98.7%, MWt 130.14, Formula C6H10O3, Purity >98%, SMILES OC(=O)[C@@H]1CCCCO1, MDL NA |
| Drug_Names: (R)-Tetrahydro-2h-pyran-3-ol, CAS: 100937-76-6, stock 20.6g, assay 99%, MWt 102.13, Formula C5H10O2, Purity >98%, SMILES O[C@@H]1CCCOC1, MDL NA |
| Drug_Names: (R)-tert-Butyl 5-methyl-1,2,3-oxathiazolidine-3-carboxylate 2,2-dioxide, CAS: 863453-61-6, stock 138.6g, assay 98.4%, MWt 237.27, Formula C8H15NO5S, Purity >98%, SMILES C[C@@H]1CN(C(=O)OC(C)(C)C)S(=O)(=O)O1, MDL NA |
| Drug_Names: (R)-tert-Butyl 4-methyl-1,2,3-oxathiazolidine-3-carboxylate 2,2-dioxide, CAS: 454248-53-4, stock 174.6g, assay 98.2%, MWt 237.27, Formula C8H15NO5S, Purity >98%, SMILES C[C@@H]1COS(=O)(=O)N1C(=O)OC(C)(C)C, MDL NA |
| Drug_Names: (R)-3-Boc-4-isopropyl-2,2-dioxo-[1,2,3]oxathiazolidine, CAS: 1858273-22-9, stock 481.4g, assay 98.2%, MWt 265.33, Formula C10H19NO5S, Purity >98%, SMILES CC(C)[C@@H]1COS(=O)(=O)N1C(=O)OC(C)(C)C, MDL NA |
| Drug_Names: (R)-tert-Butyl 4-ethyl-1,2,3-oxathiazolidine-3-carboxylate 2,2-dioxide, CAS: 1417287-40-1, stock 887.1g, assay 98.5%, MWt 251.30, Formula C9H17NO5S, Purity >98%, SMILES CC[C@@H]1COS(=O)(=O)N1C(=O)OC(C)(C)C, MDL NA |
| Drug_Names: tert-Butyl (R)-(3-(pyrrolidin-2-yl)propyl)carbamate, CAS: 1217838-01-1, stock 424.6g, assay 98.5%, MWt 228.33, Formula C12H24N2O2, Purity >98%, SMILES CC(C)(C)OC(=O)NCCC[C@H]1CCCN1, MDL NA |
| Drug_Names: (Pyrimidin-5-yl)methanamine dihydrochloride, CAS: 1956356-28-7, stock 400.5g, assay 98.5%, MWt 182.05, Formula C5H9Cl2N3, Purity >98%, SMILES Cl.Cl.NCC1=CN=CN=C1, MDL NA |
| Drug_Names: (Piperidin-4-yl)methyl 4-fluoro-4-(hydroxymethyl)piperidine-1-carboxylate hydrochloride, CAS: 2055841-23-9, stock 503.5g, assay 98.2%, MWt 310.79, Formula C13H24ClFN2O3, Purity >98%, SMILES Cl.OCC1(F)CCN(CC1)C(=O)OCC1CCNCC1, MDL NA |
| Drug_Names: Morpholin-3-ylmethanol hydrochloride, CAS: 955400-09-6, stock 354.2g, assay 99%, MWt 153.61, Formula C5H12ClNO2, Purity >98%, SMILES OCC1NCCOC1.[H]Cl, MDL NA |
| Drug_Names: (Iodomethyl)cyclobutane, CAS: 16408-62-1, stock 799g, assay 98.4%, MWt 196.03, Formula C5H9I, Purity >98%, SMILES ICC1CCC1, MDL NA |
| Drug_Names: (Cyclopropylmethyl)hydrazine dihydrochloride, CAS: 809282-61-9, stock 793.8g, assay 98.4%, MWt 159.06, Formula C4H12Cl2N2, Purity >98%, SMILES Cl.Cl.NNCC1CC1, MDL NA |
| Drug_Names: (1S,3S)-Ethyl 3-hydroxycyclobutanecarboxylate, CAS: 160351-97-3, stock 45.6g, assay 98%, MWt 144.17, Formula C7H12O3, Purity >98%, SMILES CCOC(=O)[C@@H]1C[C@H](O)C1, MDL NA |
| Drug_Names: 1-(Azetidin-3-yl)-N,N-dimethylmethanamine dihydrochloride, CAS: 321890-22-6, stock 714.4g, assay 99%, MWt 187.11, Formula C6H16Cl2N2, Purity >98%, SMILES CN1CC(CNC)C1.[H]Cl.[H]Cl, MDL MFCD09264464 |
| Drug_Names: (S)-Octahydro-2H-pyrido[1,2-a]pyrazine oxalate, CAS: 2007916-14-3, stock 137.4g, assay 98.9%, MWt 230.26, Formula C10H18N2O4, Purity >98%, SMILES OC(=O)C(O)=O.C1CCN2CCNC[C@@H]2C1, MDL NA |
| Drug_Names: (R)-octahydro-2H-pyrido[1,2-a]pyrazine oxalate, CAS: 2055840-06-5, stock 854.9g, assay 98.4%, MWt 230.26, Formula C10H18N2O4, Purity >98%, SMILES OC(=O)C(O)=O.C1CCN2CCNC[C@H]2C1, MDL NA |
| Drug_Names: (S)-Octahydropyrrolo[1,2-a]pyrazine dihydrobromide, CAS: 150208-84-7, stock 127.8g, assay 98.9%, MWt 288.02, Formula C7H16Br2N2, Purity >98%, SMILES Br.Br.[H][C@@]12CCCN1CCNC2, MDL NA |
| Drug_Names: (S)-Octahydropyrrolo[1,2-a]pyrazine dihydrochloride, CAS: 634922-11-5, stock 44.5g, assay 99%, MWt 199.12, Formula C7H16Cl2N2, Purity >98%, SMILES Cl.Cl.[H][C@@]12CCCN1CCNC2, MDL NA |
| Drug_Names: (8aR)-Octahydropyrrolo[1,2-a]piperazin-6-one hydrochloride, CAS: 1429238-55-0, stock 558.2g, assay 98.9%, MWt 176.64, Formula C7H13ClN2O, Purity >98%, SMILES Cl.O=C1CC[C@@H]2CNCCN12, MDL NA |
| Drug_Names: (R)-Tetrahydro-1H-oxazolo[3,4-a]pyrazin-3(5H)-one hydrochloride, CAS: 1212327-95-1, stock 217.2g, assay 98.8%, MWt 178.62, Formula C6H11ClN2O2, Purity >98%, SMILES Cl.O=C1OC[C@H]2CNCCN12, MDL NA |
| Drug_Names: (7S)-7-Methyl-1,4-dioxa-8-azaspiro[4.5]decane, CAS: 1419140-80-9, stock 450.7g, assay 98%, MWt 157.21, Formula C8H15NO2, Purity >98%, SMILES C[C@H]1CC2(CCN1)OCCO2, MDL NA |
| Drug_Names: (7R)-7-Methyl-1,4-dioxa-8-azaspiro[4.5]decane, CAS: 1419075-94-7, stock 560.1g, assay 98.3%, MWt 157.21, Formula C8H15NO2, Purity >98%, SMILES C[C@@H]1CC2(CCN1)OCCO2, MDL NA |
| Drug_Names: (7-Methyl-1H-indol-5-yl)methanamine, CAS: 1401726-44-0, stock 775.7g, assay 98.9%, MWt 160.22, Formula C10H12N2, Purity >98%, SMILES CC1=CC(CN)=CC2=C1NC=C2, MDL NA |
| Drug_Names: (7-Methyl-1H-indazol-5-yl)boronic acid, CAS: 1245816-07-2, stock 489.2g, assay 98.3%, MWt 175.98, Formula C8H9BN2O2, Purity >98%, SMILES CC1=C2NN=CC2=CC(=C1)B(O)O, MDL NA |
| Drug_Names: (7-Fluoro-4-methoxy-1H-indol-2-yl)methanol, CAS: 1378823-69-8, stock 684.8g, assay 98.7%, MWt 195.19, Formula C10H10FNO2, Purity >98%, SMILES COC1=CC=C(F)C2=C1C=C(CO)N2, MDL NA |
| Drug_Names: (S)-6-Methylpiperazin-2-one, CAS: 323592-68-3, stock 805g, assay 99%, MWt 114.15, Formula C5H10N2O, Purity >98%, SMILES C[C@H]1CNCC(=O)N1, MDL NA |
| Drug_Names: (6S)-4-Oxo-5-azaspiro[2.4]heptane-6-carboxylic acid, CAS: 2102412-77-9, stock 838.4g, assay 98.4%, MWt 155.15, Formula C7H9NO3, Purity >98%, SMILES OC(=O)[C@@H]1CC2(CC2)C(=O)N1, MDL NA |
| Drug_Names: (S)-2-Nitro-6,7-dihydro-5H-imidazo[2,1-b][1,3]oxazin-6-ol, CAS: 187235-08-1, stock 7.1g, assay 98.3%, MWt 185.14, Formula C6H7N3O4, Purity >98%, SMILES O[C@@H]1COC2=NC(=CN2C1)[N+]([O-])=O, MDL NA |
| Drug_Names: (6-Methylpyrimidin-4-yl)methanol, CAS: 74502-82-2, stock 128.7g, assay 98.7%, MWt 124.14, Formula C6H8N2O, Purity >98%, SMILES CC1=CC(CO)=NC=N1, MDL NA |
| Drug_Names: (6-Methylpyridazin-3-yl)methanamine dihydrochloride, CAS: 1630907-25-3, stock 99.5g, assay 98%, MWt 196.08, Formula C6H11Cl2N3, Purity >98%, SMILES Cl.Cl.CC1=CC=C(CN)N=N1, MDL NA |
| Drug_Names: (6-Methyl-1H-indol-5-yl)methanamine, CAS: 1368355-69-4, stock 733.8g, assay 98.9%, MWt 160.22, Formula C10H12N2, Purity >98%, SMILES CC1=C(CN)C=C2C=CNC2=C1, MDL NA |
| Drug_Names: (6-Methoxypyridin-3-yl)methanamine hydrochloride, CAS: 857220-13-4, stock 443.2g, assay 98.5%, MWt 174.63, Formula C7H11ClN2O, Purity >98%, SMILES Cl.COC1=CC=C(CN)C=N1, MDL NA |
| Drug_Names: (6-Fluoro-1H-indazol-5-yl)methanol, CAS: 1360894-74-1, stock 44.5g, assay 98.9%, MWt 166.15, Formula C8H7FN2O, Purity >98%, SMILES OCC1=CC2=C(NN=C2)C=C1F, MDL NA |
| Drug_Names: (6-Chloropyrimidin-4-yl)methanol, CAS: 1025351-41-0, stock 865g, assay 98.9%, MWt 144.56, Formula C5H5ClN2O, Purity >98%, SMILES OCC1=NC=NC(Cl)=C1, MDL NA |
| Drug_Names: (6-Chloropyridazin-3-yl)methanol, CAS: 1011487-94-7, stock 575.3g, assay 98.2%, MWt 144.56, Formula C5H5ClN2O, Purity >98%, SMILES OCC1=NN=C(Cl)C=C1, MDL NA |
| Drug_Names: (5S)-5-Methylpiperazin-2-one, CAS: 1240583-20-3, stock 846g, assay 98.5%, MWt 114.15, Formula C5H10N2O, Purity >98%, SMILES C[C@H]1CNC(=O)CN1, MDL NA |
| Drug_Names: (5S)-5-(Aminomethyl)-1,3-oxazolidin-2-one hydrochloride, CAS: 2007909-59-1, stock 291.5g, assay 98.5%, MWt 152.58, Formula C4H9ClN2O2, Purity >98%, SMILES Cl.NC[C@H]1CNC(=O)O1, MDL NA |
| Drug_Names: (S)-1,5-Dimethylpiperazin-2-one hydrochloride, CAS: 1887197-43-4, stock 887.3g, assay 98.5%, MWt 164.63, Formula C6H13ClN2O, Purity >98%, SMILES Cl.C[C@H]1CN(C)C(=O)CN1, MDL NA |
| Drug_Names: (R)-5-(Aminomethyl)oxazolidin-2-one hydrochloride, CAS: 1788036-27-0, stock 383.4g, assay 98.8%, MWt 152.58, Formula C4H9ClN2O2, Purity >98%, SMILES Cl.NC[C@@H]1CNC(=O)O1, MDL NA |
| Drug_Names: (R)-1-Benzyl-5-methyl-1,4-diazepane, CAS: 1620097-06-4, stock 554.6g, assay 98.4%, MWt 204.31, Formula C13H20N2, Purity >98%, SMILES C[C@@H]1CCN(CC2=CC=CC=C2)CCN1, MDL NA |
| Drug_Names: (5-Methylpyridazin-3-yl)methanol, CAS: 1788044-13-2, stock 287g, assay 98.6%, MWt 124.14, Formula C6H8N2O, Purity >98%, SMILES CC1=CN=NC(CO)=C1, MDL NA |
| Drug_Names: (5-Methylpyridazin-3-yl)methanamine hydrochloride, CAS: 1788054-82-9, stock 135g, assay 98.3%, MWt 159.62, Formula C6H10ClN3, Purity >98%, SMILES Cl.CC1=CC(CN)=NN=C1, MDL NA |
| Drug_Names: (5-Methyl-1H-imidazol-2-yl)methanol hydrochloride, CAS: 1923088-49-6, stock 883.4g, assay 98%, MWt 148.59, Formula C5H9ClN2O, Purity >98%, SMILES Cl.CC1=CN=C(CO)N1, MDL NA |
| Drug_Names: (5-Methoxypyrimidin-2-yl)methanamine hydrochloride, CAS: 1956318-42-5, stock 187.4g, assay 98.3%, MWt 175.62, Formula C6H10ClN3O, Purity >98%, SMILES Cl.COC1=CN=C(CN)N=C1, MDL NA |
| Drug_Names: (5-Methoxypyridin-3-yl)methanamine, CAS: 1044919-31-4, stock 5.7g, assay 98%, MWt 138.17, Formula C7H10N2O, Purity >98%, SMILES COC1=CN=CC(CN)=C1, MDL NA |
| Drug_Names: (5-Fluorothiophen-2-yl)methanamine, CAS: 214759-36-1, stock 836.9g, assay 98.4%, MWt 131.17, Formula C5H6FNS, Purity >98%, SMILES NCC1=CC=C(F)S1, MDL NA |
| Drug_Names: (5-Fluoropyrimidin-2-yl)methanol, CAS: 1227574-72-2, stock 654.2g, assay 98.1%, MWt 128.10, Formula C5H5FN2O, Purity >98%, SMILES OCC1=NC=C(F)C=N1, MDL NA |
| Drug_Names: (5-Fluoropyridin-3-yl)methanol, CAS: 22620-32-2, stock 118g, assay 98.4%, MWt 127.12, Formula C6H6FNO, Purity >98%, SMILES OCC1=CC(F)=CN=C1, MDL NA |
| Drug_Names: 5-Fluoropyridin-2-ylboronic acid, CAS: 946002-10-4, stock 672.7g, assay 98.8%, MWt 140.91, Formula C5H5BFNO2, Purity >98%, SMILES OB(O)C1=NC=C(F)C=C1, MDL NA |
| Drug_Names: (5-Chlorothiophen-3-yl)methanamine hydrochloride, CAS: 1108712-55-5, stock 297.5g, assay 98.4%, MWt 184.09, Formula C5H7Cl2NS, Purity >98%, SMILES Cl.NCC1=CSC(Cl)=C1, MDL NA |
| Drug_Names: (5-Chlorothiophen-2-yl)methanol, CAS: 74168-69-7, stock 133.7g, assay 98.1%, MWt 148.61, Formula C5H5ClOS, Purity >98%, SMILES OCC1=CC=C(Cl)S1, MDL NA |
| Drug_Names: (5-Chlorothiophen-2-yl)methanamine hydrochloride, CAS: 548772-41-4, stock 146.5g, assay 98.8%, MWt 184.09, Formula C5H7Cl2NS, Purity >98%, SMILES Cl.NCC1=CC=C(Cl)S1, MDL NA |
| Drug_Names: (5-Chloropyrimidin-2-yl)acetic acid, CAS: 944903-13-3, stock 833g, assay 98.2%, MWt 172.57, Formula C6H5ClN2O2, Purity >98%, SMILES OC(=O)CC1=NC=C(Cl)C=N1, MDL NA |
| Drug_Names: (5-Chloro-1H-indol-2-yl)methanol, CAS: 53590-47-9, stock 140.6g, assay 98.1%, MWt 181.62, Formula C9H8ClNO, Purity >98%, SMILES OCC1=CC2=C(N1)C=CC(Cl)=C2, MDL NA |
| Drug_Names: (5-Chlorothiazol-2-yl)methanol, CAS: 50398-78-2, stock 51.4g, assay 98%, MWt 149.60, Formula C4H4ClNOS, Purity >98%, SMILES OCC1=NC=C(Cl)S1, MDL NA |
| Drug_Names: (5-Chlorothiazol-2-yl)methanamine hydrochloride, CAS: 1187932-87-1, stock 212.8g, assay 98.8%, MWt 185.07, Formula C4H6Cl2N2S, Purity >98%, SMILES Cl.NCC1=NC=C(Cl)S1, MDL NA |
| Drug_Names: (5-Bromothiophen-3-yl)methanamine, CAS: 1087784-61-9, stock 311.1g, assay 98.4%, MWt 192.08, Formula C5H6BrNS, Purity >98%, SMILES NCC1=CSC(Br)=C1, MDL NA |
| Drug_Names: (5-Bromopyrimidin-2-yl)methanamine hydrochloride, CAS: 1240594-62-0, stock 287.6g, assay 98.5%, MWt 224.49, Formula C5H7BrClN3, Purity >98%, SMILES Cl.NCC1=NC=C(Br)C=N1, MDL NA |
| Drug_Names: (5-Bromo-3-fluoropyridin-2-yl)methanamine hydrochloride, CAS: 1257535-19-5, stock 250g, assay 98.7%, MWt 241.49, Formula C6H7BrClFN2, Purity >98%, SMILES Cl.NCC1=NC=C(Br)C=C1F, MDL NA |
| Drug_Names: (5-Bromo-2-methylpyridin-3-yl)methanol, CAS: 1346541-53-4, stock 630.3g, assay 98.3%, MWt 202.05, Formula C7H8BrNO, Purity >98%, SMILES CC1=NC=C(Br)C=C1CO, MDL NA |
| Drug_Names: (5-Bromo-2-methoxypyridin-3-yl)methanol, CAS: 351410-47-4, stock 766.2g, assay 98.9%, MWt 218.05, Formula C7H8BrNO2, Purity >98%, SMILES COC1=NC=C(Br)C=C1CO, MDL NA |
| Drug_Names: (5-Bromo-2-chloropyridin-3-yl)methanol, CAS: 742100-75-0, stock 725.8g, assay 98.8%, MWt 222.47, Formula C6H5BrClNO, Purity >98%, SMILES OCC1=CC(Br)=CN=C1Cl, MDL NA |
| Drug_Names: (4-Bromo-1H-imidazol-2-yl)methanol, CAS: 1804129-02-9, stock 630.7g, assay 98.9%, MWt 177.00, Formula C4H5BrN2O, Purity >98%, SMILES OCC1=NC=C(Br)N1, MDL NA |
| Drug_Names: (5-Bromothiazol-2-yl)methanamine hydrochloride, CAS: 1414958-88-5, stock 540.6g, assay 98.4%, MWt 229.53, Formula C4H6BrClN2S, Purity >98%, SMILES Cl.NCC1=NC=C(Br)S1, MDL NA |
| Drug_Names: (4S,5R)-4-[(tert-Butyldimethylsilyl)oxy]-5-{[(tert-butyldimethylsilyl)oxy]methyl}oxolan-2-one, CAS: 83159-91-5, stock 239.7g, assay 98.5%, MWt 360.64, Formula C17H36O4Si2, Purity >98%, SMILES CC(C)(C)[Si](C)(C)OC[C@H]1OC(=O)C[C@@H]1O[Si](C)(C)C(C)(C)C, MDL NA |
| Drug_Names: (S)-4-Methylpyrrolidin-2-one, CAS: 31551-66-3, stock 725.5g, assay 98%, MWt 99.13, Formula C5H9NO, Purity >98%, SMILES C[C@@H]1CNC(=O)C1, MDL NA |
| Drug_Names: (S)-4-Aminopyrrolidin-2-one, CAS: 160806-40-6, stock 692.1g, assay 98.9%, MWt 100.12, Formula C4H8N2O, Purity >98%, SMILES N[C@@H]1CNC(=O)C1, MDL NA |
| Drug_Names: (S)-4-Amino-1-(2,4-dimethoxybenzyl)pyrrolidin-2-one, CAS: 1638767-82-4, stock 204.7g, assay 98.9%, MWt 250.29, Formula C13H18N2O3, Purity >98%, SMILES COC1=CC=C(CN2C[C@@H](N)CC2=O)C(OC)=C1, MDL NA |
| Drug_Names: (4S)-4-(Difluoromethyl)-1,3-oxazolidin-2-one, CAS: 2059155-02-9, stock 856.3g, assay 98.5%, MWt 137.08, Formula C4H5F2NO2, Purity >98%, SMILES FC(F)[C@@H]1COC(=O)N1, MDL NA |
| Drug_Names: (S)-4-(Aminomethyl)pyrrolidin-2-one hydrochloride, CAS: 1638744-96-3, stock 753.9g, assay 98.6%, MWt 150.61, Formula C5H11ClN2O, Purity >98%, SMILES Cl.NC[C@H]1CNC(=O)C1, MDL NA |
| Drug_Names: (S)-4-(Aminomethyl)pyrrolidin-2-one, CAS: 1292289-46-3, stock 273.6g, assay 98.3%, MWt 114.15, Formula C5H10N2O, Purity >98%, SMILES NC[C@H]1CNC(=O)C1, MDL NA |
| Drug_Names: (4R,5S)-5-(3,5-Bis(trifluoromethyl)phenyl)-4-methyloxazolidin-2-one, CAS: 875444-10-3, stock 749g, assay 98.4%, MWt 313.20, Formula C12H9F6NO2, Purity >98%, SMILES C[C@H]1NC(=O)O[C@H]1C1=CC(=CC(=C1)C(F)(F)F)C(F)(F)F, MDL NA |
| Drug_Names: (4R,5R)-5-[3,5-Bis(trifluoromethyl)phenyl]-4-methyl-1,3-oxazolidin-2-one, CAS: 875444-05-6, stock 762.2g, assay 98.7%, MWt 313.20, Formula C12H9F6NO2, Purity >98%, SMILES C[C@H]1NC(=O)O[C@@H]1C1=CC(=CC(=C1)C(F)(F)F)C(F)(F)F, MDL NA |
| Drug_Names: (4R,5R)-4-[(tert-Butyldimethylsilyl)oxy]-5-{[(tert-butyldimethylsilyl)oxy]methyl}-3-chlorooxolan-2-one, CAS: 1820749-52-7, stock 592.1g, assay 98.2%, MWt 395.08, Formula C17H35ClO4Si2, Purity >98%, SMILES CC(C)(C)[Si](C)(C)OC[C@H]1OC(=O)C(Cl)[C@@H]1O[Si](C)(C)C(C)(C)C, MDL NA |
| Drug_Names: (R)-5-(Methoxycarbonyl)-2,6-dimethyl-4-(3-nitrophenyl)-1,4-dihydropyridine-3-carboxylic acid, CAS: 76093-33-9, stock 265g, assay 98.7%, MWt 332.31, Formula C16H16N2O6, Purity >98%, SMILES COC(=O)C1=C(C)NC(C)=C([C@H]1C1=CC(=CC=C1)[N+]([O-])=O)C(O)=O, MDL NA |
| Drug_Names: (R)-4-Phenylthiazolidine-2-thione, CAS: 110199-18-3, stock 427.3g, assay 99%, MWt 195.30, Formula C9H9NS2, Purity >98%, SMILES S=C1N[C@@H](CS1)C1=CC=CC=C1, MDL NA |
| Drug_Names: (4R)-4-Amino-3,3-dimethylpyrrolidin-2-one, CAS: 1638744-44-1, stock 104.1g, assay 98%, MWt 128.17, Formula C6H12N2O, Purity >98%, SMILES CC1(C)[C@@H](N)CNC1=O, MDL NA |
| Drug_Names: (R)-4-Amino-1-(2,4-dimethoxybenzyl)pyrrolidin-2-one, CAS: 1638771-15-9, stock 818.2g, assay 98.2%, MWt 250.29, Formula C13H18N2O3, Purity >98%, SMILES COC1=CC=C(CN2C[C@H](N)CC2=O)C(OC)=C1, MDL NA |
| Drug_Names: (R)-4-(Aminomethyl)pyrrolidin-2-one hydrochloride, CAS: 1434126-92-7, stock 24.3g, assay 98.2%, MWt 150.61, Formula C5H11ClN2O, Purity >98%, SMILES Cl.NC[C@@H]1CNC(=O)C1, MDL NA |
| Drug_Names: (R)-4-(Aminomethyl)pyrrolidin-2-one, CAS: 1407997-81-2, stock 158.1g, assay 98.3%, MWt 114.15, Formula C5H10N2O, Purity >98%, SMILES NC[C@@H]1CNC(=O)C1, MDL NA |
| Drug_Names: (4R)-4-(3,4,5-Trifluorophenyl)pyrrolidin-2-one, CAS: 1651179-16-6, stock 252.7g, assay 98.8%, MWt 215.17, Formula C10H8F3NO, Purity >98%, SMILES FC1=CC(=CC(F)=C1F)[C@@H]1CNC(=O)C1, MDL NA |
| Drug_Names: (4-Methylpyrimidin-2-yl)methanol, CAS: 142650-13-3, stock 891.1g, assay 98.1%, MWt 124.14, Formula C6H8N2O, Purity >98%, SMILES CC1=CC=NC(CO)=N1, MDL NA |
| Drug_Names: (4-Methylpyridin-3-yl)methanol, CAS: 4664-27-1, stock 420.4g, assay 99%, MWt 123.15, Formula C7H9NO, Purity >98%, SMILES OCC1=C(C)C=CN=C1, MDL MFCD01444898 |
| Drug_Names: (4-Methylpyridin-3-yl)methanamine, CAS: 1443-42-1, stock 655.1g, assay 98.6%, MWt 122.17, Formula C7H10N2, Purity >98%, SMILES CC1=CC=NC=C1CN, MDL NA |
| Drug_Names: (4-Methyloxan-4-yl)methanamine, CAS: 65626-24-6, stock 455.9g, assay 98.7%, MWt 129.20, Formula C7H15NO, Purity >98%, SMILES CC1(CN)CCOCC1, MDL NA |
| Drug_Names: (4-Methyl-1H-indol-5-yl)methanamine, CAS: 1369368-84-2, stock 86.1g, assay 98%, MWt 160.22, Formula C10H12N2, Purity >98%, SMILES CC1=C(CN)C=CC2=C1C=CN2, MDL NA |
| Drug_Names: (4-Methoxypyrimidin-2-yl)methanamine dihydrochloride, CAS: 1788043-89-9, stock 854.8g, assay 98.3%, MWt 212.08, Formula C6H11Cl2N3O, Purity >98%, SMILES Cl.Cl.COC1=NC(CN)=NC=C1, MDL NA |
| Drug_Names: (4-Fluoropyridin-3-yl)methanol hydrochloride, CAS: 1946021-34-6, stock 120.9g, assay 98.1%, MWt 163.58, Formula C6H7ClFNO, Purity >98%, SMILES Cl.OCC1=C(F)C=CN=C1, MDL NA |
| Drug_Names: (4-Fluorotetrahydro-2H-pyran-4-yl)methanol, CAS: 883442-46-4, stock 197g, assay 98.3%, MWt 134.15, Formula C6H11FO2, Purity >98%, SMILES OCC1(F)CCOCC1, MDL NA |
| Drug_Names: (4-Fluorotetrahydro-2H-pyran-4-yl)methanamine, CAS: 1228875-13-5, stock 430.9g, assay 98.4%, MWt 133.16, Formula C6H12FNO, Purity >98%, SMILES NCC1(F)CCOCC1, MDL NA |
| Drug_Names: (4-Chloro-1-{[2-(trimethylsilyl)ethoxy]methyl}-1H-pyrrolo[2,3-b]pyridin-2-yl)boronic acid, CAS: 888721-03-7, stock 96.3g, assay 98.9%, MWt 326.66, Formula C13H20BClN2O3Si, Purity >98%, SMILES C[Si](C)(C)CCOCN1C(=CC2=C1N=CC=C2Cl)B(O)O, MDL NA |
| Drug_Names: (4-Bromothiophen-2-yl)methanamine, CAS: 479090-38-5, stock 403.6g, assay 98.6%, MWt 192.08, Formula C5H6BrNS, Purity >98%, SMILES NCC1=CC(Br)=CS1, MDL NA |
| Drug_Names: (4aS,8aS)-Decahydro-1,5-naphthyridine, CAS: 219522-28-8, stock 744.8g, assay 98.3%, MWt 140.23, Formula C8H16N2, Purity >98%, SMILES [H][C@]12CCCN[C@@]1([H])CCCN2, MDL NA |
| Drug_Names: (4aS,7aS)-Octahydropyrrolo[3,4-b][1,4]oxazine dihydrochloride, CAS: 1881275-73-5, stock 774.9g, assay 98.1%, MWt 201.09, Formula C6H14Cl2N2O, Purity >98%, SMILES Cl.Cl.C1NC[C@@H]2OCCN[C@@H]12, MDL NA |
| Drug_Names: (4aR,8aR)-rel-Decahydro-1,5-naphthyridine, CAS: 13623-83-1, stock 878.5g, assay 98.2%, MWt 140.23, Formula C8H16N2, Purity >98%, SMILES [H][C@@]12CCCN[C@]1([H])CCCN2, MDL NA |
| Drug_Names: (4aR,8aR)-rel-1-methyl-decahydro-1,5-naphthyridine oxalic acid, CAS: 2007919-59-5, stock 231.2g, assay 98.5%, MWt 244.29, Formula C11H20N2O4, Purity >98%, SMILES OC(=O)C(O)=O.[H][C@@]12CCCN(C)[C@]1([H])CCCN2, MDL NA |
| Drug_Names: (4aR,7aS)-rel-Hexahydro-2H-[1,4]dioxino[2,3-c]pyrrole hydrochloride, CAS: 694439-04-8, stock 542.6g, assay 98.7%, MWt 165.62, Formula C6H12ClNO2, Purity >98%, SMILES Cl.[H][C@@]12CNC[C@]1([H])OCCO2, MDL NA |
| Drug_Names: (4-Aminotetrahydro-2H-pyran-4-yl)methanol, CAS: 720706-20-7, stock 407.3g, assay 98.9%, MWt 131.17, Formula C6H13NO2, Purity >98%, SMILES NC1(CO)CCOCC1, MDL NA |
| Drug_Names: (4,4-Dimethyloxetan-2-yl)methanol, CAS: 61266-55-5, stock 824.1g, assay 98%, MWt 116.16, Formula C6H12O2, Purity >98%, SMILES CC1(C)CC(CO)O1, MDL NA |
| Drug_Names: (4,4-Dimethyloxetan-2-yl)methanamine, CAS: 1408075-08-0, stock 364.1g, assay 98.4%, MWt 115.17, Formula C6H13NO, Purity >98%, SMILES CC1(C)CC(CN)O1, MDL NA |
| Drug_Names: (4,4-Difluorocyclohexyl)methanamine hydrochloride, CAS: 809273-65-2, stock 458.9g, assay 98.4%, MWt 185.64, Formula C7H14ClF2N, Purity >98%, SMILES Cl.NCC1CCC(F)(F)CC1, MDL NA |
| Drug_Names: (4,4-Difluoro-1-methylcyclohexyl)methanamine, CAS: 1708157-79-2, stock 67.2g, assay 98.8%, MWt 163.21, Formula C8H15F2N, Purity >98%, SMILES CC1(CN)CCC(F)(F)CC1, MDL NA |
| Drug_Names: (3S,6S)-5-[(tert-Butoxy)carbonyl]-1,1-difluoro-5-azaspiro[2.4]heptane-6-carboxylic acid, CAS: 1980007-35-9, stock 549.9g, assay 98.3%, MWt 277.26, Formula C12H17F2NO4, Purity >98%, SMILES CC(C)(C)OC(=O)N1C[C@@]2(CC2(F)F)C[C@H]1C(O)=O, MDL NA |
| Drug_Names: (3S,5S)-5-Methylpyrrolidin-3-ol hydrochloride, CAS: 1107658-77-4, stock 182.6g, assay 98.3%, MWt 137.61, Formula C5H12ClNO, Purity >98%, SMILES Cl.C[C@H]1C[C@H](O)CN1, MDL NA |
| Drug_Names: (3S,5S)-3,5-Dimethylpiperazin-2-one, CAS: 1152112-99-6, stock 470.4g, assay 98.3%, MWt 128.17, Formula C6H12N2O, Purity >98%, SMILES C[C@H]1CNC(=O)[C@H](C)N1, MDL NA |
| Drug_Names: (3S,5S)-1-Benzyl-3,5-dimethylpiperazin-2-one, CAS: 170211-02-6, stock 642g, assay 99%, MWt 218.29, Formula C13H18N2O, Purity >98%, SMILES C[C@H]1CN(CC2=CC=CC=C2)C(=O)[C@H](C)N1, MDL NA |
| Drug_Names: (3S,5R)-5-Methylpyrrolidin-3-ol hydrochloride, CAS: 1107658-78-5, stock 232.6g, assay 98.2%, MWt 137.61, Formula C5H12ClNO, Purity >98%, SMILES Cl.C[C@@H]1C[C@H](O)CN1, MDL NA |
| Drug_Names: (3S,5R)-5-(Hydroxymethyl)pyrrolidin-3-ol hydrochloride, CAS: 1018987-47-7, stock 471.1g, assay 98%, MWt 153.61, Formula C5H12ClNO2, Purity >98%, SMILES Cl.OC[C@H]1C[C@H](O)CN1, MDL NA |
| Drug_Names: (3S,5R)-1-[(tert-Butoxy)carbonyl]-5-methylpyrrolidine-3-carboxylic acid, CAS: 1932787-71-7, stock 186.1g, assay 98.8%, MWt 229.27, Formula C11H19NO4, Purity >98%, SMILES C[C@@H]1C[C@@H](CN1C(=O)OC(C)(C)C)C(O)=O, MDL NA |
| Drug_Names: rel-((3S,4S)-Tetrahydrofuran-3,4-diamine), CAS: 117180-87-7, stock 230.4g, assay 98.4%, MWt 102.14, Formula C4H10N2O, Purity >98%, SMILES N[C@H]1[C@H](N)COC1, MDL MFCD18833626 |
| Drug_Names: (3R,4R)-rel-tert-Butyl 3-fluoro-4-(hydroxymethyl)piperidine-1-carboxylate, CAS: 882033-94-5, stock 770g, assay 98.9%, MWt 233.28, Formula C11H20FNO3, Purity >98%, SMILES O=C(N1C[C@H](F)[C@@H](CO)CC1)OC(C)(C)C, MDL NA |
| Drug_Names: (3S,4S)-4-Aminotetrahydrofuran-3-ol, CAS: 214629-29-5, stock 92g, assay 98.2%, MWt 103.12, Formula C4H9NO2, Purity >98%, SMILES O[C@@H]1COC[C@@H]1N, MDL NA |
| Drug_Names: (3S,4S)-4-Aminooxan-3-ol hydrochloride, CAS: 1864003-03-1, stock 216g, assay 98.9%, MWt 153.61, Formula C5H12ClNO2, Purity >98%, SMILES Cl.N[C@H]1CCOC[C@H]1O, MDL NA |
| Drug_Names: (3S,4S)-4-(Trifluoromethyl)pyrrolidine-3-carboxylic acid, CAS: 1909288-71-6, stock 341.4g, assay 98.2%, MWt 183.13, Formula C6H8F3NO2, Purity >98%, SMILES OC(=O)[C@@H]1CNC[C@H]1C(F)(F)F, MDL NA |
| Drug_Names: (3S,4S)-3-Methoxyoxan-4-amine hydrochloride, CAS: 1232064-65-1, stock 117.7g, assay 98.4%, MWt 167.63, Formula C6H14ClNO2, Purity >98%, SMILES Cl.CO[C@@H]1COCC[C@@H]1N, MDL NA |
| Drug_Names: (3S,4S)-3-Fluorooxan-4-amine hydrochloride, CAS: 1895912-87-4, stock 280.7g, assay 98.5%, MWt 155.60, Formula C5H11ClFNO, Purity >98%, SMILES Cl.N[C@H]1CCOC[C@H]1F, MDL NA |
| Drug_Names: (3S,4S)-3-Aminotetrahydro-2H-pyran-4-ol, CAS: 1240390-32-2, stock 773.3g, assay 98.5%, MWt 117.15, Formula C5H11NO2, Purity >98%, SMILES N[C@H]1COCC[C@@H]1O, MDL NA |
| Drug_Names: (3S,4S)-1-Benzyl-4-[(tert-butyldimethylsilyl)oxy]pyrrolidin-3-ol, CAS: 201601-50-5, stock 797.3g, assay 98.5%, MWt 307.50, Formula C17H29NO2Si, Purity >98%, SMILES CC(C)(C)[Si](C)(C)O[C@H]1CN(CC2=CC=CC=C2)C[C@@H]1O, MDL NA |
| Drug_Names: (3S,4S)-1-[(tert-Butoxy)carbonyl]-4-methylpyrrolidine-3-carboxylic acid, CAS: 1393524-21-4, stock 328.8g, assay 98.1%, MWt 229.27, Formula C11H19NO4, Purity >98%, SMILES C[C@@H]1CN(C[C@H]1C(O)=O)C(=O)OC(C)(C)C, MDL NA |
| Drug_Names: cis-4-Aminomethyl-3-fluoropiperidine-1-carboxylic acid tert-butyl ester, CAS: 1237526-35-0, stock 529.5g, assay 98.3%, MWt 232.30, Formula C11H21FN2O2, Purity >98%, SMILES CC(C)(C)OC(=O)N1CC[C@@H](CN)[C@@H](F)C1, MDL NA |
| Drug_Names: (3S,4R)-4-Methoxypyrrolidin-3-ol hydrochloride, CAS: 473298-29-2, stock 208.3g, assay 98.6%, MWt 153.61, Formula C5H12ClNO2, Purity >98%, SMILES Cl.CO[C@@H]1CNC[C@@H]1O, MDL NA |
| Drug_Names: (3S,4R)-4-Aminotetrahydro-2H-pyran-3-ol hydrochloride, CAS: 1630815-44-9, stock 154.6g, assay 98.5%, MWt 153.61, Formula C5H12ClNO2, Purity >98%, SMILES Cl.N[C@@H]1CCOC[C@H]1O, MDL NA |
| Drug_Names: (3S,4R)-3-Methyloxan-4-amine hydrochloride, CAS: 1523530-71-3, stock 410.7g, assay 98%, MWt 151.63, Formula C6H14ClNO, Purity >98%, SMILES Cl.C[C@@H]1COCC[C@H]1N, MDL NA |
| Drug_Names: (3S,4R)-3-Methoxytetrahydro-2H-pyran-4-amine, CAS: 1523530-32-6, stock 806.3g, assay 98.8%, MWt 131.17, Formula C6H13NO2, Purity >98%, SMILES CO[C@@H]1COCC[C@H]1N, MDL NA |
| Drug_Names: (3S,4R)-3-Fluorotetrahydro-2H-pyran-4-amine hydrochloride, CAS: 1895912-85-2, stock 388g, assay 98.5%, MWt 155.60, Formula C5H11ClFNO, Purity >98%, SMILES Cl.N[C@@H]1CCOC[C@H]1F, MDL NA |
| Drug_Names: (3S,4R)-1-[(tert-Butoxy)carbonyl]-4-{[(9H-fluoren-9-ylmethoxy)carbonyl]amino}pyrrolidine-3-carboxylic acid, CAS: 346610-79-5, stock 447.7g, assay 98.1%, MWt 452.50, Formula C25H28N2O6, Purity >98%, SMILES CC(C)(C)OC(=O)N1C[C@H](NC(=O)OCC2C3=C(C=CC=C3)C3=C2C=CC=C3)[C@H](C1)C(O)=O, MDL NA |
| Drug_Names: (S)-Pyrrolidine-3-carboxylic acid hydrochloride, CAS: 1124369-40-9, stock 63g, assay 98.9%, MWt 151.59, Formula C5H10ClNO2, Purity >98%, SMILES OC([C@H]1CCNC1)=O.Cl, MDL NA |
| Drug_Names: (S)-Pyrrolidine-3-carboxamide hydrochloride, CAS: 1279048-81-5, stock 713.4g, assay 98.8%, MWt 150.61, Formula C5H11ClN2O, Purity >98%, SMILES Cl.NC(=O)[C@H]1CCNC1, MDL NA |
| Drug_Names: (S)-Pyrrolidine-3-carbonitrile hydrochloride, CAS: 1153950-49-2, stock 692.2g, assay 98.3%, MWt 132.59, Formula C5H9ClN2, Purity >98%, SMILES N#C[C@H]1CCNC1.Cl, MDL NA |
| Drug_Names: (S)-Piperidine-3-carboxamide hydrochloride, CAS: 1026661-43-7, stock 831.1g, assay 98.5%, MWt 164.63, Formula C6H13ClN2O, Purity >98%, SMILES Cl.NC(=O)[C@H]1CCCNC1, MDL NA |
| Drug_Names: (S)-Piperidine-3-carbonitrile hydrochloride, CAS: 915226-72-1, stock 212.9g, assay 98.8%, MWt 146.62, Formula C6H11ClN2, Purity >98%, SMILES Cl.N#C[C@H]1CCCNC1, MDL NA |
| Drug_Names: (S)-Tetrahydrofuran-3-carboxylic acid, CAS: 168395-26-4, stock 508.3g, assay 98.4%, MWt 116.12, Formula C5H8O3, Purity >98%, SMILES OC(=O)[C@H]1CCOC1, MDL NA |
| Drug_Names: (S)-Tetrahydrofuran-3-carbonitrile, CAS: 1363378-18-0, stock 845.5g, assay 99%, MWt 97.12, Formula C5H7NO, Purity >98%, SMILES N#C[C@@H]1CCOC1, MDL NA |
| Drug_Names: (S)-(Tetrahydrofuran-3-yl)methanol, CAS: 124391-75-9, stock 717g, assay 98.2%, MWt 102.13, Formula C5H10O2, Purity >98%, SMILES OC[C@@H]1CCOC1, MDL NA |
| Drug_Names: (3S)-Oxolan-3-ylmethanamine hydrochloride, CAS: 1403763-27-8, stock 801g, assay 98.5%, MWt 137.61, Formula C5H12ClNO, Purity >98%, SMILES Cl.NC[C@@H]1CCOC1, MDL NA |
| Drug_Names: (3S)-Oxolan-3-amine, CAS: 104530-79-2, stock 397.5g, assay 99%, MWt 87.12, Formula C4H9NO, Purity >98%, SMILES N[C@H]1CCOC1, MDL NA |
| Drug_Names: (3S)-N-Methylpiperidine-3-carboxamide, CAS: 1124199-17-2, stock 434.9g, assay 98.9%, MWt 142.20, Formula C7H14N2O, Purity >98%, SMILES CNC(=O)[C@H]1CCCNC1, MDL NA |
| Drug_Names: (S)-N-Methyltetrahydrofuran-3-amine hydrochloride, CAS: 1292324-44-7, stock 726g, assay 98.9%, MWt 137.61, Formula C5H12ClNO, Purity >98%, SMILES Cl.CN[C@H]1CCOC1, MDL NA |
| Drug_Names: (S)-5-Oxopyrrolidine-3-carboxylic acid, CAS: 30948-17-5, stock 3.5g, assay 98.3%, MWt 129.11, Formula C5H7NO3, Purity >98%, SMILES OC(=O)[C@@H]1CNC(=O)C1, MDL NA |
| Drug_Names: (S)-5-Oxo-1-((S)-1-phenylethyl)pyrrolidine-3-carboxylic acid, CAS: 173340-19-7, stock 60.4g, assay 98.3%, MWt 233.26, Formula C13H15NO3, Purity >98%, SMILES C[C@H](N1C[C@H](CC1=O)C(O)=O)C1=CC=CC=C1, MDL NA |
| Drug_Names: (S)-3-Methylpyrrolidin-3-ol hydrochloride, CAS: 1956435-14-5, stock 320.5g, assay 98.4%, MWt 137.61, Formula C5H12ClNO, Purity >98%, SMILES Cl.C[C@]1(O)CCNC1, MDL NA |
| Drug_Names: (3S)-3-Methylpyrrolidin-3-ol, CAS: 1312756-35-6, stock 866.6g, assay 98.9%, MWt 101.15, Formula C5H11NO, Purity >98%, SMILES C[C@]1(O)CCNC1, MDL NA |
| Drug_Names: (3S)-3-Methylpiperidin-3-ol, CAS: 1200132-32-6, stock 212.6g, assay 98.2%, MWt 115.17, Formula C6H13NO, Purity >98%, SMILES C[C@]1(O)CCCNC1, MDL NA |
| Drug_Names: (S)-3-Methoxypiperidine hydrochloride, CAS: 688809-96-3, stock 818.5g, assay 98.8%, MWt 151.63, Formula C6H14ClNO, Purity >98%, SMILES Cl.CO[C@H]1CCCNC1, MDL NA |
| Drug_Names: (S)-3-(Methylsulfonyl)pyrrolidine, CAS: 290328-57-3, stock 624.8g, assay 98.7%, MWt 149.21, Formula C5H11NO2S, Purity >98%, SMILES CS(=O)(=O)[C@H]1CCNC1, MDL NA |
| Drug_Names: (3S)-3-Methanesulfonylpiperidine hydrochloride, CAS: 1946010-89-4, stock 720.9g, assay 98.6%, MWt 199.70, Formula C6H14ClNO2S, Purity >98%, SMILES Cl.CS(=O)(=O)[C@H]1CCCNC1, MDL NA |
| Drug_Names: (3S)-3-Ethylpyrrolidine hydrochloride, CAS: 235094-03-8, stock 498.1g, assay 98.1%, MWt 135.64, Formula C6H14ClN, Purity >98%, SMILES Cl.CC[C@H]1CCNC1, MDL NA |
| Drug_Names: (S)-3-Ethoxypyrrolidine, CAS: 143943-75-3, stock 696.2g, assay 99%, MWt 115.17, Formula C6H13NO, Purity >98%, SMILES CCO[C@H]1CCNC1, MDL NA |
| Drug_Names: (3S)-3-Aminoazetidin-2-one hydrochloride, CAS: 2044711-48-8, stock 857.7g, assay 98.3%, MWt 122.55, Formula C3H7ClN2O, Purity >98%, SMILES Cl.N[C@H]1CNC1=O, MDL NA |
| Drug_Names: (S)-3-(Methoxymethyl)pyrrolidine hydrochloride, CAS: 1421050-43-2, stock 552.6g, assay 98.9%, MWt 151.63, Formula C6H14ClNO, Purity >98%, SMILES Cl.COC[C@H]1CCNC1, MDL NA |
| Drug_Names: (S)-3-(4-Hydroxyphenyl)hex-4-ynoic acid, CAS: 865233-35-8, stock 169.1g, assay 98.6%, MWt 204.22, Formula C12H12O3, Purity >98%, SMILES CC#C[C@@H](CC(O)=O)C1=CC=C(O)C=C1, MDL NA |
| Drug_Names: (S)-3-(2-Methoxyethoxy)pyrrolidine hydrochloride, CAS: 1810074-91-9, stock 17.9g, assay 98.7%, MWt 181.66, Formula C7H16ClNO2, Purity >98%, SMILES Cl.COCCO[C@H]1CCNC1, MDL NA |
| Drug_Names: (S)-2-Azabicyclo[2.2.2]octane-3-carboxylic acid, CAS: 109583-12-2, stock 655.6g, assay 98.3%, MWt 155.19, Formula C8H13NO2, Purity >98%, SMILES OC(=O)[C@H]1NC2CCC1CC2, MDL NA |
| Drug_Names: (3S)-1-Oxo-2-azaspiro[4.5]decane-3-carboxylic acid, CAS: 331951-85-0, stock 240.4g, assay 98.9%, MWt 197.23, Formula C10H15NO3, Purity >98%, SMILES OC(=O)[C@@H]1CC2(CCCCC2)C(=O)N1, MDL NA |
| Drug_Names: (S)-1-Methylpyrrolidine-3-carboxylic acid, CAS: 952484-58-1, stock 452.7g, assay 98.8%, MWt 129.16, Formula C6H11NO2, Purity >98%, SMILES CN1CC[C@@H](C1)C(O)=O, MDL NA |
| Drug_Names: (S)-1-Methylpyrrolidin-3-amine, CAS: 214357-95-6, stock 536.2g, assay 98.3%, MWt 100.16, Formula C5H12N2, Purity >98%, SMILES CN1CC[C@H](N)C1, MDL NA |
| Drug_Names: (S)-1-Methylpiperidine-3-carboxylic acid, CAS: 145678-68-8, stock 604.9g, assay 98.4%, MWt 143.18, Formula C7H13NO2, Purity >98%, SMILES CN1CCC[C@@H](C1)C(O)=O, MDL NA |
| Drug_Names: (S)-1-Methylpiperidin-3-ol, CAS: 62367-59-3, stock 174.2g, assay 99%, MWt 115.17, Formula C6H13NO, Purity >98%, SMILES CN1CCC[C@H](O)C1, MDL NA |
| Drug_Names: (S)-1-(Methylsulfonyl)pyrrolidin-3-amine hydrochloride, CAS: 651056-84-7, stock 84.7g, assay 98.3%, MWt 200.69, Formula C5H13ClN2O2S, Purity >98%, SMILES Cl.CS(=O)(=O)N1CC[C@H](N)C1, MDL NA |
| Drug_Names: (3S)-1-Ethylpyrrolidin-3-amine dihydrochloride, CAS: 1336912-66-3, stock 29.6g, assay 98.9%, MWt 187.11, Formula C6H16Cl2N2, Purity >98%, SMILES Cl.Cl.CCN1CC[C@H](N)C1, MDL NA |
| Drug_Names: (3S)-1-Acetylpiperidine-3-carboxylic acid, CAS: 111479-21-1, stock 309.6g, assay 98.1%, MWt 171.19, Formula C8H13NO3, Purity >98%, SMILES CC(=O)N1CCC[C@@H](C1)C(O)=O, MDL NA |
| Drug_Names: (S)-1-(2,4-Dimethoxybenzyl)-5-oxopyrrolidine-3-carboxylic acid, CAS: 755025-16-2, stock 62g, assay 98.3%, MWt 279.29, Formula C14H17NO5, Purity >98%, SMILES COC1=CC=C(CN2C[C@H](CC2=O)C(O)=O)C(OC)=C1, MDL NA |
| Drug_Names: (3S)-1,2,3,4-Tetrahydroquinolin-3-ol, CAS: 206563-20-4, stock 269g, assay 98.3%, MWt 149.19, Formula C9H11NO, Purity >98%, SMILES O[C@@H]1CNC2=C(C1)C=CC=C2, MDL NA |
| Drug_Names: (3S)-1-(Propan-2-yl)pyrrolidin-3-amine dihydrochloride, CAS: 914498-27-4, stock 128.6g, assay 98.4%, MWt 201.14, Formula C7H18Cl2N2, Purity >98%, SMILES Cl.Cl.CC(C)N1CC[C@H](N)C1, MDL NA |
| Drug_Names: (3S)-1-(Propan-2-yl)pyrrolidin-3-amine, CAS: 914603-85-3, stock 154.3g, assay 99%, MWt 128.22, Formula C7H16N2, Purity >98%, SMILES CC(C)N1CC[C@H](N)C1, MDL NA |
| Drug_Names: (3S)-1-(Oxetan-3-yl)pyrrolidin-3-amine, CAS: 1256667-60-3, stock 171.6g, assay 98.5%, MWt 142.20, Formula C7H14N2O, Purity >98%, SMILES N[C@H]1CCN(C1)C1COC1, MDL NA |
| Drug_Names: (3R,6S)-5-[(tert-butoxy)carbonyl]-1,1-difluoro-5-azaspiro[2.4]heptane-6-carboxylic acid, CAS: 1430105-52-4, stock 129g, assay 99%, MWt 277.26, Formula C12H17F2NO4, Purity >98%, SMILES CC(C)(C)OC(=O)N1C[C@]2(CC2(F)F)C[C@H]1C(O)=O, MDL NA |
| Drug_Names: (3R,5S)-5-methylpyrrolidin-3-ol hydrochloride, CAS: 1107658-76-3, stock 309.6g, assay 98.5%, MWt 137.61, Formula C5H12ClNO, Purity >98%, SMILES Cl.C[C@H]1C[C@@H](O)CN1, MDL NA |
| Drug_Names: (3R,5S)-5-{[bis(4-methoxyphenyl)(phenyl)methoxy]methyl}pyrrolidin-3-ol, CAS: 151953-64-9, stock 323g, assay 99%, MWt 419.51, Formula C26H29NO4, Purity >98%, SMILES COC1=CC=C(C=C1)C(OC[C@@H]1C[C@@H](O)CN1)(C1=CC=CC=C1)C1=CC=C(OC)C=C1, MDL NA |
| Drug_Names: (3R,4S,5R)-2-(acetyloxy)-4-(benzyloxy)-5-[(benzyloxy)methyl]-5-ethenyloxolan-3-yl acetate, CAS: 1146197-36-5, stock 119.6g, assay 98.1%, MWt 440.49, Formula C25H28O7, Purity >98%, SMILES CC(=O)OC1O[C@@](COCC2=CC=CC=C2)(C=C)[C@@H](OCC2=CC=CC=C2)[C@H]1OC(C)=O, MDL NA |
| Drug_Names: (3R,4S)-4-Amino-1-methylpyrrolidin-3-ol dihydrochloride, CAS: 2068138-04-3, stock 336.1g, assay 98.2%, MWt 189.08, Formula C5H14Cl2N2O, Purity >98%, SMILES Cl.Cl.CN1C[C@H](N)[C@H](O)C1, MDL NA |
| Drug_Names: (3R,4S)-4-Aminotetrahydro-2H-pyran-3-ol hydrochloride, CAS: 1096594-11-4, stock 884.4g, assay 98.3%, MWt 153.61, Formula C5H12ClNO2, Purity >98%, SMILES Cl.N[C@H]1CCOC[C@@H]1O, MDL NA |
| Drug_Names: (3R,4S)-3-Fluorooxan-4-ol, CAS: 1893404-91-5, stock 518.2g, assay 98.2%, MWt 120.12, Formula C5H9FO2, Purity >98%, SMILES O[C@H]1CCOC[C@H]1F, MDL NA |
| Drug_Names: (3R,4R)-rel-4-Fluoropiperidin-3-ol hydrochloride, CAS: 955028-83-8, stock 598.8g, assay 98.4%, MWt 155.60, Formula C5H11ClFNO, Purity >98%, SMILES O[C@@H]1CNCC[C@H]1F.[H]Cl, MDL NA |
| Drug_Names: (3R,4R)-rel-1-[(tert-butoxy)carbonyl]-4-methylpiperidine-3-carboxylic acid, CAS: 1469287-58-8, stock 391.1g, assay 98.3%, MWt 243.30, Formula C12H21NO4, Purity >98%, SMILES C[C@@H]1CCN(C[C@@H]1C(O)=O)C(=O)OC(C)(C)C, MDL NA |
| Drug_Names: (3R,4R)-3-Methoxyoxan-4-amine hydrochloride, CAS: 1232064-63-9, stock 722g, assay 98.8%, MWt 167.63, Formula C6H14ClNO2, Purity >98%, SMILES Cl.CO[C@H]1COCC[C@H]1N, MDL NA |
| Drug_Names: (3R,4R)-3-Aminotetrahydro-2H-pyran-4-ol, CAS: 1350734-61-0, stock 317.1g, assay 98.4%, MWt 117.15, Formula C5H11NO2, Purity >98%, SMILES N[C@@H]1COCC[C@H]1O, MDL NA |
| Drug_Names: (3R,4R)-1-[(tert-Butoxy)carbonyl]-4-(trifluoromethyl)pyrrolidine-3-carboxylic acid, CAS: 1808807-76-2, stock 36.1g, assay 98.6%, MWt 283.24, Formula C11H16F3NO4, Purity >98%, SMILES CC(C)(C)OC(=O)N1C[C@@H]([C@H](C1)C(F)(F)F)C(O)=O, MDL NA |
| Drug_Names: (3R,4S,5R,6R)-3,4,5-Tris(benzyloxy)-tetrahydro-6-methylpyran-2-one, CAS: 1461750-25-3, stock 450.3g, assay 98.3%, MWt 432.51, Formula C27H28O5, Purity >98%, SMILES O=C1[C@H](OCC2=CC=CC=C2)[C@@H](OCC3=CC=CC=C3)[C@H](OCC4=CC=CC=C4)[C@@H](C)O1, MDL NA |
| Drug_Names: (R)-Pyrrolidine-3-carboxylic acid hydrochloride, CAS: 1202245-51-9, stock 550.6g, assay 98.8%, MWt 151.59, Formula C5H10ClNO2, Purity >98%, SMILES O=C([C@H]1CNCC1)O.[H]Cl, MDL NA |
| Drug_Names: (R)-Pyrrolidine-3-carbonitrile hydrochloride, CAS: 1153950-54-9, stock 874.4g, assay 98.4%, MWt 132.59, Formula C5H9ClN2, Purity >98%, SMILES Cl.N#C[C@@H]1CCNC1, MDL NA |
| Drug_Names: (R)-Piperidine-3-carboxamide hydrochloride, CAS: 1214903-21-5, stock 502.7g, assay 98%, MWt 164.63, Formula C6H13ClN2O, Purity >98%, SMILES Cl.NC(=O)[C@@H]1CCCNC1, MDL NA |
| Drug_Names: (R)-(Tetrahydrofuran-3-yl)methanol, CAS: 124506-31-6, stock 588g, assay 98.4%, MWt 102.13, Formula C5H10O2, Purity >98%, SMILES OC[C@H]1CCOC1, MDL NA |
| Drug_Names: (R)-(Tetrahydrofuran-3-yl)methanamine, CAS: 1048962-82-8, stock 121.6g, assay 98.6%, MWt 101.15, Formula C5H11NO, Purity >98%, SMILES NC[C@H]1CCOC1, MDL NA |
| Drug_Names: (3R)-N-Methylpiperidine-3-carboxamide, CAS: 1124199-15-0, stock 99.7g, assay 98.7%, MWt 142.20, Formula C7H14N2O, Purity >98%, SMILES CNC(=O)[C@@H]1CCCNC1, MDL NA |
| Drug_Names: (3R)-N-{3,6-dichloro-1H-pyrazolo[3,4-d]pyrimidin-4-yl}piperidin-3-amine hydrochloride, CAS: 2007916-10-9, stock 124.6g, assay 99%, MWt 323.61, Formula C10H13Cl3N6, Purity >98%, SMILES Cl.ClC1=NNC2=C1C(N[C@@H]1CCCNC1)=NC(Cl)=N2, MDL NA |
| Drug_Names: (R)-Morpholine-3-carboxylic acid, CAS: 106825-81-4, stock 741.2g, assay 98.4%, MWt 131.13, Formula C5H9NO3, Purity >98%, SMILES OC(=O)[C@H]1COCCN1, MDL MFCD03426306 |
| Drug_Names: (3R)-5-Oxo-1-[(1R)-1-phenylethyl]pyrrolidine-3-carboxylic acid, CAS: 99735-43-0, stock 758.3g, assay 98.4%, MWt 233.26, Formula C13H15NO3, Purity >98%, SMILES C[C@@H](N1C[C@@H](CC1=O)C(O)=O)C1=CC=CC=C1, MDL NA |
| Drug_Names: (3R)-3-Methylpyrrolidin-3-ol, CAS: 392338-65-7, stock 172.3g, assay 98.3%, MWt 101.15, Formula C5H11NO, Purity >98%, SMILES C[C@@]1(O)CCNC1, MDL NA |
| Drug_Names: (R)-3-(Methylsulfonyl)pyrrolidine, CAS: 1234576-84-1, stock 254.1g, assay 98%, MWt 149.21, Formula C5H11NO2S, Purity >98%, SMILES CS(=O)(=O)[C@@H]1CCNC1, MDL NA |
| Drug_Names: (R)-3-Fluoropiperidine hydrochloride, CAS: 787564-37-8, stock 745.4g, assay 98.7%, MWt 139.60, Formula C5H11ClFN, Purity >98%, SMILES Cl.F[C@@H]1CCCNC1, MDL NA |
| Drug_Names: (3R)-3-Ethylpyrrolidine hydrochloride, CAS: 235093-99-9, stock 230.5g, assay 98.7%, MWt 135.64, Formula C6H14ClN, Purity >98%, SMILES Cl.CC[C@@H]1CCNC1, MDL NA |
| Drug_Names: (3R)-3-Amino-2,3-dihydro-1H-inden-5-ol hydrochloride, CAS: 169105-03-7, stock 34.9g, assay 98.6%, MWt 185.65, Formula C9H12ClNO, Purity >98%, SMILES Cl.N[C@@H]1CCC2=C1C=C(O)C=C2, MDL NA |
| Drug_Names: (R)-1,3'-Bipyrrolidine dihydrochloride, CAS: 913702-34-8, stock 199.7g, assay 98.5%, MWt 213.15, Formula C8H18Cl2N2, Purity >98%, SMILES Cl.Cl.C1CCN(C1)[C@@H]1CCNC1, MDL NA |
| Drug_Names: (3R)-3-(Propan-2-yl)pyrrolidine hydrochloride, CAS: 1949805-98-4, stock 513.8g, assay 98.7%, MWt 149.66, Formula C7H16ClN, Purity >98%, SMILES Cl.CC(C)[C@H]1CCNC1, MDL NA |
| Drug_Names: (R)-3-(Methoxymethyl)pyrrolidine hydrochloride, CAS: 955400-18-7, stock 628g, assay 98.4%, MWt 151.63, Formula C6H14ClNO, Purity >98%, SMILES Cl.COC[C@@H]1CCNC1, MDL NA |
| Drug_Names: (R)-3-(Phenylsulfonyl)pyrrolidine, CAS: 1268521-39-6, stock 640.5g, assay 98.3%, MWt 211.28, Formula C10H13NO2S, Purity >98%, SMILES O=S(=O)([C@@H]1CCNC1)C1=CC=CC=C1, MDL NA |
| Drug_Names: (R)-3-(2-Methoxyethoxy)pyrrolidine hydrochloride, CAS: 1315591-34-4, stock 217.9g, assay 98.6%, MWt 181.66, Formula C7H16ClNO2, Purity >98%, SMILES Cl.COCCO[C@@H]1CCNC1, MDL NA |
| Drug_Names: (R)-2-Azabicyclo[2.2.2]octane-3-carboxylic acid, CAS: 146144-65-2, stock 679.4g, assay 98.2%, MWt 155.19, Formula C8H13NO2, Purity >98%, SMILES O=C([C@@H]1NC2CCC1CC2)O, MDL NA |
| Drug_Names: (R)-1-Methylpyrrolidin-3-amine, CAS: 457097-75-5, stock 632.3g, assay 98.7%, MWt 100.16, Formula C5H12N2, Purity >98%, SMILES CN1CC[C@@H](N)C1, MDL NA |
| Drug_Names: (R)-1-Methylpiperidin-3-ol, CAS: 28808-26-6, stock 427.3g, assay 98.4%, MWt 115.17, Formula C6H13NO, Purity >98%, SMILES CN1CCC[C@@H](O)C1, MDL NA |
| Drug_Names: (R)-1-Methylpiperidin-3-amine dihydrochloride, CAS: 1157849-50-7, stock 850.5g, assay 98.8%, MWt 187.11, Formula C6H16Cl2N2, Purity >98%, SMILES Cl.Cl.CN1CCC[C@@H](N)C1, MDL NA |
| Drug_Names: (R)-1-(Methylsulfonyl)pyrrolidin-3-amine hydrochloride, CAS: 651056-85-8, stock 537.5g, assay 98.3%, MWt 200.69, Formula C5H13ClN2O2S, Purity >98%, SMILES Cl.CS(=O)(=O)N1CC[C@@H](N)C1, MDL NA |
| Drug_Names: (3R)-1-Ethylpyrrolidin-3-amine dihydrochloride, CAS: 1286208-97-6, stock 201.4g, assay 98.6%, MWt 187.11, Formula C6H16Cl2N2, Purity >98%, SMILES Cl.Cl.CCN1CC[C@@H](N)C1, MDL NA |
| Drug_Names: (3R)-1-Acetylpiperidine-3-carboxylic acid, CAS: 712270-39-8, stock 866.4g, assay 98.3%, MWt 171.19, Formula C8H13NO3, Purity >98%, SMILES CC(=O)N1CCC[C@H](C1)C(O)=O, MDL NA |
| Drug_Names: (R)-1-(2,4-Dimethoxybenzyl)-5-oxopyrrolidine-3-carboxylic acid, CAS: 1629681-80-6, stock 820.4g, assay 98.2%, MWt 279.29, Formula C14H17NO5, Purity >98%, SMILES COC1=CC=C(CN2C[C@@H](CC2=O)C(O)=O)C(OC)=C1, MDL NA |
| Drug_Names: (3R)-1,2,3,4-Tetrahydroquinolin-3-ol, CAS: 1119238-24-2, stock 263.2g, assay 98.5%, MWt 149.19, Formula C9H11NO, Purity >98%, SMILES O[C@H]1CNC2=C(C1)C=CC=C2, MDL NA |
| Drug_Names: (3R)-1-(Propan-2-yl)pyrrolidin-3-amine dihydrochloride, CAS: 1201013-61-7, stock 283.3g, assay 98.5%, MWt 201.14, Formula C7H18Cl2N2, Purity >98%, SMILES Cl.Cl.CC(C)N1CC[C@@H](N)C1, MDL NA |
| Drug_Names: (3R)-1-(Oxetan-3-yl)pyrrolidin-3-amine, CAS: 1256667-56-7, stock 114.5g, assay 98.8%, MWt 142.20, Formula C7H14N2O, Purity >98%, SMILES N[C@@H]1CCN(C1)C1COC1, MDL NA |
| Drug_Names: (R)-1-(Oxetan-3-yl)piperidin-3-amine, CAS: 1349700-06-6, stock 49.6g, assay 98.7%, MWt 156.23, Formula C8H16N2O, Purity >98%, SMILES N[C@@H]1CCCN(C1)C1COC1, MDL NA |
| Drug_Names: (3R)-1-(Azetidin-3-yl)-3-fluoropyrrolidine dihydrochloride, CAS: 1403763-26-7, stock 85.3g, assay 98.8%, MWt 217.11, Formula C7H15Cl2FN2, Purity >98%, SMILES Cl.Cl.F[C@@H]1CCN(C1)C1CNC1, MDL NA |
| Drug_Names: (3-Phenyloxetan-3-yl)methanol, CAS: 114012-43-0, stock 355.7g, assay 98.2%, MWt 164.20, Formula C10H12O2, Purity >98%, SMILES OCC1(COC1)C1=CC=CC=C1, MDL NA |
| Drug_Names: (3-Methylpyrrolidin-3-yl)methanamine dihydrochloride, CAS: 1630907-02-6, stock 812.6g, assay 98.4%, MWt 187.11, Formula C6H16Cl2N2, Purity >98%, SMILES Cl.Cl.CC1(CN)CCNC1, MDL NA |
| Drug_Names: (3-Methylpyridin-4-yl)methanol, CAS: 38070-73-4, stock 239.5g, assay 98%, MWt 123.15, Formula C7H9NO, Purity >98%, SMILES CC1=CN=CC=C1CO, MDL NA |
| Drug_Names: (3-Methylpyrazin-2-yl)methanol, CAS: 160818-32-6, stock 178.6g, assay 98.1%, MWt 124.14, Formula C6H8N2O, Purity >98%, SMILES CC1=C(CO)N=CC=N1, MDL NA |
| Drug_Names: (3-Methylpiperidin-3-yl)methanol hydrochloride, CAS: 955027-74-4, stock 581.4g, assay 98.4%, MWt 165.66, Formula C7H16ClNO, Purity >98%, SMILES Cl.CC1(CO)CCCNC1, MDL NA |
| Drug_Names: (3-Methyltetrahydrofuran-3-yl)methanamine, CAS: 864814-30-2, stock 406.3g, assay 99%, MWt 115.17, Formula C6H13NO, Purity >98%, SMILES CC1(CN)CCOC1, MDL NA |
| Drug_Names: (3-Methylazetidin-3-yl)methanol hydrochloride, CAS: 1458653-12-7, stock 351.2g, assay 98.1%, MWt 137.61, Formula C5H12ClNO, Purity >98%, SMILES Cl.CC1(CO)CNC1, MDL NA |
| Drug_Names: (3-Methylazetidin-3-yl)methanamine dihydrochloride, CAS: 96308-73-5, stock 112.4g, assay 98.6%, MWt 173.08, Formula C5H14Cl2N2, Purity >98%, SMILES Cl.Cl.CC1(CN)CNC1, MDL NA |
| Drug_Names: (3-Methyl-1H-indol-5-yl)boronic acid, CAS: 590417-54-2, stock 503g, assay 98.4%, MWt 174.99, Formula C9H10BNO2, Purity >98%, SMILES CC1=CNC2=C1C=C(C=C2)B(O)O, MDL NA |
| Drug_Names: (3-Methyl-1H-indazol-7-yl)boronic acid, CAS: 1310404-47-7, stock 193.8g, assay 98.9%, MWt 175.98, Formula C8H9BN2O2, Purity >98%, SMILES CC1=NNC2=C1C=CC=C2B(O)O, MDL NA |
| Drug_Names: (3-Methyl-1H-indazol-4-yl)boronic acid, CAS: 1310383-41-5, stock 714.3g, assay 98.2%, MWt 175.98, Formula C8H9BN2O2, Purity >98%, SMILES CC1=NNC2=C1C(=CC=C2)B(O)O, MDL NA |
| Drug_Names: (3-Methoxypyridin-4-yl)methanamine, CAS: 909895-75-6, stock 864.7g, assay 98.6%, MWt 138.17, Formula C7H10N2O, Purity >98%, SMILES COC1=C(CN)C=CN=C1, MDL NA |
| Drug_Names: (3-Methoxyoxetan-3-yl)methanol, CAS: 1620017-02-8, stock 630.8g, assay 98.5%, MWt 118.13, Formula C5H10O3, Purity >98%, SMILES COC1(CO)COC1, MDL NA |
| Drug_Names: (3-Methoxyoxetan-3-yl)methanamine, CAS: 1554288-27-5, stock 88.8g, assay 98.9%, MWt 117.15, Formula C5H11NO2, Purity >98%, SMILES NCC1(OC)COC1, MDL MFCD28629621 |
| Drug_Names: (3-Fluoropyridin-2-yl)methanamine hydrochloride, CAS: 1260903-05-6, stock 99.5g, assay 98.9%, MWt 162.59, Formula C6H8ClFN2, Purity >98%, SMILES Cl.NCC1=NC=CC=C1F, MDL MFCD11505887 |
| Drug_Names: (3-Fluorocyclobutyl)methanol, CAS: 1260654-20-3, stock 858.2g, assay 98.7%, MWt 104.12, Formula C5H9FO, Purity >98%, SMILES OCC1CC(F)C1, MDL NA |
| Drug_Names: (3-Ethyloxetan-3-yl)methanamine, CAS: 929900-20-9, stock 489.3g, assay 98.9%, MWt 115.17, Formula C6H13NO, Purity >98%, SMILES CCC1(CN)COC1, MDL NA |
| Drug_Names: (3-Chlorothiophen-2-yl)methanol, CAS: 193602-41-4, stock 111.7g, assay 98.3%, MWt 148.61, Formula C5H5ClOS, Purity >98%, SMILES OCC1=C(Cl)C=CS1, MDL NA |
| Drug_Names: (3-Chlorothiophen-2-yl)methanamine hydrochloride, CAS: 643088-03-3, stock 49.4g, assay 98.7%, MWt 184.09, Formula C5H7Cl2NS, Purity >98%, SMILES Cl.NCC1=C(Cl)C=CS1, MDL NA |
| Drug_Names: (3-Chloropyrazin-2-yl)methanol, CAS: 89283-32-9, stock 876.2g, assay 98.4%, MWt 144.56, Formula C5H5ClN2O, Purity >98%, SMILES OCC1=NC=CN=C1Cl, MDL NA |
| Drug_Names: (3aS,6aS)-2,2-Dimethyl-3aH-cyclopenta[d][1,3]dioxol-4(6aH)-one, CAS: 104010-72-2, stock 695.3g, assay 98.6%, MWt 154.16, Formula C8H10O3, Purity >98%, SMILES CC1(C)O[C@H]2C=CC(=O)[C@H]2O1, MDL NA |
| Drug_Names: (3aS,4R,6aR)-6-[(Benzyloxy)methyl]-5-fluoro-2,2-dimethyl-2H,3aH,4H,6aH-cyclopenta[d][1,3]dioxol-4-ol, CAS: 491578-02-0, stock 703.9g, assay 98.8%, MWt 294.32, Formula C16H19FO4, Purity >98%, SMILES O[C@H]1C(F)=C(COCC2=CC=CC=C2)[C@]3([H])[C@@]1([H])OC(C)(C)O3, MDL NA |
| Drug_Names: (3aR,7aS)-1-Methylhexahydrooxazolo[5,4-c]pyridin-2(1H)-one hydrochloride, CAS: 1523541-92-5, stock 596.5g, assay 98.2%, MWt 192.64, Formula C7H13ClN2O2, Purity >98%, SMILES Cl[H].[H][C@@]12CNCC[C@]1([H])N(C)C(=O)O2, MDL NA |
| Drug_Names: (3aR,7aR)-2-Methylhexahydro-1H-pyrrolo[3,4-c]pyridin-3(2H)-one, CAS: 1400744-16-2, stock 58.1g, assay 98.1%, MWt 154.21, Formula C8H14N2O, Purity >98%, SMILES [H][C@]12CN(C)C(=O)[C@@]1([H])CNCC2, MDL NA |
| Drug_Names: (3aR,6aR)-2,2-Dimethyl-hexahydrocyclopenta[d][1,3]dioxol-4-one, CAS: 595581-64-9, stock 696.3g, assay 98.3%, MWt 156.18, Formula C8H12O3, Purity >98%, SMILES CC1(C)O[C@@H]2CCC(=O)[C@@H]2O1, MDL NA |
| Drug_Names: (3aR,5R,7aS)-rel-5-Hydroxy-2H-isoindole hydrochloride, CAS: 52865-10-8, stock 703.3g, assay 98.4%, MWt 177.67, Formula C8H16ClNO, Purity >98%, SMILES Cl.O[C@@H]1CC[C@@H]2CNC[C@@H]2C1, MDL NA |
| Drug_Names: (3aR,5R,6aS)-5-(((tert-Butyldiphenylsilyl)oxy)methyl)-2,2-dimethyldihydrofuro[2,3-d][1,3]dioxol-6(3aH)-one, CAS: 75783-45-8, stock 314.4g, assay 98.1%, MWt 426.58, Formula C24H30O5Si, Purity >98%, SMILES CC(C)(C)[Si](OC[C@H]1O[C@@H]2OC(C)(C)O[C@@H]2C1=O)(C1=CC=CC=C1)C1=CC=CC=C1, MDL NA |
| Drug_Names: (3-Aminooxolan-3-yl)methanol, CAS: 1132878-81-9, stock 679.5g, assay 98.2%, MWt 117.15, Formula C5H11NO2, Purity >98%, SMILES NC1(CO)CCOC1, MDL NA |
| Drug_Names: (3-Aminocyclobutyl)methanol hydrochloride, CAS: 130369-06-1, stock 585g, assay 98.4%, MWt 137.61, Formula C5H12ClNO, Purity >98%, SMILES Cl.NC1CC(CO)C1, MDL NA |
| Drug_Names: (3-Amino-6-methylpyridin-2-yl)methanol, CAS: 32398-86-0, stock 488g, assay 98.8%, MWt 138.17, Formula C7H10N2O, Purity >98%, SMILES CC1=CC=C(N)C(CO)=N1, MDL NA |
| Drug_Names: (3-Amino-5-chloropyridin-2-yl)methanol, CAS: 1638767-59-5, stock 400.3g, assay 98.2%, MWt 158.59, Formula C6H7ClN2O, Purity >98%, SMILES NC1=CC(Cl)=CN=C1CO, MDL NA |
| Drug_Names: (3-Amino-5-bromopyridin-2-yl)methanol, CAS: 1363381-68-3, stock 405.7g, assay 98%, MWt 203.04, Formula C6H7BrN2O, Purity >98%, SMILES NC1=CC(Br)=CN=C1CO, MDL NA |
| Drug_Names: (3,3-Dimethoxy-1-{[(4-methylbenzenesulfonyl)oxy]methyl}cyclobutyl)methyl 4-methylbenzene-1-sulfonate, CAS: 1023815-74-8, stock 875.6g, assay 98.9%, MWt 484.58, Formula C22H28O8S2, Purity >98%, SMILES COC1(CC(COS(=O)(=O)C2=CC=C(C)C=C2)(COS(=O)(=O)C2=CC=C(C)C=C2)C1)OC, MDL NA |
| Drug_Names: (3,3-Difluoropiperidin-4-yl)methanol hydrochloride, CAS: 1783945-29-8, stock 246.9g, assay 98.8%, MWt 187.62, Formula C6H12ClF2NO, Purity >98%, SMILES Cl.OCC1CCNCC1(F)F, MDL NA |
